|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2015/4/2 ¤W¤È 09:36:27
|
¯E¹©°O¡G 1¡n¯E¹©2015¦~3¤ë¥¿¦¡±q¿³ÂdÂà¤WÂd,«o±q400¤¸¶^¨ì250¤¸ 2¡nÀHµÛ¸Ñª¼®É¶¡±µªñ,¥«³õ¤W°ª«×ªºÃöª`»P°l±·,¿v©³Ãk¤É¨ì750¤¸ªº¤Ñ»ù 3¡n2016/2/21¸Ñª¼«á, ¥Ñ©ó¸Ñª¼¥¼¹F¹w¥ý³]©wªº¥Ø¼Ð, ¦A¥[¤W¦W¼L¥ß©e´CÅé½Ñ¦h¥H³_¶Ç³_,¥H°¾·§¥þ, ¥B¥¼¸gÃҹꪺ«ü±± ÁöµM¤½¥q»¡¯à°÷²£¥Í§ÜÅ骺±Ú¸s´N¯à°÷²£¥ÍÁ{§É¤WªºÀø®Ä,©ó¬O¦³©Ò¿×ªº"¤@ӸѪ¼,¨âºØ¸ÑŪ,¦U¦Ûªíz" ¤@¸ô¤U¶^¨ì350¤¸¥ª¥k 4¡n¦ý¦b2016/3/31²×©óªï¨ÓÀò±oASCO Oral presentationªº®¶¾Ä®ø®§,4¤ë1¤é·M¤H¸`·í¤Ñ,ªï¨Ó¤F¤[¹Hªº¤@¸ôº¦°±ªO 5¡n6¤ëªìªºASCO, ÁÞ¤k§Y±N´¦¶}¦oªº¯«¯µ±¯½ ¨Ì¾Ú²Î¤@§ëÅU±i¥ß¸s¤ÀªR®v¬ã¨s¡G https://www.google.com.tw/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&cad=rja&uact=8&ved=0ahUKEwins9egnPzLAhVikIMKHcc1DN8QFgggMAE&url=http%3A%2F%2Fpcmc.uni-psg.com%2Fvip%2F20160226-01.pdf&usg=AFQjCNHCCWDKl493HzcquFVIcJoolRPgnQ »PµL±¡¤jªº¤ÀªR¡G http://tsjh301.blogspot.tw/2014/08/obipharma.html ¥»µÛªø´Á§ë¸ê, °l®Ú¨s©³ªººë¯«¨Ó±´¯Á¯E¹©ªº§ë¸ê»ùÈ, ¤£¦]µu´ÁªÑ»ùªi°Ê°_¥ñ¦Ó¼vÅT¹ï "¥þ²y²Ä¤@ÁûFirst in class, Best in classªº§ÜÀùÁÞ¤À¤l¥þ·sÃĪ«"§ë¸êªº¼ö±¡ ¨ÃÅé²{¤½¥qÄ@´º: "³Ð³y¥xÆW¥Í§Þ«~µP,¦¨¬°Àù¯gÀøªkªº¥þ²y»â¯èªÌ" "2025¦~¦¨¬°¥xÆW¥Í§Þ²Ä¤@«~µP, 2035¦~¦¨¬°¥þ²yÀù¯gªvÀø»â¾É¤½¥q" Åwªï¤À¨É¥ô¦ó¹ï¯E¹©Ä@´º»P»ùȵû¦ôªº¬Ýªk»P°ª¨£~~ |
|
·|û¡G¶³²H·»´10142966 µoªí®É¶¡:2017/2/24 ¤W¤È 09:23:20²Ä 4300 ½g¦^À³
|
·PÁ¹x¥Û¤j ¤p§Ì¯uªº»Ýn¦A§V¤O¤F §ÚÀ³¸Ó¦A¦hªáÂI®É¶¡¬ã¨s ¤]·PÁ¤ѩR¤j ¥xÁÞ¤jµ¥°ª¤âºëÅP¤ÀªR ^^ |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2017/2/24 ¤W¤È 08:00:27²Ä 4299 ½g¦^À³
|
¶³²H·»´¤j¡A ¥h¦~6/15¤½¥qªk»¡·|²³ø·í¤¤¦³µª®×¡C°µ§ë¸ê´Nn°µ¥\½Ò¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/2/23 ¤U¤È 09:48:31²Ä 4298 ½g¦^À³
|
¥ßªk°|²Ä¤E©¡²Ä¤T·|´Á¦U©eû·|¥l©e¦W³æ¦p¤U¡G ¤º¬F©eû·|¡G«À¤å´¼¡]¥Á¡^¡B´¿»Ê©v¡]°ê¡^¡F ¥~¥æ°ê¨¾©eû·|¡G¤ý©w¦t¡]¥Á¡^¡B¦¿±Ò¦Ú¡]°ê¡^¡F ¸gÀÙ©eû·|¡G°ª§ÓÄP¡]¥Á¡^¡Bªôij¼ü¡]¥Á¡^¡F °]¬F©eû·|¡G¤ýºa¼ý¡]¥Á¡^¡Bù©ú¤~¡]°ê¡^¡F ±Ð¨|©eû·|¡G³\´¼³Ç¡]¥Á¡^¡B¬_§Ó®¦¡]°ê¡^¡F ¥æ³q©eû·|¡G³¯¼Ú¬Ä¡]¥Á¡^¡B¾GÄ_²M¡]¥Á¡^¡F ¥qªk©eû·|¡G¬q©y±d¡]¥Á¡^¡B½²©ö¾l¡]¥Á¡^¡F ½ÃÀôªÀºÖ©eû·|¡G³¯¼ü¡]¥Á¡^¡B§õ«Û¨q¡]°ê¡^¡C ¤j®a«ÜÃö¤ßªº ¥qªk©eû·|¥l©e ¥Ñ½²©ö¾l ¬q©y±d¨â¦ì©eû·í¿ï ¸gÀÙ©eû·|¥l©e ¥Ñ°ª§ÓÄP¡Bªôij¼ü¨â¦ì©eû·í¿ï ´Á¬ß¥[³t¥qªk§ï² Åý¥xÆW¸gÀÙ¦V«e½Ä |
|
|
·|û¡G¶³²H·»´10142966 µoªí®É¶¡:2017/2/23 ¤U¤È 01:43:31²Ä 4297 ½g¦^À³
|
¹x¥Û¤j ¤p§Ì¤£¤~ ½Ð°ÝYK¬O½Ö§r@@ |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2017/2/23 ¤U¤È 12:35:29²Ä 4296 ½g¦^À³
|
°ª¼h¤H¨Æ²§°Ê·íµM¬OÃöÁä¡A¨Æ³£¬O¤H°µ¥X¨Óªº¡C§Þ³N/ºÞ²z¤H¤~ªºÂX¥R»P°ö¾i¡A¤]¨ü¨ì°ª¼h¤H¨Æ²§°Êªº¨î¬ù¡A¤£¬O¶Ü¡H YK ªºÂ÷¾¬O¨Æ¹ê¡A¦Ü©ó¹ï¯E¹©ªø´Áµo®iªº§Q¹ú¡A¤p§Ì¤£²M·¡¡C ¤p§Ì¥uª¾¹D¡A¥ø·~ªºµo®in¬Ý¤@¸s¤H¡A¤£¬O¤@Ó¤H¡Cn¬Ý¥¦ªº¹B§@¼Ò¦¡¯à§_¤£Â_ªº§l¯ÇÀu¨q¤H¤~¡B´£¤É³o¨Ç¤H¤~¡BÅý³o¨Ç¤H¤~µo´§³Ì¤jªº®Ä¥Î¡C¦pªG³Ð·~ªÌ³£¥æ¤£¤F´Î¡A¥ø·~¤~·|¥X°ÝÃD¡C¬Ý¬Ý¥xÆWªº¹q¤l·~¦p¤µ³o¥I¤@Åy¦º¤ôªºª¬ªp¡Aĵı¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/2/21 ¤U¤È 11:21:24²Ä 4295 ½g¦^À³
|
²î¨à·n¹L¬K¤ô¤£°±¯d¡ã §r¡@·n¨ì·¨à§jªi¤Ñ²Dªº¬î A ¯E¹©³Ì«nªº¬O: 1 °]°Èn°·¥þ ¸êª÷¥R¸Î¨¬¥H¨ÑÀ³¤£Â_ÂX¥Rªº¬ãµo¶µ¥Ø 2 ¥¼¨Ó¤½§iªº¨ÅÀù¼Æ¾Ú MOS «GÄR¹F¼Ð ( ASCO §ë¼v¤ù 13 ,17) 3 ©Û¶Ò§ó¦h°ª¶¥¤H¤~ 4 ±M§Q§G§½ªø«× ¼s«× ¨¾½Ã«× ¨¬°÷ 5 ±ÂÅv¶¶§Q ¨ä¥L°ªøʦ³¨S¦³½æ ,¥qªk®×¥ó, ¿Õ¨©º¸¼ú, °ª¼h¤H¨Æ²§°Êµ¥ ¤w¸g¤£¬O¥Dnªº¼vÅT¦]¤l,¤j®a¤£¥Î¾á¤ß , ¤Q¦h¦~¨Ó¯E¹©¤w¸g°ö¾i¤£¤Ö°ª¶¥ºÞ²z¤H¤~ , ³Ì«nªº¬O«e±¨º¤¶µ B ÀR«Ý¯E¹©»ùÈ°ªÂIªº¨ÓÁ{ ¯E¹©°ª¼h²`¤ôÀR¬y¤£»¡¸Ü, ·t¤¤¦bÀ°ÁÞ¤k§ä´M¤F¸Ñ¦o¨Ã¯à¨ó§Uµo®i¼ç¤Oªº¦X¾A¹ï¶H,(¤£¤@©w¬O¶ù§©³Ì¦hÁY¨äµo®iªº²Â¦§g) ²îºqºqµü¬M·Ó¤~»ªÂù¥þªºÁÞ¤kªº¤ß¹Ò,²î¨à·n¹L¬K¤ô¤£°±¯d¡ã §r¡@·n¨ì·¨à§jªi¤Ñ²Dªº¬î·|¤£·|¬O¯E¹©»ùȹF¨ì°ªÂI§ä¨ì¦p·N¦§gªº©¯ºÖ®É¨è ? ²îºq §@µü¡Gù¤j¦ö §@¦±¡Gù¤j¦ö ºt°Û: ®ü §B ©j¨àÀY¤WÀ¹µÛ§ùÃYªá¡ã§r¡@ªïµÛ·¨àÀH®ö³v±mÁø, ²î¨à·n¹L¬K¤ô¤£»¡¸Ü¡ã§r¡@¤ô¶m·Å¬X¦ó³B¬O§Ú®a, ²î¨à·n¹L¬K¤ô¤£»¡¸Ü¡ã §rÀHµÛºq¨à¹º¦V¹Ú¸Ìªº¥L, ¼L¨à»´»´°Û§r¤£»¡¸Ü¡ã§r¡@¤ô¶m·Å¬X¹³¨º¹Ú¸Ìªºµe. ¼L¨à»´»´°Û§r°Û¤£¥ð¡ã§r¡@¦~µØÄƹLºqÁn¦ü¤ô¬y, ²î¨à·n¹L¬K¤ô¤£°±¯d¡ã§r¡@·n¨ì·¨à§jªi¤Ñ²Dªº¬î, ²î¨à·n¹L¬K¤ô¤£°±¯d¡ã§r¡@³½¨àÂùÂùµ²¦ñ¤ô©³´å, ½Öªº²îºq°Û±oÁn±y±y ¤ô¶m·Å¬X¨Ó¨ì¤Ñ²Dªº¬î. ½Öªº²îºq°Û±oÁn±y±y¡@½Ö®a©h®Q¤ô¶mªx«ó¦à, ½Öªº¹Ú¤¤¥L§r¤£»¡¸Ü¡@½Öªº¥L§r¦ó³B¬O§Ú®a, ©j¨àÀY¤WÀ¹µÛ§ùÃYªá¡ã§r¡@ªïµÛ·¨àÀH®ö³v±mÁø, ²î¨à·n¹L¬K¤ô¤£»¡¸Ü¡ã§r¡@¤ô¶m·Å¬X¦ó³B¬O§Ú®a, ²î¨à·n¹L¬K¤ô¤£»¡¸Ü¡ã §r¡@¤ô¶m·Å¬X¦ó³B¬O§Ú®a. www.youtube.com/watch?v=SLOQPYMwqSs C¤ô¶m·Å¬X¦ó³B¬O§Ú®a ÁÞ¤k±¡Âk¦ó³B? Merck, BMS ,GSK, Pfizer, Novartis D ¥þ²y¤T´ÁÁ{§Épµe®Ñ¤½§i¶i¤J˼Ƥ¤, ¥ý«eªº®À§é¿Eµo¤F¤½¥q§¹¦¨³Ì¨ÎªºÁ{§É³]pªº°Ê¾÷, ³oÓ¥þ²y¤T´ÁÁ{§Épµe·|¤£·|±NÄAÂФj³¡¥÷¤Hªº«äºûºë±m³s³s,Ó¤H»{¬°¾÷²v«Ü°ª ²q´ú¨Ì¾Ú 1 FDA¹ïÀù¯g§K¬ÌÀøªk¤£·|¥u¬Ý³æ¤@¼Æ¾Ú,¦pªG¹ï¯S©w¤p±Ú¸s¦³Àø®Ä, ¦w¥þ©Ê¨S¦³°ÝÃD¹ï¯f¤H¦³¦nªº¥Í¬¡«~½èFDA·|¯S§O¦Ò¶q¨Ã·|¦n¦n·¾³q¦p¦ó¹ï¯f±w¦³À°§U,³o¬OFDA ªº·s¬Fµ¦ 2 ¥þ¬üÁÙ¦s¬¡ªº¨ÅÀù¯f±w¬ù300¸U¤H,Âಾ©Ê¨ÅÀù¦s¬¡ªº¬ù60¸U¤H ,°£¼Ð¹vÃÄ¥~¥Ø«e¤j³¡¥÷µL¦nÃÄ¥iÂå, ¨C¦~¦º¤`40500¤H 3 822¬O³Ð·s«¬·sÃÄ¡A¦w¥þ©Ê°ª¤S¦³¦nªº¥Í¬¡«~½è»PÀø®Ä¡A¦b¦h¤¸¨ó°Ó½Í§P¤¤°j±ÛªÅ¶¡´N¶V¤j 4 ¬ü°êÀù¯g®g¤ëpµe¹ïÀù¯g«Å¾Ôªº®É¶¡À£¤O 5 ¤t´¶ªº³Ìªñ¹ï·sÃĪº½×z 6 ¯E¹©ªÑªF·|ªk»¡·|½×z ¥H¤W¤À¨É ¦³¨Ç¥i¯à¬OÓ¤H°¾¨£ ¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/2/5 ¤U¤È 01:48:19²Ä 4294 ½g¦^À³
|
¥t¥~¤]¥i°Ñ¦Ò ²Ä¤Q¤HÆ[ÂIª© ²á¤Ñª© ¯E¹©²£«~½u»PÄvª§¹ï¤â ¦³Ãö¥i¯àªº¬D¾Ô»P·ÀI¤]·|¦³ºëÅPªº½×z, ¥Í§ÞªÑªi°Ê¤ñ¸û¤j,·íµMn¥ýºÞ±±¦n¦Û¤vªº·ÀI»P«ùªÑ¤ñ²v ¤½¥qªº·ÀIºÞ±±¡@+¡@ªÑªFÓ¤H·ÀIºÞ±± |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/2/5 ¤U¤È 01:31:21²Ä 4293 ½g¦^À³
|
FaFaFa §g ¦b104¦~¦~³ø ¥i°Ñ¦Ò ¤»¡B·ÀI¨Æ¶µ¤ÀªRµû¦ô 120¶¨ì126¶ ¬Ý¨ì 126¶³o¬q¬°¤î 3. ·sÃĶ}µo²£·~±¤§·ÀI-Àù¯g·sÃÄÁöµMÀò§Q¥i´Á¡A¦ý¬ãµo®Éµ{ªø¡Bªá¶O¥iÆ[ ¦]À³¹ïµ¦¡G (1) ¥»¤½¥q²{金¬y¤Î¤º³¡¤H¤~¸g¾ú§¡¨¬¥HÀ³¥I¥Ø«e¶}µo»Ý¨D¡AµM¬°«O«ù µ¦²¤¼u©Ê¡A¥[³t·s²£«~¤Î·s¾AÀ³¯g¶}µo¡A¥»¤½¥q¥ç¤£±Æ°£»P°ê»Ú¤j Ãļt¦X§@¶i¦æÁ{§É¸ÕÅç¡A³z¹L§Þ³N±ÂÅvñ¬ù金¤Î¨½µ{金¦¬¤J¡A©Î¦@ ¦P¤À¾á¸ÕÅç¶O¥Î¤è¦¡¡A降§C¬ãµo¦¨¥»¡A¨Ã¥[³t²£«~¶}µo³t«×¡C (2) ¥»¤½¥q¬ãµo¹Î¶¤¦b·sÃĶ}µo¨ã¦³Â×´Iªº°ê»Ú¦¨¥\¸gÅç¡A¤w¸g§¹¦¨ OBI-822 ¦b¥xÆWªº¤G/¤T´ÁÁ{§É¸ÕÅç¡A¥Ø«e³W¹º¦V»OÆW¹«~ÃĪ«ºÞ²z ¸p(TFDA)¥Ó½Ð¦³±ø¥óªº¤W¥«³\¥iÃÒ¡A¨Ã§Q¥Î¤G/¤T´Áªºµ²ªG¡A«·s ³W¹º¦V¬ü°ê FDA ¥Ó½Ð¥þ²y²Ä¤T´ÁÁ{§É¸ÕÅç¡C |
|
|
·|û¡GFaFaFa10140966 µoªí®É¶¡:2017/2/5 ¤U¤È 12:56:54²Ä 4292 ½g¦^À³
|
¥xÁÞ§g: ¥i§_¤À¨Éù¦C±z©Ò¤F¸Ñ¡A»`¶°¡A¤ÀªR¡A¬ã§PÃö©ó¯E¹©ªº®zÂI¤Î¥i¯àªº¬D¾Ô»P·ÀI¡C ·PÁÂ! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/2/4 ¤U¤È 09:45:54²Ä 4291 ½g¦^À³
|
¦³FU¤j ¥u¬Oªá®É¶¡¾ã²z¤@¤Uªñ´Á¸ê°T,¤½¥qªºªk»¡·| ªÑªF·| ©Î ¤w¤½§iªº¸ê°T , Á|¤â¤§³Ò, ½Í¤£¤W¤°»ò¤j®v ª©¤W¦³³\¦h¤j¤j¾A®É´£¨Ñ«n¸ê°T, µL¨p¤À¨É,Åý²³¤j¨ü¯q,¤]¦³¨Ç¤j¤j¶K¤å¤£¦h¦ý¸ê°T¬Ã¶Q, ³o¨ÇÂIÂIºwºw³£¥O¤H·q¨Ø ¤]Åý§Ú¨ü¯q,¨ä¹ê¤j³¡¤ÀªººÃ´b¨Ó¦ÛÁ{§Éªk³W»PÀø®Ä¤ÀªR,§Úªºì«h¬O¬Û«H¤½¥qªº±M·~»P°ê¤º¥~±M®aªº½×z»P°ê»ÚÂå¾Ç·|ªºªÖ©w °O±o¦´Á®ÉÔªO¤W°Q½×OBI822 ¨âºØ§ÜÅé, ¾á¤ßIgG§ÜÅ餣¨¬ , §Ú«H¥ô±i¸³ªºªÑªF·|½×z, ¤O±Æ²³Ä³,¨Ã¶K¤å¤À¨É ASCO ¼Æ¾Ú¤½§i«á§¹¥þ½Âà¹L¥hªº»{ª¾, ´X¥G¤H¤H¥i¥H²w²w¤W¤f: IgG §ÜÅé®Ä»ù>=1:160 2016 ESMO ³\¦h¤j¤j¶K¤å»¡¤£·|¤½§i¼Æ¾Ú, ³Ì«áÃÒ©ú¬Û«H¤½¥q½×zªº¤H¬O¹ïªº «Ü¦h¤j¤j«ÜÃö¤ß±ÂÅv°ÝÃD: µª®×¦b³o¨â¦~ªºªÑªF·|¸Ì, Ó¤H»{¬°¯E¹©n§âOBI822ªº»ùÈ©¹¤W±À¤É¤~·|¦³±ÂÅvªº¤½§i, Á{§É¶i«×, ±M§Q§G§½, ¥þ²y¤T´Á ¨È¬w¤T´Áªº±À¶i, ¥xÆW¤T´Á¼Æ¾Ú¥þ³¡¤½§iµ¥ ´N¬O §âOBI822ªº»ùÈ©¹¤W±À¤Éªºµ¦²¤, ¯¸¦b¤jÃļtªº¥ß³õ¤£·|·Qn³æÃıÂÅv, ¥unTable ¤W±ø¥ó¬O¦nªº¤½¥q¨S¦³©Úµ´ªº²z¥Ñ, §Ú¥H«e¤w¸g»¡¹L¤zÄ[¨Æ¥ó«á·|´«¯E¹©¥XµP, ¥u¬O¤£ª¾¹D³Ì¤jªº¨º±i¤ýµP¦ó®É·|¥X? ¦u®è«Ý¨ß§a! ¤£nµ¹¤½¥qÀ£¤O |
|
|
·|û¡G¦³FUªº¤H10136189 µoªí®É¶¡:2017/2/4 ¤U¤È 07:19:08²Ä 4290 ½g¦^À³
|
¥xÁÞ¤j~~ ·PÁ±z«ùÄòÅý©Ò¦³¯E¤Íª¾¹D¥Ø«e¯E¹©ªº©Ò¦³¶i«×. ¥u¯à»¡¯E¤Í¦³±z³o¦ì¤j®v¯uªº«Ü¦n |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/2/4 ¤W¤È 09:16:03²Ä 4289 ½g¦^À³
|
¬ü°êÁ`²Î¤t´¶ªºÃÄ»ù¬ÛÃö«ÂI¸ê°T:¸É¥R E ¤t´¶¶D¨DÃĪ«»s³y·~¦^¬ü°ê F ¤t´¶¥D±i¥[³t°ê¥~ÃÄ«~¶i¤f,¨Ã¾A·íªº¶}©ñÃĨƵ¹¥IºÞ²z¤½¥qµ¥ºÞ²zªÌ¥«³õÄvª§¡A¥H¸Ñ¨M°ªÃÄ»ùªº°ÝÃD G ¥D±i¼o°£Obama Care :Obama Care¥Dn°w¹ï¤¤§C¦¬¤J¤áªºÂåÀø«OÀI»PªA°È¬°¥D¡A¤]´N¬O³h¥Á¤]¯à°÷ÂǥѸû¬° ¥»ùªº«OÀI¶O¤ä¨ÓÀò±o¥¼¨Ó¥i¯àªºÂåÀø¤ä¥X¡A«O»Ù¨äÂåÀøÅv¡A³o»PÃÄ»ùµLÆ[ Ó¤H¬Ýªk¤À¨É¶È¨Ñ°Ñ¦Ò:¸É¥R E ¤t´¶¶D¨DÃĪ«»s³y·~¦^¬ü°ê³o¹ï¦L«×¤¤°êµ¥ÃĪ«¥N¤u¬O§_·|³y¦¨q³æ´î¤Ö »Ý±K¤ÁÆ[¹î F ¥[³t°ê¥~ÃÄ«~¶i¤f: ³o¹ï¥¿¦bµo®i¥Í§Þ·~ªº¥xÆW¦³§Q G Right to try: µ¹¤©¥½´Á¯f¤H¹Á¸Õ³q¹L°ò¥»¦w¥þ´ú¸Õ¦ý©|¥¼³QÃÒ©ú¦³®Äªº¹êÅ礤ªºÃĪ«,³oÓ¶D¨D¬O¦]¬°¬ü°êÀù¯g¯f±w¦³¾÷ ·|°Ñ»PÁ{§É¸ÕÅ窺¾÷·|»PÃĪ«¬ãµo¦¨¥\¾÷²v¤@¼Ë§C, ¤£¹LÓ¤H»{¬°¦Ü¤ÖÃÄn¦w¥þ, ¤G´Á¥H¤WÃÒ©ú¦³®Ä¤~¯à¹ê¬I,§_«h¥i¯à·|¨Ï ¥Î¨ìµL®ÄªºÃÄ,³o¹ï«æ¯f§ïµ½¨ÃµLÀ°§U H ¬ü°êFDA ¤µ¦~¥u®Öã22Áû·sÃÄ, ³Ð¤Uªñ¦~¨Ó·s§C (¤µ¦~¥H«á®Ö㪺ÃĦb¤t´¶ªº¬Fµ¦¤UÀ³·|«ùÄò¼W¥[), ³oªí¬O¯à§ä¨ìªº¶Àª÷ ¶V¨Ó¶V¤Ö, me too ªºÃĤ]¤£®e©ö¦³¬ð¯}©Êªº¶i®i,¯E¹©¯à¨«¨ì¤µ¤Ñ³oÓ¦a¨B¤j®aÀ³·P¨ì¼y©¯, äãÃ¥´, ¥HÁÞ¤À¤l·sÃÄ,°ª ¦w¥þ©Ê,°ª¥Í¬¡«~Ȥιï¯à²£¥Í§ÜÅé±Ú¸s·|¦³ÅãµÛÀø®Ä,¾A¥Î±Ú¸s¼s, ¹ïÀù²ÓM¦³¼Ð¹v©Êµ¥ºØºØÀu¶Õ¨Ó¬Ý»P¨ä¥L¶Ç²Î¤p¤À¤lÃÄ, ³J¥Õ½èÃĩεo®i¤¤ªº§K¬ÌÀøªk¤ñ¸û¦³«Ü±jªºÄvª§¤O¼ç¤O»Pµo®i©Ê www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm483775.htm ¥H¤W¤À¨É ¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/2/4 ¤W¤È 12:59:14²Ä 4288 ½g¦^À³
|
²q·Q¤j ¤Ñ©R¤j ¤p©_¤j ·x·x¤j Lin ¤j ¦³FU ¤j PT¤j µL¤j ½²¦Ñ®v¤j ¦Uª©²³¤j¤j: A ¬ü°êÁ`²Î¤t´¶ªºÃÄ»ù¬ÛÃö«ÂI¸ê°T: 1¬ü°êÁ`²Î¤t´¶³Ìªñ©M¦U¤jÃļt°õ¦æªø·|±¡A¥]§t¿ÕµØ¡B±j¥Í¡BÀq§J¶°¹Î¡BÁÉ°ò »P§¨Ó¡B¦w¶iµ¥µ¥¡C·|±´Á¶¡¤t´¶»}¨¥nÅýÃÄ»ù°§C ,¥L¤]©Ó¿Õ·|¥H¥[§Ö·sÃļf®Ö¡BÃP¸jªk³W 2¥L·|¦bªñ´Á¬£¤H±µºÞ¹«~ÃĪ«ºÞ²z§½(FDA)¡AÀu¥ý¥[§Ö®Öãµ{§Ç¡A¥¼¨ÓÃÄ«~¬ã·sÃĮ֥iªº³t«×·|§Ö¤W³\¦h¡C 3¼Ð·Ç¼f¬d¬yµ{²{¦b¥§¡»Ýn10Ó¤ë¡A¦ý¦b2005¦~®Éªñ13Ó¤ë¡C¦pªG¥Ḻo¨ìÀu¥ý¼f¬d¡A¥i¥H¦A´î¤Ö¨âÓ¤ë¡C( ¤]´N¬O8Ó¤ë) 4 Right to try: µ¹¤©¥½´Á¯f¤H¹Á¸Õ³q¹L°ò¥»¦w¥þ´ú¸Õ¦ý©|¥¼³QÃÒ©ú¦³®Äªº¹êÅ礤ªºÃĪ«¡C Ó¤H¬Ýªk¤À¨É¶È¨Ñ°Ñ¦Ò: A°ªÃÄ»ù¦b«ç»ò°ÁÙ¬O¶Q,³o¹ï¯E¹©¨ÅÀùÃÄ822 ¤¤µ¥ÃÄ»ù(3-4¸U¬ü¤¸) ¨Ó»¡»á¨ãÄvª§¤O B¥[§Ö®Öãµ{§Ç ¹ï¥Í§Þ¤½¥q¨Ó»¡À³¬O¦n®ø®§, ¬ü¥x¥ý«áµo§G¥[³t¼f¬dÃĪ«®Éµ{ ¹ï¯E¹©¨Ó»¡¬OÂù«§Q¦h C¶ÀÁ`¦bªÑªF·|¦³´£¨ì : ¥þ²y«Ü¤Ö¦³ÃĪ«¯à»POBI 822 ¦b¦w¥þ©Ê¤WÄvª§ D ¯S§Oª`·N¤t´¶¬Fµ¦·|Åý«Ü¦h³Ð·sÃĪ«¦b¤@´ÁÁ{§É«á¦pªGªí²{Àu²§ÀòªºBTDªº¾÷·|¼W¥[ ¦³¿³½ì¥i°Ñ¦Ò¥H¤U¸ê°T: freebeacon.com/issues/terminally-ill-applaud-trumps-pledge-change-fda-rules/ www.statnews.com/2017/01/31/trump-pharma-reality-check/ fortune.com/2017/01/31/trump-pharma-ceos-meeting-demands/ www.chicagotribune.com/business/ct-trump-drug-costs-20170202-story.html alveice.blogspot.tw/2017/02/blog-post_2.html B ¥xÆW¯E¹©¬ãµo¬ÛÃö¶i«×¬d®Öªí ( ) ªí¥ÜÁÙ¥¼¹ê²{ 1 OBI822/821 ¨ÅÀù§¹¦¨¥xÆW¤G/¤T´ÁÁ{§É (¤w³¡¤À¸Ñª¼) 2§Z±_Àù¥xÆW¤G´ÁÁ{§É (¶i¦æ¤¤) 3 OBI833/821 ªÍÀù GÀù ¤j¸zÀù ¨ÅÀù ¤@´ÁÁ{§É ( ¶i¦æ¤¤) 4 2016 ASCO ¼Æ¾Ú¤½§i ( ¤w§¹¦¨) ¦³§ÜÅ骺PFS ¦³¹F¼Ð , P17 M OS ¹w¦ô«Üº}«G , P13 ¹w¦ô¦³¾÷·|¹F¼Ð 5 2016 ESMO ¼Æ¾Ú¤½§i ( ¤w§¹¦¨) igG §ÜÅé®Ä»ù¬ù80% ³s¦PIgM§ÜÅé®Ä»ù ¤@°_ºâ¦³§ÜÅ骺·|¶W¹L90% igG§ÜÅé®Ä»ù 1:40 1:80 1:160 ¥|¦~¦s¬¡²v «Ü±µªñ 74.8% - 78.1% §ÜÅé®Ä»ù 1:320 ¥|¦~¦s¬¡²v85.9% §ÜÅé®Ä»ù 1:640 ¥|¦~¦s¬¡²v 91.8% 6³q¹L¸gÀÙ³¡¤u·~§½¥xÆW´¼¼z°]²£ºÞ²z³W½d¡]TIPS¡^(µûŲA¯ÅªÖ©w) 7 OBI-822Àu¶V¡B³Ð·sªºÀù¯g§K¬ÌÀøªkProof of Concept (¤wÀò±o¦LÃÒ) P46 www.ir-cloud.com/taiwan/4174/events/17/CH/417420160615M001_AfAFleBQq587.pdf 8¯E¹©OBI-833·s±M§Q¥Ó½Ð: (Àò¥x¡B¿D®Öã³q¹L) ¥H¥Õ³ïÃþ¬r¯À¡]DT¡^¬°³J¥Õ½è¸üÅé¡A¥iÃì±µªºGlobo H§ó¦h¡A¹B¥Î¦¹§Þ³N¡A¥i¹F¦¨°ªºÒ¤ô¤Æ¦Xª«±K«×ªº¬Ì]¡C 9 FDA Adagloxad Simolenin EOP2 ·|ij ( ¤w§¹¦¨) 10 ¤¤°ê®Öã Adagloxad Simolenin (OBI-822) ²Ä¤T´ÁÁ{§É¸ÕÅç( ¤w§¹¦¨) 11 °ê®aÃĪ«¼f¬d¤¤¤ß³]¸m±ø¨Ò ¯ó®× (Àò¦æ¬F°|³q¹L) 12°ê»ÚÂå¾Ç´Á¥Z½×¤å¼Æ¾Ú¤½§i ( ) 13¥þ²y¤T´ÁÁ{§É¸ÕÅçpµe¤½§i( ) ¬ü¤é±Ä¨úsilence approval: ¥Ó½Ð´£¥X30¤Ñ¨S¦³¦¬¨ì¸É¥ó³qª¾«K¥i¶i¦æÁ{§É 14¨È¬w¤T´ÁÁ{§É¸ÕÅçpµe¤½§i( ) 15 MOS ¼Æ¾Ú¦¨¼ô¤½§i ( ) 16 OBI822/821 X ºØ¾AÀ³¯g¶i¦æÁ{§É ( ) 17 OBI888 X ºØ¾AÀ³¯g¶i¦æÁ{§É ( ) 18 §¹¦¨¶Ò¸ê»P§¹¦¨¨ÖÁÊ ( ) 19 OBI833/834 X ºØ¾AÀ³¯g¶i¦æÁ{§É ( ) 20 OBI822 ¨t¦C©Î³æÃĦX§@±ÂÅv¤½§i ( ) 21 ¦×¬r±ìµß¯À¦X§@±ÂÅv¤½§i ( ) ¨ä¥L¸É¥R 1 ¶ë¯Î¥¢°¨ ²jª¾«DºÖ, OBI822±q¥xÆW¤T´Á©ÒÀò±oªºÄ_¶Q¸ê®Æ¦p¦P¿O¶ð¯ë¤Þ»â¥¼¨ÓÁ{§É¸ÕÅ窺¥¿½T¤è¦V, ÅýOBI822/821 OBI833/821 OBI833/834 OBI888 ¦¨¥\¾÷²v·¥¤j¤Æ 2 ¹ï¥¼¨Ó·|¹ê²{ªº¶i«×©Î§Q¦h¦pªG¤£ª¾¹D¦ó®É·|µo¥Í³Ì¦nªºµ¦²¤´N¬O¦u®è«Ý¨ß,ºò©ê«ùªÑ ¯¬ºÖ²³¤j¤j¦b³oÓ¬K·xªá¶},¬K·N¯sµM ,·sªº¤@¦~,¤B¨»¦~°]·½¼s¶i ¤ß·Q¨Æ¦¨ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/1/27 ¤U¤È 04:46:06²Ä 4287 ½g¦^À³
|
¯¬ºÖ¯E¹©¦Uª©ªºªB¤Í ¦U¦ì¤j¤j ¤B¨»¦~ °]·½¼s¶i ¤ß·Q¨Æ¦¨ ¯E¹©¨«¶Õ, ºD©Ê¤w§ïÅÜ, ¤zÂZ¦]¤l¤w°£, ¦³§QªÅ¥XºÉ §_·¥®õ¨Ó¤§¶H ,¬Û«H¯E¹©·|«H¦uªÑªF·|©Ó¿Õ,¤£Â_§â¦n®ø®§§i¶D¤j®a ÁÞ¤k¨ÌµM¦b¤H¶¡ , ¯E¹©¹Î¶¤»P¥þ²y±M®a¹ï¨ä¤wª¾»P¥¼ª¾ªº»â°ì¥Rº¡¦n©_¨Ã®i¶}¤j³W¼Ò±´¯Á¤§®È............... ¯E¹©ÀÀ¼W¸ê2¸U±i Äw±¹60»õ¤¸ A ¨Ì¾ÚªÑªF·|½×z¼W¸ê¥Øªº: 1 ¥¼¨Ó°t¦X822 833 888 ¾AÀ³¯g©µÅó°ê»Ú¤H¤~, ÂX¥R¬ãµo¹Î¶¤ 2 ¨ÖÁʰꤺ¥~¥Í§Þ¤½¥q ´£°ª¯E¹©°ê»ÚÄvª§¤O B Ó¤H¨ä¥L¸É¥R¬Ýªk: Åý±ÂÅv¦X§@¤½¥q »P investor ª¾¹D: a ¯E¹©¦³¦h¤¸ªºpipeline b ³Ð·sªºÁÞ¤À¤l¼Ð¹v·sÃÄ ¦w¥þ ¦³®Ä c ±M§Q¼s«×ªø«×»P¨¾½Ã¯à¤O¨¬¹L d ¦³°ªªº¥Í¬¡«~½è µ¥¥H¤W4 ¯S¦â¥~ ¤]nÅý¹ï¤èª¾¹D¯E¹©²{ª÷¬y¬O¥R¸Îªº,¤£·|Åý¹ï¤è¬Ý«ó, ¬Ý°I ¯E¹©¨«¶Õ, ºD©Ê¤w§ïÅÜ, ¤zÂZ¦]¤l¤w°£, ¦³§QªÅ¥XºÉ §_·¥®õ¨Ó¤§¶H ,¬Û«H¯E¹©·|«H¦uªÑªF·|©Ó¿Õ,¤£Â_§â¦n®ø®§§i¶D¤j®a ÁÞ¤k¨ÌµM¦b¤H¶¡ , ¯E¹©¹Î¶¤»P¥þ²y±M®a¹ï¨ä¤wª¾»P¥¼ª¾ªº»â°ì¥Rº¡¦n©_¨Ã®i¶}¤j³W¼Ò±´¯Á¤§®È............... |
|
|
·|û¡G¤p½¼¦Ì10143503 µoªí®É¶¡:2017/1/26 ¤W¤È 11:38:21²Ä 4286 ½g¦^À³
|
ª©¤W²³¦ì¤j¤j·s¦~§Ö¼Ö! ³o¤@¦~·PÁ¦U¦ì¤j¤jªº¨¯W»P©^Äm¡AÅý§Ú̪¾ÃѦ¬Ã¬º¡¸ü! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/1/24 ¤U¤È 12:13:25²Ä 4285 ½g¦^À³
|
§ÜPD-1 PD-L 1 ÃĪ«¥Ø«eªº±J©R ¤Ñ©R¤j´£¨ìªº¥h¦~³QFDA ®ÖãÃÄÃÒªºÂಾ©Ê«D¤p²ÓMªÍÀù ÃĪ« TECENTRIQ (atezolizumab) (PD-L 1) ¹êÅç²Õ144¤H¤¤ «ÈÆ[¤ÏÀ³²v¥u¦³15% (22¤H) , §¹¥þ¤ÏÀ³1¤H 0.7% , ³¡¤À¤ÏÀ³21¤H 15% ³o¬O¬ãµoPD-L 1 ÃþÃĪ«±Á{ªº§x§½, ¤ÏÀ³²v¤Ó§C , ¤ÏÀ³²v¤Ó§C¥¼¨Ó¨Ï¥Î¤H¤f¬Û¹ï¤]·|¤ñ¸û¤Ö, ¨ü¯qªº¤H¤]ÅÜ¤Ö ³o¬O¥xÆWÁÞ¤À¤l·sÃĪº¾÷·|, ÁöµMÁÞ¤À¤l·sÃĨÅÀùOBI822 ©|¥¼¤½§i«ÈÆ[¤ÏÀ³²v,¤£¹L±qASCO ESMO ¬ÛÃö¸ê°T ¦³§ÜÅé´N¦³Àø®Ä , «ÈÆ[¤ÏÀ³²v·|«Ü³¡¿ù ,¥¼¨Ó¨Ï¥Î¤H¤f¬Û¹ï¤]·|¤ñ¸û¦h, ¨ü¯qªº¤H¤]Åܦh www.roche.com/media/store/releases/med-cor-2016-10-19.htm |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/1/23 ¤W¤È 09:53:24²Ä 4284 ½g¦^À³
|
Cumulative CBER Breakthrough Therapy Designation Requests Received by Fiscal Year Cohort: July 9, 2012* - September 30, 2016 Data as of December 31, 2016 Fiscal Year Total Requests ¾ú¦~²Îp ( biological products) ----- Received -----Granted -----Denied ----Withdrawn --2016--- 23 ----------8----------14 --------1 --2015--- 20-----------8 ----------9 --------3 --2014----26---------- 7 ---------19 --------0 --2013 ---12-----------1----------10---------1 Center for Biologics Evaluation and Research (CBER) www.fda.gov/AboutFDA/CentersOffices/.../CBER/ CBER is the Center within FDA that regulates biological products for human use under applicable federal laws, including the Public Health ... ¤]¥i¬d: CDER Breakthrough Therapy Designation Requests Received by Fiscal Year Cohort: July 9, 2012* - September 30, 2016 Data as of December 31, 2016 www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/INDActivityReports/UCM481540.pdf |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/1/22 ¤U¤È 11:48:39²Ä 4283 ½g¦^À³
|
°Ñ¦Ò¸ê®Æ www.fda.gov/downloads/drugs/developmentapprovalprocess/smallbusinessassistance/ucm185881.pdf www2.cde.org.tw/FAQ/NDA/Pages/%E8%97%A5%E7%89%A9%E5%8B%95%E5%8A%9B(PK%20PD).aspx |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/1/22 ¤U¤È 11:39:11²Ä 4282 ½g¦^À³
|
´§§O¤þ¥Ó¯P¤õ¼õ ªï¦V¤B¨»¤@¤ä¬K EOP 2 Meeting (cont) • Objectives:¥Ø¼Ð ¡V To obtain agreement on pivotal study designs,and safety and efficacy endpoints for Phase 3 studies ¤T´ÁÁ{§É¼Ï¯Ã©Ê¬ã¨s³]p ,¦w¥þ»P¦³®Ä©Êªº¬ã¨s²×ÂI¹F¦¨¦@ÃÑ Ó¤H¸É¥R: ¤T´ÁÁ{§É³]p,¤H¼Æ¦h¤Ö ,¥´´X°w, ¾¯¶q , n¥Î¦óºØEndpoint ·|¤¤¤w¸g½Í¦n),(OS PFS §ÜÅé®Ä»ù ©ÎORR ) ¡V To update on progress of PK studies and discuss additional studies needed §ó·sÃİʾǶi«×¨Ã°Q½×¨ä¥¦¦³»Ýnªº¬ã¨s ( Ó¤H¸É¥R: ¦pn¦³¤@²Õ¦h¥´´X°w¥i¨Ì¾Ú³oӥؼХh°Q½×) Á{§ÉÃİʾǸÕÅ糡¤À(human PK study): ¼f¬d«ÂI¬°¥Íª«ÀËÅ餧¤ÀªR¤èªk¤Î¨ä½T®Ä¡B¤HÅé§l¦¬¡B¤À§G¡B¥NÁ¡B±Æªn¡B¯S®í±Ú¸s¡B¹ª«-ÃĪ«¥æ¤¬§@¥Î©MÃĪ«-ÃĪ«¥æ¤¬§@¥Îªº ¡V To assure that pre-clinical data with regard to duration, route of administration, and formulation are supportive of the dose to be used in clinical trials ½T©wÁ{§É«e¸ê®Æ ( @¨ü©Ê , µ¹n³~®|, »P¨Ï¥Î¦bÁ{§É¸ÕÅç°t¤èªº¦³®Ä¾¯¶q) EOP 2 Meeting (cont) • CMC ¤Æ¾Ç»s³yºÞ¨î ¡V To discuss approach to specifications and test methods °Q½×³W½d»PÀË´ú¤èªk ¡V To discuss ¡§to be marketed¡¨ formulation °Q½×ÃĪ«¤W¥«ªº³W®æ¤Æ ¡V To evaluate appropriate protocols µû¦ô¦X¾Aªº¨óij¯ó®× ¡V To identify other issues or potential problems ½T»{¨ä¥LijÃD©Î¼ç¦b°ÝÃD EOP2 meeting briefing package ²³ø¸ê®Æ • Summaries of Phase 1 and Phase 2 investigations 1´Á 2´Á Á{§ÉºKn • Summary information on plans for Phase 3 trials ¤T´ÁÁ{§É¸ÕÅçpµeºKn¸ê°T • Specific protocols for Phase 3 studies ¨ãÅ骺¤T´ÁÁ{§É¸ÕÅçpµe®Ñ • Plans for pediatric studies (X) • Plans for additional non clinical studies (if required) ( ¦p»Ýnªº¸Ü ¥i°Q½×ÃB¥~«DÁ{§É¬ã¨s) During the meeting ¶}·|¤¤¦b·F¬Æ»ò? • Summarize key discussion points,agreements, and action items ¥Dn°Q½×ijÃDnÂI, Âù¤è¦@ÃÑ, ¦æ°Ê¤è®×µ¥ºKn • Make sure that your questions have been addressed ½T©w°ÝÃD¦³¦^µª¨ì ¨ä¥L¸É¥R: BTD ¥i»P¤T´ÁÁ{§É¦P®É°e¥ó¥Ó½Ð( 10¤ë) ¤]¥i¥H±ß¤@ÂI°e( ¦p 11¤ë 12¤ë.. ) ¼f®Ö¬O¤£¦P³æ¦ì³¡ªù , ¬O¨â¥ó¤£¦Pªº¥Ó½Ð®×¥ó, ®Ú¾Ú¬ü°êFDA¤w¤½§i¸ê®Æ2017·|p¦~«×¦³12¥ó¥Ó½Ð¬ð¯}©ÊªvÀø¼f®Ö breakthrough therapy designation(BTD )2¥ó¤w®Öã, ºM¾P0¥ó, 4¥ó§_¨M, 6¥ó«Ý¼f ¥H¤W¬O 2016 12¤ë31¤é¸ê®Æ (Data as of December 31, 2016) OBI 822¦b«Ý¼f¤¤¾÷·|³Ì¤j 2017·|p¦~«× : October 1, 2016 - September 30, 2017 °£¤Fbreakthrough therapy designation(BTD) ¥~, ¤]¦³ accelerated approval (AA ) ©Î¨ä¥L¦³§Q822µo®iªº¤è®× ¤]ÁÙ¦³¤£¥²°µÁ{§Éªº conditional approval (µ¥OS¼Æ¾Ú) ©Î ¥u°µ³¡¤À¨ÅÀù¨È«¬ªº¥þ²y¤T´Á ¨ä¥L¨È«¬®Öã¨Ï¥Î ¤è®×«Ü¦h,¤£¥²¥u»EµJ©ó¤@¶µ EOP 2 Meeting ¶i®i¶¶§Q ,Áö¥Rº¡·Q¹³ªÅ¶¡ ,ÁÙ¬O¥H¥±`¤ß ,¤@¨B¤@¸}¦L«e¶i, ªï¦V¥¼¨Ó·sªº¤@¦~ ¯¬ºÖ¤j®a·sªº¤@¦~ °]·½¼s¶i ¨Æ¨Æ¦p·N ¥H¤W¤À¨É¦³¨Ç¬OÓ¤H°¾¨£ ¶È¨Ñ°Ñ¦Ò ¦³¿ù½Ð§ó¥¿ |
|
|
·|û¡G¤p¯E°g10137673 µoªí®É¶¡:2017/1/21 ¤W¤È 10:03:23²Ä 4281 ½g¦^À³
|
½Ð°Ý¬ð¯}©ÊÀøªk¦³¥i¯à·|³q¹L¶Ü¡A®É¶¡ÂI¡AÁÙ¦³§@¤T´Á¥Nªí¨S¦³¥i¯à´£¦¥Ó½ÐÃÄÃҶܡAÁÂÁ¡C |
|
|
·|û¡Gfun10138468 µoªí®É¶¡:2017/1/21 ¤W¤È 09:41:51²Ä 4280 ½g¦^À³
|
¤Ñ©R¤j·PÁ±z´£¨Ñ«n¸ê°T¡A¤p©f·Q½Ð°Ý±z±qþ¸Ì¸ê°T¥i¬Ý¥Xtriple negative¯f¤H³£¤wPD,¦pªG¯uªº¬O¦p¦¹¯uªº¬O¤@¶µ§Q¦h¡A¥i¬O§Ú¦³¤@ÂIºÃ´b¡A¦]¬°¹ï·Ó²Õ¤]¾Ö¦³¬Û¦P¤ñ¨Òªºtriple negative¯f¤H¡A©Ò¥HOS¤£´Nºû«ù¤@¼Ëµ²ªG¶Ü?Àµ½Ð¤Ñ©R¤j¯à¤@¸Ñ¦¹ºÃ¼{¡AÁÂÁ±z¡C |
|
|
·|û¡Gdennislu10137962 µoªí®É¶¡:2017/1/21 ¤W¤È 09:24:52²Ä 4279 ½g¦^À³
|
¬üFDA¦P·N¯E¹©¨ÅÀù·sÃĤT´ÁÁ{§É www.chinatimes.com/newspapers/20170121000249-260206 |
|
|
·|û¡Gªü®¶10139782 µoªí®É¶¡:2017/1/17 ¤U¤È 09:25:18²Ä 4278 ½g¦^À³
|
¯à³Q¤Ñ©R¤j®vÂI¨ì¦W ¯u¬O°ª¿³·¥¤F 888±N·|¬O²Ä¤GÓ§âÄ_¼C ¦Ó¥B³t«×·|¤ñ¹w´Á¤¤§Ö ¤S§¨µÛ¯à±q¤HÅé¦Ó«D°Êª«°ö¾i¥Xªº§ÜÅé ³o¯u¬O«Ü´Îªº¤W¤Ñµ¹¯E¤ÍªºÂ§ª« |
|
|
·|û¡GÂyªÌ10142287 µoªí®É¶¡:2017/1/13 ¤U¤È 12:14:44²Ä 4277 ½g¦^À³
|
nÅý¤@ÓÀI¿Ñ¥¢±Ñ,º¥ý±oÅý¨eÌ®»¨g¡A¬Ý¨ì¯E¹©¥½L¤W´N¡u«÷©R¡v©ñªÅ⋯, ´N¹³¬Q¤Ñ¨º¼Ë⋯,¤@¤Ñ¯Ó±¼¨eÌɨé315±i¡A¥un¦A¨Ó¤QÓ¦p¦¹¼Ò¦¡⋯, ¤â¤¤ªº¨é½æ¤]·|¨ì16000±i,¨e̪ºÉ¨é¥´À£¤]´X¥G¨ì³»¤F⋯, ¦A¥[¥H¯E¹©¥XɤH,ÀH®ÉªºCALL¦^³±¼v⋯,¨rÆN·|§¤¥ßÃø¦w, ɨé§Q®§¨göt¥u¬O±N¨e̤f¤¤ªºªÎ¦×,¦R¤@㸃¥X¨ÓÁÙ§ë¸ê¤H¦Ó¤w¡A ±µ¤U¨Ó¡A¤~¬O¤jÀ¸⋯, ¸Õ·Q¤@¸s¨rÆN⋯,¨S¦³¨é³æ¥iªÅ,·|¬O¤°»ò§½±¡A§AÌÉ¥X¥hªº¤H¡A ¤SÀH®ÉCALL¦^¡A¨º§Q®§¤@©w¤@ª½©¹¤W¨«¡A ©Î³\¨ęü¤£¤F⋯,¥h±oÁ٨餣¥i⋯, ¨º¦n⋯, ¥Ñ¥«³õ¶R¦^⋯,¨º¥´¦Û¤vªº¨r¼LªÑ»ùº¦¦^¨Ó¡AÁÙ§ë¸ê¤H¤½¹D¡A ¥Ñ¥L¤è¥NÁÙ⋯,¨º´NÃn¥ú¤F½Ö¬O¥D¨ÆªÌ¡A¨rÆN²{§Î §A̯E¹©ªÑªF¡A¦n¦n·Q·Q¡A¬O¤£¬O¸Ó¦p¦¹§@¡A»°ºò¥þ±CALL¦^ɨé¡AÁY¤p¨rÆNªº§Q¯q¡A¬Æ¦Ü°t¦X¤½¥q¬ãµo¶i®i¡A¶i¦æ¤ÏÀ»⋯,Åý¨rÆN¤j½ß⋯,§éÁl¼²Àð⋯,¦Ó«á¤º³¡¨rÆN¸s½Áy¡A°t¦Xªº°Å±¥¡B´CÅé¡B½P¼L¡B§Qµä¤º閧¡A«è¨¥¥|°_⋯, ¨º¯E¹©®×¤~¦³¯u¶H¡AÁٯΰ|ªø¤Î¤½¥q¤@Ó²M¥Õ⋯! |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/12 ¤U¤È 11:41:16²Ä 4276 ½g¦^À³
|
¯Î±Ò´f³g¦¾¸o°_¶D¡I¦t©÷®×¡B¯E¹©®×¡@´À¥xÆW¥Í§Þ¤Wªº¨â°ó¬Fªv½Ò ¤å¡þ³¯µqñü 2017-01-09 15:13 www.peoplenews.tw/news/b4fa26da-c716-4d7a-9fd3-47a45546d1df |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/12 ¤U¤È 11:29:56²Ä 4275 ½g¦^À³
|
²Ä4¥xªº³q¹B§ëÅU ±iX°a23¡G00-23¡G30 ¦³´£¨ì¤p¤T´Áªº»ùÈ®@ ¦³¿³½ìªºªB¤Í¥i¥HÅ¥¬Ý¬Ý |
|
|
·|û¡GÂyªÌ10142287 µoªí®É¶¡:2017/1/12 ¤U¤È 10:22:04²Ä 4274 ½g¦^À³
|
¤µ¤Ñ¨rÆNɨé633¡B³Q¤H®aCALL¦^315±i¡A縂pɨé¾lÃB¨Ó¨ì13378±i¡A ¾Ú¥«³õ®ø®§¤H¤h³zÅS¡AÂy¤H²q´ú¤µ¤ÑÁÙªº315±i¬O¤T¤Ñ«e⋯,¥XɤH¥l¦^ªº¡A ¬Û«H¡u¬Q¤Ñ¡v¯E¹©±þ¶^°±¡AÀ³¸Ó§ó¦h§ë¸ê¤H©ú¾é秃ÆN¤âªk¡A¼ÝµMCALL¦^ɨé¡A ¹Gªº¨rÆN̤µ¤Ñ¡uºò«æ¡v±À°ªÉ¨é§Q²v¨ì10¢H¥H¤W¡A¥HÀ³¥IÅ«¦^¼ö¼é¡A ©Ò¥H¦³¥Xɨ骺§ë¸ê¤H¡A©ú¤Ñ¤@¦¤EÂIÄÁ¡A²Ä¤@¥ó¨Æ¡A¥´¹q¸Üµ¹Àç·~û¡A CALL¨é¦^¨Ó¡A¦Ü¤Ö¤@¥b¡A¬Û«H¨rÆN㑹«Ü¡u¯í¡v©Î¡u¦£¡vªº⋯,µM«á§Q²v¦A«×¨«°ª⋯, n¹L¦~¤F¡A¸ò¨rÆNµ²ºâ¤@¤Uɨé§Q®§¡A¨e̤£«Ä³¡A´£髙¨ì15¢H¡A¨º´N§âªÑ²¼©ñ¶°«O¡A ¤@¨Ç§Q®§¤£ÁÈ¡A¤S¦p¦ó¡A¦³±Ë¤~¦³±o°Ú⋯! §A̪ѪFÀ³¸Ó¡A¶X¹L¦~«e¦n¦n¸ò¨rÆNÌ¡AºâºâµU¦~³Q¨ȩé¿iªº±b¡A¥þ±CALL¦^13000±i¡A ¤@¦~5¢H§C²vªº¨é¡AÂê¶i¶°«O¡A¨S15¢H¡A§KÁ¿°Õ¡A ¦^³ø¨rÆN̤µ¦~¹ï§A̯E¹©ªÑªFªº¡u·ÓÅU¡v¡C ¤£À³¸Ó¦p¦¹¶Ü¡H §AÌ¥h¬Ý¬Ý¡A¤H®a¨rÆN¤µ¤Ñ¥Îɨé¡A©ñªÅ¯E¹©315±i¡A¦³¤â³n¶Ü? ¨C¦¸¥Î³yÁÁ©Ù¶Â¼vÅTªÑ»ù¡A¡]¬Q¤Ñ¶^°±´N¬O¨e̳yªºÁÁ¨¥¡^¡A ¦Ó¤µ¤Ñ¨é½æ¤F315±i¡A§A̪¾¹D½æ»ù¬O¦h¤Ö¶Ü¡H ¥h¬d¬d¼¯®Ú¤j³q¡B³ÍÂû¥x¥_¡Bµ¥¨é½æªº¸¹¤l¡A´X¥G³£¬O266¤¸¥ª¥k¡]¥½L¤W¤@ÀÉ¡^ ¡A¬G·N¥´À£¤§¤ß¬LµMYÅã¡A±q4¡B500¤U¨Ó¡A´X¥G³£¥Î³o©Û¡A§A̪ѪF¤£¥Îµ¹¨eÌÃC¦âÁ@Á@¶Ü¡H ²{¦b¨é½æ±i¼Æ¤w¸g逹12458±i¤F¡A ¦³É¨éªº¤H¡Aªñ¤é¤À§åCALL¡A旣´£髙§Q²v¡A¤]¦³§Æ±æ¹ïªÑ»ù¦³§U¯q¡A ³oÓ¬O§A̪ѪFµ¹¨rÆN³Ì¦nªº¡u³øµª¡v°Õ |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/12 ¤U¤È 09:53:16²Ä 4273 ½g¦^À³
|
Æ[ÂI§ë®Ñ¡G¯Îû£´f©Ò¯A¯E¹©®×¬OªÀ·|¾D¨ü»X½ªªº¬Fªv¢®`¡H ©|²M©ú 2017¦~01¤ë11¤é 06:00 www.storm.mg/article/211190 ÁÙ¨S¶i¤J¥qªk¼f§P Àˤ賺¥iÄêÅv¶}°OªÌ·|«ü±±µL¸o±À©wªº¶ûºÃªÌ Y´X¸gªk®x§ð¨¾«á ¯E¹©¤º½u¤£¦¨¥ß ¯Î°|ªøµL¸o Àˤè¬O§_Ä@·N¶}°OªÌ·|¹Dºp ¸g°ê½ßµ{§Ç½ß¿úµ¹·í¨ÆªÌ¥H«ì´_¦WÅA¡H »OÆWªº¥qªk¯uªºn§ï² ¥q§ï·|³ºµM¨S¤H¥X¨Ó©áÀ»ÀˤèÄêÅv¡H »OÆW¦U¤j¾Çªk«ß¨t±Ð±Â̯uªº©ñ¥ôÀˤè¦k¬°¡H ª©¥DY¥Í®ð§Úªº¦k¬° ¥i¥H³w¦æ§R°£®@ |
|
|
·|û¡GÂyªÌ10142287 µoªí®É¶¡:2017/1/12 ¤U¤È 07:43:48²Ä 4272 ½g¦^À³
|
¦bªÑ²¼¥«³õ²V¤F¦h¦~¤F¡A µý¨é°Ó´N¬O¡u«Ü³Q°Ê¡A ¤Ï¥¿nÅý§Qµ¹«È¤áªº¡A«È¤á¤£¥D°ÊÁpµ¸¡B³qª¾¡A ¥LÌ´Nµø¦Ó¤£¨£¡A ·Q·Q¬ÝÃÒ¨é°Ó¥H«eªº°h¶Ä¬O¦p¦¹¡]«È¤á¤£´£¡A¥ð·Q ¥L㑹¥D°Êµ¹©Î´£髙¡^¡A ¿Ä¸ê§Q²v¤]¬O¡A¥un«È¤á´£¥X¡A§O»¡¥Ñ6¢H°¨ì5¢H¡A ¦³¨Ç«È¤á⋯,¬Æ¦Ü4¢H¥H¤U³á¡A ¦Ó²{¦b¯E¹©É¨é§Q²v¤w¸gÃk¤É¨ì10¢H¥H¤W¡A¥H¤µ¤Ñɨ馨¥æ 633±i¡A¨ä¤¤10¢H¥H¤Wɨé±i¼Æ¶W¹L500±i¡A¬Æ¦Ü¦³11¢Hªº¡A Ây ¤Hª¾¹D¡A§A̲{¦b¤â¤¤É¥X¥hªº13000¦h±i¨é¡A´X¥G³£ ¶È¶È¤@¦~5¢H¡A§O·Q¨é°Ó·|¥D°Ê´«¬ù¤F¡A¨ºÓ¬O¨rÆN©M¨é°Ó ªºÀq«´¡A«È¤á¦³´£¥X¨Ó¦A«Ä³¡A ©Ò¥H§AÌn¥D°Ê´£¥X⋯,·í¤j®a³£CALL¦^¡A¨rÆN¨S»³ªº⋯, §Q²v«Ü§Ö¯}15¢H¡A¨£20¢Hªº¡A¯uªº¥«³õ¯E¹©ªº¨é«Ü¯Ê¡A ·í±Á{¥þ±CALL¦^¡A¨rÆN¶È¯à¡u±ÂÅv¡v¨é°Ó¡A𣎴p»ùÉ¨ì »Ýnªº¨é¡A©Î³\ÁÙ¦]¨é¤£¨¬¡AµLªk¦A¤U¨é½æ³æ³á¡I §O«È®ð¡AºÉ¶qCALL¦^ɨé¡A§A̳̤jªº·l¥¢¬OÁȤ£¨ì´X¤Ñ §Q®§¡A¦ý©Î³\ªÑ»ù¤@©w¦^õXªºÅý§Aº¡·N |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/12 ¤W¤È 12:41:44²Ä 4271 ½g¦^À³
|
¯Î±Ò´fªº¦³¸o»PµL¸o¤§¶¡ 2017-01-11 11:07 www.peoplenews.tw/news/c45ddbd7-64f2-48d7-bfc8-f94db93140a8 ªk«ß±M®aªº·Qªk¡A´f½Ð°Ñ¦Ò¡Aª©¥DYı±o¤£§´¡A¦Û¦æ¨M©w§R°£¡AÓ¤H¬ã§P³o¥ó®×¤l¯E¹©·|¤j³Ó¡A¯Î°|ªø¯à°÷¥þ¨¦Ó°h¡CµL¸o±À½×ì«h¤U¡AÀˤ賺¶}°OªÌ·|¡A¦n¹³¦Û¤v¬Oªk©x¦b©w¸o¤@¼Ë¡Aþ¤@¦ìªk«ß¤H·|»{¦P©O ¯E¹©¤@©w·|´ç¹LÃøÃöªº ¯Î°|ªø³Ì²×¥²·|³Ó§Qªº |
|
|
·|û¡G¦¿¤j¤á10140161 µoªí®É¶¡:2017/1/11 ¤W¤È 11:48:41²Ä 4270 ½g¦^À³
|
¬~Áy?©p¶Ü? |
|
|
·|û¡G¦¿¤j¤á10140161 µoªí®É¶¡:2017/1/11 ¤W¤È 11:42:44²Ä 4269 ½g¦^À³
|
¨º¥«È¤£´N§Ö20»õ¤F¡A¦n¼F®`! |
|
|
·|û¡G¶Wô10139528 µoªí®É¶¡:2017/1/11 ¤W¤È 11:37:54²Ä 4268 ½g¦^À³
|
THERFªÑ»ù¤w¸gº¦¨ì2.2¬ü¤¸¥H¤W,«ô°U¦pªGn®³¦³§Q¼Æ¾Ú½Ð®³³Ì·sªº,©ÎªÌ´£¥X±z¸ÔºÉ¬Ýªk¸ò¤ÀªR,¤£n¦b³oÃ仡¼L,¤S³Q¤H¬~Áy,¤§«e¤w¸g³Q¬~¤@¦¸¤F,¦pªGn³Q¦h¬~´X¦¸,§Ú¤]¤£¤¶·N |
|
|
·|û¡GÂyªÌ10142287 µoªí®É¶¡:2017/1/11 ¤W¤È 11:23:34²Ä 4267 ½g¦^À³
|
°Ñ¦Ò°Õ ¬Ý¨ì¥~¸ê°µû¯E¹©§ë¸ê¥Ø¼Ð¡A ¹ê¦b¥O¤H·P¼Û°Ú⋯, ¤H®a¡u¦³¿ú¡v¤S¦³¡uÅv¶Õ¡vªº¨rÆN¡A ¥i¥Hµ²¦X°Å±¼¨Ó°t¦X¶g¥Z¡B´CÅé¨Ó¼vÅT¤½¥qªÑ»ù¡A ¦ûºÉ«K©y¡A ɨéªÅ³æ©ñ¤F12000¦h±i¡A´X¥G¬O¥«³õ¥i¥Î¨é³æªº80¢H¤F¡A ¦Ó¨rÆN¤]ª¾¹D¡A¦b°_¶D¯Î°|ªø¤Î¯E¹©¤½¥q¤Hû«á¡A¤]¨S¦³¤°»ò ªÅ¶¡¥i¦A¥´À£¯E¹©¡A ·íµM±o§ä¡u³Æ´©¡v¥X³õ¡A¥H¨Ï¯E¹©§ë¸ê¤HÅ宣¡A¦Û¬Û´Ý±þ¡A ¨e̦n§C»ù¦^¸É⋯,»°ºòµ²±b²æ¨¡A ¦]¬°¨rÆN¥un¤@·Q¨ì⋯,¨e̦ÃöG¤F¯Î¡B±iµ¥¤H¡A 쥻¬O¬Ý¡u¥ì¡v¤H¤½¥qªº¸gÀç³´¤J§x¹Ò¡A·Q¶X¾÷¬ð撃⋯, ¦ý·Q¤£¨ì¡u«nX¤H¹Ø¡v¥h¦~Àò§Q¡A¤j¯«¦^¡A¨rÆN¦¤w¨£]ÀY ¤£¹ï⋯, ¦Óªñ¤ë¨Ó¼íX¦b»´ä±¾µPªº¡u髙øÊ¡v¡A§ó¬O¨gº¦80¢H⋯, ¨rÆNµû¦ô¡u¥ì¡vªº°]¤O¡A¤£¶È¨SÅÜ®t¡A¤Ï¦Ó§ó±j¡A³o¤U¨rÆN§ó¬O§¤¥ßÃø¦w⋯,Y¦¹®É¡u¥ì¡v¨M©w¥X¤â¡A¨e̤@©wÆN°©µL¦sªºXD¡A ©Ò¥H¤~¤@¤U¥qªk¡A¤@¤U¥~¸ê¡A¨ä¥ØªºµL«D¬O¡u»°§ÖºM¡v¡A ¥i´N¬O°¾°¾¹J¤WµwÀVªº¯E¹©§ë¸ê¤H⋯,·Q¸É¤]¸É¤£¦^¨Ó¡I ©Ò¥HÂy¤H¤~¡u«ô°U¡v⋯,§A̯E¹©ªÑªF¦æ¦æ¦n¡A 12000ӪѪF¡A¤j®a¨C¤H¶R¤@±i¡Aèè¦nÀ°¨e̸ɧ¹¡A¯uªº«ô°U¤j®a¤F⋯! ¡]¥H¤W¯Âºé½¼ÙT¡A¯u¹ê¦p¦³¹p¦P¡A¥²µM¥©¦X¡^ |
|
|
·|û¡G¦¿¤j¤á10140161 µoªí®É¶¡:2017/1/11 ¤W¤È 10:54:26²Ä 4266 ½g¦^À³
|
¤@¦~3»õ¬üª÷¡A¥u§ä¾P°â¹Ù¦ñÀ禬¥þºâ¥Lªº¡A12¦~36»õ¬üª÷±z»¡¥´´X§é©O?? |
|
|
·|û¡G¦³¹Ú³Ì¬ü10141895 µoªí®É¶¡:2017/1/11 ¤W¤È 10:51:33²Ä 4265 ½g¦^À³
|
½Ð¦¿¤j¤á¶}¥Ün¥´´X§é?¥H«K°Ñ¦Ò |
|
|
·|û¡G¦¿¤j¤á10140161 µoªí®É¶¡:2017/1/11 ¤W¤È 10:31:39²Ä 4264 ½g¦^À³
|
µM«á?³o»ò§Q®`¤£¬OÀ³¸Ón®u±²¥þ¥@¬É¥´Ãz¥þ¬ü¤jÃļt?? ±q¤@¦~3»õ¬üª÷¨ìÁ`±ÂÅvª÷ÃB2.2»õ¬üª÷?³o¨Ç¤H»¡¸Ün¥´´X§é? |
|
|
·|û¡GµL¹Ð10141268 µoªí®É¶¡:2017/1/11 ¤W¤È 10:27:41²Ä 4263 ½g¦^À³
|
tmb355q»ù¤@¦~4.5¸U¬üª÷¡A¥Ø«e¹wp22500¬ü°ê¤H±N¨Ï¥Î |
|
|
·|û¡G¦¿¤j¤á10140161 µoªí®É¶¡:2017/1/11 ¤W¤È 10:21:41²Ä 4262 ½g¦^À³
|
2014 ±i©Àì¤ÀªR¡A¬ü°ê·R´þ¯f±w±µ¨üªvÀøªº¬ù¦³80¸U¤H¡A¨ä¤¤ÄÝ©ó«á´Á±Ú¸sªº¬ù¦³5-10¸U¤H¡A¦Ó«á´Á¥i¥ÎÃĪ«¬ù¦³5-6ºØ¡A¦pªG¦ôºâ2-3¸U¤H¾A¦X¥ÎTMB-355¡AY³o¨Ç¤H¤§¤¤¡A¤S¦³1/3½T©w¨Ï¥ÎTMB-355¡A¥H¹L¥h«á´Á·R´þ¯f¥ÎÃĤ@¦~¥§¡¬ù»Ýªá¶O2¸U¬ü¤¸pºâ¡ATMB-355¥¼¨Ó¥«³õ»ùȦܤ֦³3»õ¬ü¤¸¡C |
|
|
·|û¡G¦¿¤j¤á10140161 µoªí®É¶¡:2017/1/11 ¤W¤È 10:11:56²Ä 4261 ½g¦^À³
|
2015/8 ¦Ü©ó¥~¬ÉÃö¤ßªº¡u±ÂÅv¡v¡A±i©Àì±j½Õ¡A¤¤¸În§äªº¬O¡u¦æ¾P¹Ù¦ñ¡v¡A©Ò¥HÄY®æ¨Ó»¡¤£¬O±ÂÅv¡A¦]¬°¥¼¨ÓÃÄ«~ªº«~µP¡BÃÄÃÒ³£¬OÄÝ©ó¥xÆW¤¤¸Î¡A¤£¬O±M§QÅv§QÂಾªºLicence Out¡A¥Î¡u±ÂÅv¡v¨Ó§Î®eÂù¤è¦X§@¡A¤£°÷ºë½T¡C ¡@¡@±i©Àìªí¥Ü¡A¥Ø«e·R´þ¯f¦æ¾P³q¸ô³£´x´¤¦b´XÓ¤j¼t¤â¤W¡A¥LµLªk¹w´ú¥i¯à¡uªá¸¨½Ö®a¡v¡A³o¨Ç¤j¼t³£¬O¤f³U¤¤ªº¹Ù¦ñ¦W³æ¡C ¡@¡@¤£¹L¡A·~¬É¤]¹w¦ô¡A¥H¤¤¸Î²{¦³ªºªº§Ü·R´þ¯f²£«~²Õ¦X¡A¥]¬A¤w¸g¦bÁ{§É¤T´Á¡B§Y±N¥Ó½ÐÃÄÃÒªºÀR¯ßª`®g¾¯«¬¡AÁÙ¦³¥Ö¤Uª`®g¡BLM52µ¥¦hºØ²£«~¡A³£¬O·¥¨ã¦³Ävª§¤O§Ü·R´þ¯f¥ÎÃÄ¡A´«¨¥¤§¡A´X¥G¥i¥H¹è¥e·R´þ¯f±w¥ÎÃÄ¥«³õ¡A³W¼Ò¥iÆ[¡C ¡@¡@¦]¦¹¡A¤¤¸Î»P¹Ù¦ññÄݦX§@¨óij«á¡A¥ý´Á¥i¯à¨ú±oªº¡u¦X§@Åv§Qª÷¡v¡A¬Æ¦Ü¾ãÅ骺¾P°âÅv§Qª÷¡A¤]»á¨ã·Q¹³ªÅ¶¡¡C¸¬É¬Æ¦Ü¹w¦ô¡A±N³Ð¤U¥xÆW·sÃĦb°ê»Ú±ÂÅvªº¬ö¿ý¡C 2016/3 ¤¤¸Î(4147)·R´þ¯f·sÃÄTMB-355²×©ó½T©w°ê»Ú±ÂÅv®×¡A¦X§@¾P°â¹Ù¦ñ¬°¥[®³¤jTheratechnologies Inc.(THERF)(ªÑ²¼¥N¸¹¡GTH.TO)¡A½T©w¦b¬ü°ê¤Î¥[®³¤j¦a°Ï¿W®a12¦~¾P°â¦æ¾P«´¬ù¡A¦X¬ù¤º®e¥]¬ATMB-355ÀR¯ßª`®g¥H¤Î¥¼¨Ó¶}µoªº¦Ù¦×¾¯«¬¡A¾P°â¤À¼í¤ñ¨Ò«e´Áª÷1050¸U¬ü¤¸(³¡¤À¬OTHERFªÑ²¼)¡A«áÄòÁÙ¦³¬ãµo¨½µ{ª÷¤Î¾P°â¨½µ{ª÷¤Î¤À¼íª÷¡A¦Xp³Ì°ª¾P°â±ÂÅvª÷¹F2.2»õ¬ü¤¸¡C ±i©Àì¹w¦ô¡AY2017¦~²Ä1©u¥i®³¨ìÃÄÃÒ¡A2¦~¤º®³¨ì2000¸U¬ü¤¸ªº«e´Áª÷¤£¬O°ÝÃD¡F¨Ã¥B±j½Õ¡A¾P°â¤À¼í52¢H¤~¬O³o¦¸¦X¬ùªºÃöÁä¡A¤¤¸Î¬Ý¦nTHERF¥¼¨Ó¾P°â¼ç¤O¡A¦P®É¤]¹ïTMB-355¦³«H¤ß¡A¤~·|±N«ÂI©ñ¦b«á±ªº¤À¼í¤ñ¨Ò¡C ¹ï¦¹¡A°õ¦æªø±i©Àì¬Û·íº¡·N¡A»{¬°¤À¼í¤ñ§QÀu©ó¹w´Á¡A¥´¤Fº}«Gªº¤@¥M¡A¤£¹L¨é°Óªk¤HˬO·N¥~¦a¤£¬Ý¦n¡A»{¬°§Y¨Ï¤À¼í¤ñ¨ÒÀu©ó¥§¡È¡A¦ý±ÂÅv¹ï¶H¥«È»·§C©ó¤¤¸Î¡AB©@¼t°Ó¯à§_±N¤¤¸Î³oÁû·sÃijФU¾P°â¨ÎÁZ¡A¥´¤F¤@Ó¤j°Ý¸¹¡C ¥ý±q±ÂÅv¹ï¶HTHERF¨Ó¬Ý¡A¶È¶È¬O¤@®a¥[®³¤jÃÄ«~¦æ¾Pªº¤p¤½¥q¡A¥H¥Ø«eªÑ»ù1.3¬ü¤¸¨Ó¬Ý¡A¥«È¶È3260¸U¬ü¤¸(¦X¬ù¥x¹ô10»õ¤¸)¡A»·§C©ó¤¤¸Î¬ù527»õ¤¸ªº¥«È¡A§Y¨Ï¾P°â¤À¼í°ª©ó·~¬É¥§¡¦æ±¡¡A¦ý¥¼¨Ó¯à³Ð³y¦h¤Ö·~ÁZÁÙ¦³«ÝÆ[¹î¡C 52¢H¾P°â¤À¼í¤Wªº¥È¾÷ ¦b±q52¢H¤À¼íªº²Ó¸`¤W¨Ó©î¸Ñ¡A³o¨ä¤¤ÁÙ¥]§t©e°U¤¤¸Î»s³y·sÃĪº¦¨¥»¡A§Y¤ä¥IÃÄ©ú±d¼w¥N¤u»s³yTMB-355»s¾¯ªº¶O¥Î¡C¥xÆW¤u»È§ëÅU¨ó²z¹ù©÷«G«ü¥X¡A¨Ì·~¬É¥§¡¤ô·Ç¡A±À¦ô¸Ó»s³y¶O¥Î¬ù¬°¾P°â»ù®æªº15¡ã20¢H¡A¯u¥¿ªº¤À¼í¶È30¢H¥ª¥k¡A³o¼Ë¸ò¤@¯ë¾P°â¤À¼í¨S¦³¤Ó¤j®t²§¡A¥u¯à»¡±ÂÅv½Í§Pªí²{±o¤¤³W¤¤¯x¡A®t±j¤H·N¡C |
|
|
·|û¡G¦¿¤j¤á10140161 µoªí®É¶¡:2017/1/11 ¤W¤È 09:55:12²Ä 4260 ½g¦^À³
|
1.¥«³õ¤£·|¥þ¬O§Aªº¡A¦³10%¡Aºâ¤£¿ù¤F¡A¥±`ªá¤F¨º»ò¦h¿ú¸òÂå°|¡B¬F©²¥´¥æ¹D¡A§O§â¥@¬É¯ÅÃļt·í²Â³J¡C 2.¤£¥i¯àª½±µ½æ¡A©e°U¾P°â¦¬¨ú±ÂÅvª÷30%¤£¿ù¤F 3.¾P°âÃĪ«¦³°ª§C®p´Á ¯uªº°µ¥X¨Ó±ÂÅv´Á¶¡³Ì«á§é²{¦³3,4¦Ê»õÀ禬¤£¿ù¤F¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/1/11 ¤W¤È 09:48:41²Ä 4259 ½g¦^À³
|
¤Ñ©R¤j ¥unFDA ¦P·N¤T´ÁÁ{§Éªí¥Ü¤w¥´±Ñ85¡P5¢Hªº¨ÅÀù·sÃĬãµo®×¥ó¡C ¥xÆW¯E¹©¤w»P¬ü°êFDA°ÓÀÀ¥X2´Á«á3´Á«e¿Ô¸ß·|ij¡]End-of-Phase 2 Meeting¡^ijÃD ijÃD³£±Æ¦n¤Fªí¥Ü¤G´Á¦³¯S¦â¦³Àø®Ä ,¦P·N¤T´ÁÁ{§É¤w¤£¬O°ÝÃD,¥uµ¥²Ó¸`...... 1.¨Æ¹êµo¥Í¤é:106/01/10 2.¤½¥q¦WºÙ:¥xÆW¯E¹©¥Í§ÞªÑ¥÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¤£¾A¥Î 4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î 5.¶Ç¼½´CÅé¦WºÙ:¸gÀÙ¤é³øA2ª© 6.³ø¾É¤º®e:¸gÀÙ¤é³øA2ª©³ø¾É¡u...¯E¹©ªºOBI-822¬ü°êÁ{§É²×©ón°Ê°_¨Ó¡A¤¸¤ë¤¤¤U¦¯ ¯E¹©¥i±æ«e©¹¬ü°ê»PUSFDA¶i¦æÁ{§É³]p²Ó¸`ªº°Q½×¡Aºâ¬O¥t¤@Ó·s¶i«×¡C¡v 7.µo¥Í½t¥Ñ:¼á²M¸gÀÙ¤é³øA2ª©³ø¾É 8.¦]À³±¹¬I: ¥»¤½¥q¹ï©óOBI-822ªºÁ{§É¤T´Á¸ÕÅç³]p¤§³W¹º¤@ª½¿n·¥¶i¦æ¤¤¡A¤w»P¬ü°êFDA°ÓÀÀ¥X 2´Á«á3´Á«e¿Ô¸ß·|ij¡]End-of-Phase 2 Meeting¡^ijÃD¡A±N°t¦X¬ü°êFDA¿ï©w¤§¾A·í ®Éµ{¥l¶}¦¹¿Ô¸ß·|ij¡AY¬ü°êFDA¦³¥¿¦¡µ²½×¡A¤½¥q·|¨Ì·Óªk¥O¹ï¥~¤½§i |
|
|
·|û¡G±¡¸q10143273 µoªí®É¶¡:2017/1/11 ¤W¤È 07:33:19²Ä 4258 ½g¦^À³
|
ªáºX¹ï¯E¹©°µû¦Ü½æ¥X¡A³o¤U¦³½ì¤F¡A§CÀÉÃa®ø®§¤£Â_¡A²f·Ò©³³¡¡A §OºÞk¤j»¡¤°»ò¤F¡AªÑ»ùº¦°_¨Ó¡A¥L¦ÛµM¼L¤Ú³¬¤W §ë¸ê¯E¹©¬O±ø¨¯Wº©ªøªº¸ô¡A¤j®a¥[ªo |
|
|
·|û¡Gbellad10142239 µoªí®É¶¡:2017/1/11 ¤W¤È 03:24:17²Ä 4257 ½g¦^À³
|
µ§»~:µS°O ª©¦W:À˵ø¯E¹©®×¬ÛÃö³Q°_¶DªÌ¬O§_¸o¦³À³±o¤Îªk½ü¥\»PªÑ²¼°Q½×°ÏªºÃö«Y |
|
|
·|û¡Gbellad10142239 µoªí®É¶¡:2017/1/11 ¤W¤È 03:13:45²Ä 4256 ½g¦^À³
|
Ksj¤j¡A¦³¾÷±z¤@ª½nª©¤Í´L«§Aªºµo¨¥Åv¡CµM¦Ó§g¤l¥²¦Û«¡A¦Ó«á¤H·q¤§¡C½Ð±z§O¦b±M·~ª©¶K¤¥|¤Tªº³sµ²¡A¦n¤£®e©ö¨S¤Fªk½ü¥\¤]¥i¶iASCOªº·s»D¡A²{¦b¤S¤@ª½¶K¨Ç´CÅ骺¤H¤ª ¥ç¤ª¡A¤Z¨Æ¾A¥i¦Ó¤î¡C «Øij±z¡A¤@¡A§O¦b³o¯ë«V°d¤F¶}ª©ªº¤j¤jªº±M·~¡C¤G¡A¦pªG±z»{¬°±z³o¼Ë°µ¬O¹ïªº¡A«Øij¥t¦æ¶}ª©¡C ¤]½Ð±z´L«¨ä¥Lª©¤Í¹ï¯E¹©¦Uª©±M·~ªº´L«¡A¿í¦u¹CÀ¸³W«h¡A¨S¦³¤Hªý¤î±z¥t¶}·sª©ªº¡C |
|
|
·|û¡G½ÞÀY¸£10142651 µoªí®É¶¡:2017/1/11 ¤W¤È 12:27:37²Ä 4255 ½g¦^À³
|
ksj ¤j¤j±z¦n¡I ¤p§Ì²`ª¾·íªì±z©Ò»¡¹Lªº¸Ü¡A¦ý¬O«Øij§â³o¨Ç¸ê®Æ³sµ²¡A PO¦b¯E§b²á¤Ñ«Ç¡A¤å¤¤¥[µù¨£¸Ñ¡AÀ³¸Ó¸ûµLª§Ä³¡C ¦³¨Ç½t¥Ñ¦p¦ó¡A¦³¤ß¤H¦ÛµM¤FµM©ó¯Ý¡A¤p§ÌÀµ½Ð±zÄÀÃh¡C ÝÅ¥«h©ú¡A°¾Å¥«h·t¡C±zªºW¤ß¡A¤£·\«Îº|¡C |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/11 ¤W¤È 12:14:35²Ä 4254 ½g¦^À³
|
¡i¤O®¼¯Î°|ªø¡j ¦Û¥Ñ¼s³õ¡n¯Î±Ò´f ¸o»P»@ goo.gl/M3NwvD ª©¥D¥i¦Û¦æ¨M©w¬O§_§R°£ §ÚºÉ¤O¤F |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/10 ¤U¤È 10:47:53²Ä 4253 ½g¦^À³
|
¡iÀˤè¥i¯à¥Î¿ùªk±ø¤F¡j ¤¤¬ã°|¬ã¨sû¤£¬O¤½°Èû 2014/05/13 13:18 m.appledaily.com.tw/realtimenews/article/new/20140513/396866/ ¯Î±Ò´f¦³¥Ç¸o¶Ü 2016/03/25 00:08 m.appledaily.com.tw/realtimenews/article/new/20160325/823643/ ¬ã¨sû¦P¤½°Èû ¯Î±Ò´f°Ý¥x¬F°|ªø 2014¦~07¤ë02¤é 2:05 PM www.epochtimes.com/b5/14/7/2/n4191277.htm/amp?client=ms-android-sonymobile ³s¦¿©y¾ì... www.wetalk.tw/thread-14378-1-1.html |
|
|
·|û¡G¦³FUªº¤H10136189 µoªí®É¶¡:2017/1/10 ¤U¤È 10:08:25²Ä 4252 ½g¦^À³
|
ksj¤j§Aµoªº¤º®e»P³oª©ªº¼Ð´£µL¥ô¦óÃöÁp³á |
|
|
·|û¡Gbill10135881 µoªí®É¶¡:2017/1/10 ¤U¤È 09:59:37²Ä 4251 ½g¦^À³
|
K¤j¡A¯E¤Í³£¬}±x§Aªº¡¨¥Î¤ß¡¨¡A³o©Û¡¨悪°µ¹Ãij桨¦b³o¸Ì¬JµL®Ä¤]µL²á¡I¥u·|Åý§A¦Û¤v³±¼w©Û·l¡A½Ðk¤j´N¦¹¥´¦í§a¡I |
|
|
·|û¡Gyo10138368 µoªí®É¶¡:2017/1/10 ¤U¤È 09:42:36²Ä 4250 ½g¦^À³
|
¤@¬N¶K·s»D-.- §¹¥þ´N¸òªOÀY¼ÐÃD¤ÎÅó±ø±ø¤j³Ì«á¤@¥y ¡qÅwªï¤À¨É¥ô¦ó¹ï¯E¹©Ä@´º»P»ùȵû¦ôªº¬Ýªk»P°ª¨£~~¡r §¹¥þµL¥ô¦ó¬ÛÃö!! |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/10 ¤U¤È 09:33:22²Ä 4249 ½g¦^À³
|
¡i¯Î°|ªø¥[ªo¡j bill¤j¡A¨ü±Ð¤F §Ú±o§V¤O¾\Ū ¤À¨É¨ì³o¥¥x ª©¥D¥i¥H¦Û¦æ¨M©w§R°£®@ ¯Î´¿«ù¯E¹©°O¦WªÑ²¼ ¦Ü¤Ö4000±i 2017-01-10 m.ltn.com.tw/news/focus/paper/1069906 5»õ°|ªø¡I ¯Î±Ò´f¨®aÃn¥ú 2017-01-10 07:45 m.ltn.com.tw/news/life/breakingnews/1942469 ¹J¨ì¤@¥ó½èºÃ ´N¤@¥ó¤@¥ó¸Ñ¨M §Ṳ́ߤ¤ªººÃ´b»P«÷¹Ï °OªÌ̤]¦b«÷´ê §Ú̳£¦³¦Û¤vªº§PÂ_¯à¤O ³o¨Ç³£¸ò§Ú̪º§ë¸ê¦³Ãö ¤£Ãö¦³§Qªº©ÎµL§Qªº¸ê°T §Ú̳£À³¸Ó¼sªx¾\Ū®@ §Ú·|¥þ¤O¬°¯Î°|ªø¯¬Ã«ªº |
|
|
·|û¡Gsuperjoe10141522 µoªí®É¶¡:2017/1/10 ¤U¤È 09:33:05²Ä 4248 ½g¦^À³
|
³o³Ã¥ë¬O¨Ó¶Ãªº, É°T®§´£¨Ñ, ¨Ó·d¯}Ãa. °T®§¤j®a³£ª¾¹D,¨S¨Æ½ÐÂ÷¶}§a! ©^ÄU§A¦h¿n¼w,¤Ö³yÄ^! |
|
|
·|û¡G¥m¾´10141821 µoªí®É¶¡:2017/1/10 ¤U¤È 09:28:54²Ä 4247 ½g¦^À³
|
ksj¤j¡A§A³oºØ¤âªk§Ú¤w¸g¬Ý¹L¦n¦h¦¸¤F¡Aªí±¤W¬°¯E¹©¬°¯Î°|ªø¥s©}¡A¨Æ¹ê¤WÂà¶Kªº«o¬O ¦¾öG¤£¹êªº¸ê°T¡A·N¦b²V²cµøÅ¥¥´À»¯E¤Íªº«H¤ß¡Aºô¸ôªºÁÁ¨¥¥H¤Î°²·s»D¡AÁÙ¤£°÷¦h¶Ü¡H «Ü¦h¤j¤j¦b¦¹¤p¤ßÁlÁl¡A¤Þ¥Î¼Æ¾Ú¼·¶Ã¤Ï¥¿¡A¶Ç»¼¥¿½Tªº¸ê°T¡C¦ý§A«o¨Ó³o¸Ì´²¥¬¦³¤ß´CÅé©Ò¼gªº·s»D¡A §¹¥þ¤£¹LÂo¡A¥xÆWªº´CÅé¯à³Q¦¬¶R¡A¦¤w¤£¯à¥NªíÁֽסA¦³¿ìªk¬Ý²M¨Æ¹ê¤À¿ë¬O«Dªº¤H¡A¯à¦³´X¤H¡H ¤Ï¥¿´CÅé¼g¥X¨Óªº°²·s»DÁ`·|¦³¤H¬Û«H¡A¤T¤H¤]¯à¦¨ªê¡A§A̬O³o¼Ë·Qªº§a¡Iª©¤W¤£¤Ö°°µ½ªº¯E¤Í¡A ³£¥Î³oºØ¤âªk¡C ksj¤j¡AY»~·|§A¤F¡A¨º´N½Ð§A¥ý¹LÂo¤£¹êªº³ø¾É¦A¶K§a¡AY§A¨S¯à¤O¹LÂo¡A¦ó¥H¾¬±æ¨ä¥L¯E¤Í¯à¤½Â_¡H |
|
|
·|û¡Gbill10135881 µoªí®É¶¡:2017/1/10 ¤U¤È 09:23:27²Ä 4246 ½g¦^À³
|
K¤jªºpo¤å«Ü©Ç²§®@¡I«e±¤O®¼°|ªø¡A¨ì«á±«oË¥´¤@§â¡A¤ß«äÁ`Åý¤Hı±o²§±`©Ç²§¡I |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/10 ¤U¤È 09:10:53²Ä 4245 ½g¦^À³
|
¡i¤O®¼¯Î°|ªø¡j ¯Î±Ò´f°_¶DÂÅÀçn¤p^¿å¦@ ¤ý©w¦t¤@¥y¸Ü¬ð¯}ª¼¸z¡I 2017-01-10 11:19 m.ltn.com.tw/news/politics/breakingnews/1942675 ...Y¨S¦³¥Ç¿ù§O§â¤@Ӯפl©ì¨º»ò¤[¡A¹³·í®É¤¤¬ã°|ªº¥Íª«©Ò©Òªø¡A§P¨ì³Ì«á§PµL¸o¡A¤@Ó¬ì¾Ç®a³£³Q·´±¼¡C ¯E¹©®×°»µ² ¯Î±Ò´f.±i©À·O³g¦¾¾D°_¶D 2017/ 01/ 10 19:49 video.udn.com/news/625757 ...¬d¦©¯E¹©¤º³¡ªºªÑÅv¤À°tªí¡Aµo²{¸ü©ú±i©À·O«ù¦³ªº1500±i§Þ³NªÑ¡A¨ä¹ê¬OÄÝ©ó¯Î±Ò´f©Ò¦³¡A¦Ó³o1500±i§Þ³NªÑ¡AÀˤè»{©w¬O¯Î±Ò´f¨p¤U´£¨Ñµ¹¯E¹©¤¤¬ã°|¬ãµo§ÜÀù¬Ì]ªºÃöÁä§÷®ÆÁÞ¤À¤lªº§Q¯q¥æ´«¡A¡iÁöµM¥æ©ö³Ì²×¨S¦³§¹¦¨¡A¦ý¤´ºc¦¨´Á¬ù¦¬¸ì¡j... |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/10 ¤U¤È 08:23:20²Ä 4244 ½g¦^À³
|
¡i¯Î°|ªø¥[ªo¡j ¯Î±Ò´fªÑ²¼¥æ©ö²§±`¡@ ¬ü°ê¥qªk³¡ÁÙ¨Sµ²®×¡H 2017/01/10 18:45 m.appledaily.com.tw/realtimenews/article/new/20170110/1032225/ ³o¬O·í¦~ªº¦Ñ®×¤l Y¯à¸Ñ¨M¥xÆWÀ˽ճo³¡¥÷ºÃ¼{ «h¯Î°|ªø¥i¥H¥þ¨¦Ó°h |
|
|
·|û¡G¦¿¤j¤á10140161 µoªí®É¶¡:2017/1/10 ¤U¤È 05:36:57²Ä 4243 ½g¦^À³
|
¥Î³oºØ²³æºâ¦¡pºâ¥X¯E¹©»ùȯu¬O¤Ñ¤~¡A¨Ì³o³oºØÅÞ¿è¡A²Î¤@À³¸Ó¬O¯E¹©³Ì¤jªÑªF§a¡C |
|
|
·|û¡Gsuperjoe10141522 µoªí®É¶¡:2017/1/10 ¤U¤È 04:55:37²Ä 4242 ½g¦^À³
|
·PÁ ¤Ñ©R¤j,¥xÁÞ¤j ¹ï¯Eô¤£Â÷¤£±óªººë¯«¤Î¥J²Ó¤ÀªR !! ¤]³\¤µ¦~¤j®a³£¹ï¯Eô¥¢±æ¤F! ¦ý¦p¥xÁÞ¤j©Ò»¡¥xÆW¯E¹©¤w¶i¤J¦¬³Î´Á¤@ÂI¤]¤£¬°¹L, ¬y²\¼»ºØªº¡A ¥²Åw©I¦¬³Î¡I ®É¶¡¤w¦b¯Eô³oÃä, «á±«Ü¦³¬ÝÀY!! ÁÂÁ¦U¦ìªºµ½©À!! ¦³¦nªºªG³ø!! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2017/1/10 ¤U¤È 04:37:54²Ä 4241 ½g¦^À³
|
¤jÃø¤£¦º ¥²¦³«áºÖ |
|
|
·|û¡Gsuperjoe10141522 µoªí®É¶¡:2017/1/10 ¤U¤È 04:11:16²Ä 4240 ½g¦^À³
|
¦U¦ì¤j¤j, ¯Eô³Ì¤j§QªÅ¤w¥h,¤j¦h¼Æ¤HÁÙ¬O°Û°I, ³o¹ï¯Eô¬O¦n¨Æ,ÀRԨε§a,»Ýn®É¶¡§a! ¯¬ºÖ¤j®a!! ¼ç¤ô¥h¤F.... |
|
|
·|û¡GºÃ´bªÌ10140504 µoªí®É¶¡:2017/1/10 ¤U¤È 03:44:38²Ä 4239 ½g¦^À³
|
¯E¹©¦b¤µ¤Ñ³o«h¤¤¤j°T®§´£¨ì,¤w»P¬ü°êFDA°ÓÀÀ¥X2´Á«á3´Á«e¿Ô¸ß·|ij¡]End-of-Phase 2 Meeting¡^ijÃD¡A±N°t¦X¬ü°êFDA¿ï©w¤§¾A·í®Éµ{¥l¶}¦¹¿Ô¸ß·|ij¡AY¬ü°êFDA¦³¥¿¦¡µ²½×¡A¤½¥q·|¨Ì·Óªk¥O¹ï¥~¤½§i¡C 1.¨Æ¹êµo¥Í¤é:106/01/10 2.¤½¥q¦WºÙ:¥xÆW¯E¹©¥Í§ÞªÑ¥÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¤£¾A¥Î 4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î 5.¶Ç¼½´CÅé¦WºÙ:¸gÀÙ¤é³øA2ª© 6.³ø¾É¤º®e:¸gÀÙ¤é³øA2ª©³ø¾É¡u...¯E¹©ªºOBI-822¬ü°êÁ{§É²×©ón°Ê°_¨Ó¡A¤¸¤ë¤¤¤U¦¯¯E¹©¥i±æ«e©¹¬ü°ê»PUSFDA¶i¦æÁ{§É³]p²Ó¸`ªº°Q½×¡Aºâ¬O¥t¤@Ó·s¶i«×¡C¡v 7.µo¥Í½t¥Ñ:¼á²M¸gÀÙ¤é³øA2ª©³ø¾É 8.¦]À³±¹¬I:¥»¤½¥q¹ï©óOBI-822ªºÁ{§É¤T´Á¸ÕÅç³]p¤§³W¹º¤@ª½¿n·¥¶i¦æ¤¤¡A¤w»P¬ü°êFDA°ÓÀÀ¥X2´Á«á3´Á«e¿Ô¸ß·|ij¡]End-of-Phase 2 Meeting¡^ijÃD¡A±N°t¦X¬ü°êFDA¿ï©w¤§¾A·í®Éµ{¥l¶}¦¹¿Ô¸ß·|ij¡AY¬ü°êFDA¦³¥¿¦¡µ²½×¡A¤½¥q·|¨Ì·Óªk¥O¹ï¥~¤½§i¡C 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:³æ¤@Á{§É¸ÕÅçµ²ªG¡A¨Ã¤£¨¬¥H¥R¤À¤Ï¬M¥¼¨Ó·sÃĶ}µo¤W¥«¤§¦¨±Ñ¡A§ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¨Ã¥¼«OÃÒ¯à¤@©w¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A§ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C |
|
|
·|û¡GºÃ´bªÌ10140504 µoªí®É¶¡:2017/1/10 ¤U¤È 03:11:09²Ä 4238 ½g¦^À³
|
¥H¤U³o¬q¸Ü,¬O¦b¬ü°êFDAºô¯¸§ä¨ìªº Ideally, a Breakthrough Therapy designation request should be received by FDA no later than the end-of-phase-2 meetings if any of the features of the designation are to be obtained. Because the primary intent of Breakthrough Therapy designation is to develop evidence needed to support approval as efficiently as possible, FDA does not anticipate that Breakthrough Therapy designation requests will be made after the submission of an original BLA or NDA or a supplement. FDA will respond to Breakthrough Therapy designation requests within sixty days of receipt of the request. ³o¬q¸Ü¬O§_ªí¥Ü¯E¹©n¦bthe end-of-phase-2 meetings ¤§«e´N´£¥X¬ð¯}©ÊÀøªk¸ê®æªº¥Ó½Ð©O¡H ¦pªG¬Oªº¸Ü,FDA¤S¥²¶·¦b60¤Ñ¤º¦^ÂЬO§_µ¹¤©¬ð¯}©ÊÀøªk¸ê®æ ¨º´N·N¿×¤£¤[¤§«á,¯E¤Í§Y¯à±oª¾¯E¹©¬O§_®³¨ì¬ð¯}©ÊÀøªk¸ê®æ ¥H¤WY¦³»~,·Ð½Ð¦U¦ì«e½ú¤j¤j¤£§[«ü¥¿¡I |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2017/1/10 ¤U¤È 02:37:25²Ä 4237 ½g¦^À³
|
¦U¦ì¯E¤Í¡A³\¤[¤£¨£¡C §ë¸ê¨Mµ¦¡A¨Ì¿àªº¬O data point¡C¦Ó¯E¹©¤w¸g³\¤[¥¼¤½¥¬¥ô¦ó data¡C¯à¦³¦U¦ì¯E¤Í¦bª©¤W¤£°±¦a©µÄòÁ~¤õ¡A¥O¤H·P°Ê¡C ¨S¦³ data ªº¤é¤l¸Ì¡A¯à¤ä¼µ¯E¤Íªº¡A°£¤F«H¤ßÁÙ¬O«H¤ß¡C ¤@Ó¦r¡Aµ¥¡K µ¥¨ì¨£¨ì¤U¤@Ó data point¡A¦A¨Ó¬ã¨s¯E¹©ªº¯u»ùÈ¡C ¤p§Ì¼È°h¡K¡K |
|
|
·|û¡G¦N¦Ì¦Ï10000583 µoªí®É¶¡:2017/1/10 ¤U¤È 02:30:01²Ä 4236 ½g¦^À³
|
¥¬µÜ®¦¤j: (§ó¥¿) 20161222¨º¤@¬q¬O¸gÀÙ¤é³ø¦Û¦æÁr´ú¨ÃµL¨Æ¹ê®Ú¾Ú©Ò³ø¾Éªº¤º®e,¨Ã«D¯E¹©ªº¤½§i; ½Ð¤Å±i«a§õÀ¹¸ò20170110¯E¹©ªº«°T¼á²M¤å·d²V¤F~ |
|
|
·|û¡G¦N¦Ì¦Ï10000583 µoªí®É¶¡:2017/1/10 ¤U¤È 02:24:58²Ä 4235 ½g¦^À³
|
¥¬µÜ®¦¤j: 20161222¨º¤@¬q¬O¸gÀÙ¤é³ø¦Û¦æÁr´ú¨ÃµL¨Æ¹ê®Ú¾Ú©Ò³ø¾Éªº¤º®e,¨Ã«D¯E¹©ªº¤½§i; ½Ð¤Å±i«a§õÀ¹¸ò20160110¯E¹©ªº«°T¼á²M¤å·d²V¤F~ |
|
|
·|û¡G¥¬µÜ®¦10140670 µoªí®É¶¡:2017/1/10 ¤U¤È 01:38:28²Ä 4234 ½g¦^À³
|
½Ð°Ýªk³W¤W¤U¦C¨âºØ·|ij¬O¬Û¦Pªº¶Ü¡H a.¯E¹©20161222¤½§i ¡K.¡y¹©ºX¤U§Ü¨Å·sÃÄOBI-822¬ü°êÁ{§É¤T´Á¸ÕÅç³]p¡A¤w¸g©ó10¤ë¤¤¦¯¦V¬ü°êFDA»¼¥óÁ{§É³\¥i(IND)¥Ó½Ð¡A±M®a«ü¥X¡A¦¹¦¸Âù¤è°Q½×ªºµ²ªG¡A±N¥i¨M©w¸ÓÁ{§É³W¼Òªº¤j¤p¡AYÀòã°µ¡u¤p¤T´Á¡v¡A«h±N¤j´TÁYµuÁ{§É¸ÕÅç®Éµ{¡C¡z.. b.¯E¹©20170110¤½§i ¡K.¡y¥»¤½¥q¹ï©óOBI-822ªºÁ{§É¤T´Á¸ÕÅç³]p¤§³W¹º¤@ª½¿n·¥¶i¦æ¤¤¡A¤w»P¬ü°êFDA°ÓÀÀ¥X2´Á«á3´Á«e¿Ô¸ß·|ij¡]End-of-Phase 2 Meeting¡^ijÃD¡A±N°t¦X¬ü°êFDA¿ï©w¤§¾A·í®Éµ{¥l¶}¦¹¿Ô¸ß·|ij¡AY¬ü°êFDA¦³¥¿¦¡µ²½×¡A¤½¥q·|¨Ì·Óªk¥O¹ï¥~¤½§i¡C¡z¡K ½Ð°Ýa. »Pb. ¨â¥ó¨Æ¯à¦X¦Ó¬°¤@ªº¸ÑÄÀ¶Ü¡H End-of-Phase 2 Meeting ·|ijµ²§ô«á¡A¯à¥ß§Y¦³Á{§É²Ä¤T´Áªº³W½d¡B±ø¥ó¡Kµ¥¡A¯E¹©´N¯à¥ß¨èµÛ¤â¶i¦æPhase 3¶Ü¡H ©Î¬O¦b End-of-Phase 2 Meeting «á¡A¤´¦³¥i¯à»Ýn¤@¨ÇÂù¤è¦³¨ÇÀË°Q¡B·|ij¡Kªº¤¬°Ê¤è¯à½T©w«áÄòPhase 3¡H¬Æ©Î¦Ü§ó®tªº³Q°±¤î OBI-822 Phase3ªº¥Ó½Ð¡I¡H «e«á¤G½g¤½§i¡A¬O§_¦³½Ä¬ð¤§³B©O¡H ¯u§Æ±æ¤½¥q¤½¥¬FDAµ¹¤½¥q^¤åì¤å¥ó¡I ¤£·Q¦³Â½Ä¶®É»y·N¤Wªº®t²§¡I ¡¹¤£¬O¨rÆN¤]¤£»Ýn°Û°I¥ô¦ó¤½¥q¡K¡A¥u¬O·QÂç²M¯u¹ê¦Ó¤w¡I |
|
|
·|û¡G12310132455 µoªí®É¶¡:2017/1/10 ¤U¤È 12:40:47²Ä 4233 ½g¦^À³
|
¤Ñ©R¤j¡A·íµM¿ï¾Ü¬Û«H¯E¹©¡A ¦D¨Æ¶D³^ªk²Ä 154 ±ø²Ä 2 ¶µ³W©w¡G¡u¥Ç¸o¨Æ¹êÀ³¨ÌÃÒ¾Ú»{©w¤§¡AµLÃÒ¾Ú¤£±o»{©w¥Ç¸o¨Æ¹ê¡C¡v¡AÃÒ¾Ú¤Ó»é®z |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/10 ¤U¤È 12:14:18²Ä 4232 ½g¦^À³
|
¡i¦uÅ@¯E¹© ¤O®¼¯Î°|ªø¡j ±q¤U¤È§ÚÌ´N³°ÄòÃö¤ß¥qªk®×¥óªºµo®i §Ú¾á¤ß¯Î°|ªø¬O§_¯à°÷®¼¹L¥h ¬Q±ß¤]¼g«H¹ªÀy¯Î°|ªø ±¹ï¼A¤Ñ»\¦aªº°ê®a¾÷¾¹ ¯Î°|ªø²{¦b¤@©w«Ü©t³æ §Ú¬Û«H §Ú̪ѪF¬O¯Î°|ªø³Ì±jªº«á¬Þ ©Ò¦³ªº¸ê°T³£«Ü«n ³£¥i¥HÀ°¯Î°|ªø·Q¿ìªk´ç¹LÃøÃö®@ |
|
|
·|û¡G12310132455 µoªí®É¶¡:2017/1/10 ¤U¤È 12:00:42²Ä 4231 ½g¦^À³
|
¬dÅ礤¤ß¹ï·sÃĬdÅçµn°O®×¤§Àø®ÄÃҾڼзǬ°¦ó¡H °w¹ï«ÅºÙ¾AÀ³¯g´£¨Ñ²Å¦Xªk³W³æ¦ìn¨Dªº¥R¤ÀÀø®ÄÃÒ¾Ú¡C©Ò¿×¥R¤ÀÀø®ÄÃÒ¾Ú¡ACDE²Îp¼f¬d¸ÑŪ¬°¡G ¦Ü¤Ö¨âÓ³]p¾A·í¡B¨ã±±¨î²Õ¼Ï¯Ã©Ê¸ÕÅç (pivotal trial)¡A¥B±o¨ì²Îp¤W¦³·N¸qªºÀø®Äµ²ªG (¥DnÀø®Ä¤ÀªR³æ§À p < 0.025)¡C ¯S©w±¡ªp¤U¡A³æ¤@¼Ï¯Ã©Ê¸ÕÅç¥ç¥i³Q»{©w¬°¥R¤ÀÀø®ÄÃÒ¾Ú¡C ¦AÃÄ«~¬dÅ礤¤ßªººô¶¬O³o¼Ë¼gªº¡A¤ñ¸û¦n©_³o¥÷·Ç«h¬O¬dÅ礤¤ßµ¹ªº¡AÁÙ¬OÀ˽զۤv¦¬´M¨ìªº¡A«Ü©úÅã¹ï³Q§i¦³§QªºÃÒ¾Ú¡AÀ˽ըS»¡¥X¨Ó |
|
|
·|û¡GD10142776 µoªí®É¶¡:2017/1/10 ¤W¤È 11:34:14²Ä 4230 ½g¦^À³
|
www.ir-cloud.com/taiwan/4174/irwebsite_c/announcedetail.php?id=188 01.10 ¼á²M¸gÀÙ¤é³ø³ø¾É 1.¨Æ¹êµo¥Í¤é:106/01/10 2.¤½¥q¦WºÙ:¥xÆW¯E¹©¥Í§ÞªÑ¥÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¤£¾A¥Î 4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î 5.¶Ç¼½´CÅé¦WºÙ:¸gÀÙ¤é³øA2ª© 6.³ø¾É¤º®e:¸gÀÙ¤é³øA2ª©³ø¾É¡u...¯E¹©ªºOBI-822¬ü°êÁ{§É²×©ón°Ê°_¨Ó¡A¤¸¤ë¤¤¤U¦¯¯E¹©¥i±æ«e©¹¬ü°ê»PUSFDA¶i¦æÁ{§É³]p²Ó¸`ªº°Q½×¡Aºâ¬O¥t¤@Ó·s¶i«×¡C¡v 7.µo¥Í½t¥Ñ:¼á²M¸gÀÙ¤é³øA2ª©³ø¾É 8.¦]À³±¹¬I:¥»¤½¥q¹ï©óOBI-822ªºÁ{§É¤T´Á¸ÕÅç³]p¤§³W¹º¤@ª½¿n·¥¶i¦æ¤¤¡A¤w»P¬ü°êFDA°ÓÀÀ¥X2´Á«á3´Á«e¿Ô¸ß·|ij¡]End-of-Phase 2 Meeting¡^ijÃD¡A±N°t¦X¬ü°êFDA¿ï©w¤§¾A·í®Éµ{¥l¶}¦¹¿Ô¸ß·|ij¡AY¬ü°êFDA¦³¥¿¦¡µ²½×¡A¤½¥q·|¨Ì·Óªk¥O¹ï¥~¤½§i¡C 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:³æ¤@Á{§É¸ÕÅçµ²ªG¡A¨Ã¤£¨¬¥H¥R¤À¤Ï¬M¥¼¨Ó·sÃĶ}µo¤W¥«¤§¦¨±Ñ¡A§ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¨Ã¥¼«OÃÒ¯à¤@©w¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A§ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C |
|
|
·|û¡G¤p³½10141408 µoªí®É¶¡:2017/1/10 ¤W¤È 09:32:53²Ä 4229 ½g¦^À³
|
ÁÂÁ Ksj ¤j¡AÀ°¦£·j¶°¸ê°T¡A |
|
|
·|û¡Gsuperjoe10141522 µoªí®É¶¡:2017/1/10 ¤W¤È 08:16:37²Ä 4228 ½g¦^À³
|
ksj ¦ó®ÉÅܶÀ¹«¯T°Õ?? ¤£¦w¦n¤ß³á! ÃaªF¦è! |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/10 ¤W¤È 08:09:27²Ä 4227 ½g¦^À³
|
¡i¦uÅ@¯E¹© ¦uÅ@»ùÈ¡j ¥m¤j¦¤W¦n ·j¶°¸ê°T ¤F¸ÑÁÖ½× ±q¤¤µo²{¥iij¤§³B Y³ø¾É°¾»á ¦Û¦³¤½½× ªÑª©ªB¤Í¦Û·|¬dÃÒ»P«ü¥X¤£¦X²zªº¦a¤è®@ §ÚªºÂà¶K°Ê§@Åý±z¤£µÎªA ¦V±zPºp ±z¬O¹ïªº ¯E¹©¥[ªo |
|
|
·|û¡G¥m¾´10141821 µoªí®É¶¡:2017/1/10 ¤W¤È 01:31:00²Ä 4226 ½g¦^À³
|
¼L¤ÚÁ¿¯Î°|ªø¥[ªo¡A¤â¤W«oÂà¶K¦¾öG¯Î±Ò´fªº·s»D¡A³oºØɫǧA¨ì©³n¥Î´X¦¸ªü¡I |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/10 ¤W¤È 12:47:56²Ä 4225 ½g¦^À³
|
¯Î±Ò´f±Ä§ÞÂà¬õ½u¡H ±M®a¡G¤@³s¦ê¿ù»~³y¦¨ 2017-01-10 00:26 m.ltn.com.tw/news/society/breakingnews/1942433 ¤Ñ¦ö±Ò´f |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/10 ¤W¤È 12:42:44²Ä 4224 ½g¦^À³
|
¯Î±Ò´f¯A³g ¥Î³o¤âªkÀç³y¤k¨àÁʪѰ²¶H 2017-01-10 00:10 m.ltn.com.tw/news/society/breakingnews/1942420 ¯Î°|ªø¥[ªo |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/9 ¤U¤È 11:51:49²Ä 4223 ½g¦^À³
|
¯Î±Ò´f¾D°_¶D ´¿»Ê©v¡GÃÒ©ú§Úªº½è¸ß¬O¹ïªº udn.com/news/story/1/2219130 ¯E¹©®×¡n¯Î±Ò´f¨S¤¶¤J¦X¬ù½Í§P ¦¬Optimer®½´Ú¤£¹Hªk 2017-01-09 18:44 m.ltn.com.tw/news/society/breakingnews/1942076 ¯Î±Ò´f¯A³g³Q¶D Á`²Î©²¦^À³¤F¡K udn.com/news/story/1/2219407 ¯E¹©®×¯A³g¦Ã¸o¶û ¯Î±Ò´f±Á{7¦~¥H¤W¦D³d 2017-01-09 16:15 m.ltn.com.tw/news/society/breakingnews/1941955 ¤£¼Ä¯E¹©§Q¯qªÈ¸¯ ¯Î±Ò´f¾Ç³N¥ú¨~»X¹Ð ¤¤¥¡ªÀ 2017/01/09 16:38 times.hinet.net/mobile/news/19927471 ¤T«×´£¡u°Ý¤ßµL·\¡v ¯Î±Ò´f¡G¤£«á®¬¦^¥xªA°È 2016-06-21 12:07 m.ltn.com.tw/news/politics/breakingnews/1736519 ¤µ±ß¯Î°|ªøÀ³¸Ó«ÜÃø¹L ¼g«Hµ¹¯Î°|ªø «jÀy¥Ln°í±j»P°í©w chwong@gate.sinica.edu.tw ·íªì¬°¯Î°|ªøÂIªººq¦± ¸ôn¦Û¤v¨« youtu.be/e3t3Mgntey0 ¯Î°|ªø¥[ªo |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/9 ¤U¤È 10:33:05²Ä 4222 ½g¦^À³
|
¡i¯E¹©®×¡j ¹q¶l¦¨ÅKÃÒ¡@¯Î±Ò´f³g°ý²{§Î¡@¡@ 2017/01/09 17:30 m.appledaily.com.tw/realtimenews/article/new/20170109/1031169/ «e°|ªø¯Î±Ò´f¾D°_¶D ¤¤¬ã°|¡G«D¹w´Á¤¤ªºµ²ªG 2017¦~01¤ë09¤é 16:41 ³¯©y¥[ www.chinatimes.com/realtimenews/20170109004871-260402 ¯Î±Ò´f¾D°_¶D ¤¤¬ã°|¡G·N¥~¦ý´L« ·sÀY´ßnewtalk | §õĬµ¤ ºî¦X³ø¾É µo¥¬ 2017.01.09 | 05:35 PM newtalk.tw/news/view/2017-01-09/80848 |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/9 ¤U¤È 08:45:25²Ä 4221 ½g¦^À³
|
¡i¦uÅ@¯E¹© ¬Û«H´N¦³¤O¶q¡j ©ú¤Ñ±N·|¶}¬õ½L®@ ¦³½Ð¶O¤j °ß±©¤j¥X¨Óªí¹F·Qªk |
|
|
·|û¡GGodiva10143584 µoªí®É¶¡:2017/1/9 ¤U¤È 03:33:39²Ä 4220 ½g¦^À³
|
https://tw.news.yahoo.com/%E6%B5%A9%E9%BC%8E%E6%A1%88%E5%81%B5%E7%B5%90-%E5%BC%B5%E5%BF%B5%E6%85%88%E7%BF%81%E5%95%9F%E6%83%A0%E8%B5%B7%E8%A8%B4-070448550.html ¯Î°|ªø¤º½u¥æ©ö¤£°_¶D,¦ý¬O³Q°_¶D³g¦¾¦¬¸ì µM«á¤@¦p¹w´Áªº,¦¹®×¬dµL¨rÆN |
|
|
·|û¡GµL¹Ð10141268 µoªí®É¶¡:2017/1/9 ¤U¤È 03:24:16²Ä 4219 ½g¦^À³
|
ÃöÁä¦bªk°|¤é«á§P¨M |
|
|
·|û¡G«Øcc10140016 µoªí®É¶¡:2017/1/9 ¤U¤È 03:10:46²Ä 4218 ½g¦^À³
|
¨rÆNÁ`³¡Y¶¶«K¤½¥¬¥L§ì¨ìÁ±K¨rÆN ¨ºÁÙȱo¤@¬Ý |
|
|
·|û¡G12310132455 µoªí®É¶¡:2017/1/9 ¤U¤È 02:59:48²Ä 4217 ½g¦^À³
|
¤Ñ°Ú |
|
|
·|û¡G12310132455 µoªí®É¶¡:2017/1/9 ¤U¤È 02:42:39²Ä 4216 ½g¦^À³
|
KSJ ¤j ÁÂÁ±z¤À¨É -------------------------------------- ¬°Ô£¬Y·s»Dªºª½¼½ªº¼ÐÃD¬O¥´ °_¶D °OªÌ·|??? |
|
|
·|û¡GD10142776 µoªí®É¶¡:2017/1/9 ¤U¤È 02:38:27²Ä 4215 ½g¦^À³
|
ksj ¤j ÁÂÁ±zªº°T®§ ¤ß¤¤¯u¬O¤C¤W¤K¤U... XDDDDD |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/9 ¤U¤È 02:33:07²Ä 4214 ½g¦^À³
|
¡i¬°¯Î°|ªø¯¬Ã« ¬°¯E¹©¯¬ºÖ¡j ¤¤¬ã°|«e°|ªø¯Î±Ò´f±²¤J¤º½u¥æ©ö ¯E¹©®×±N°»µ²¡I udn.com/news/story/6656/2218823 ¯E¹©®×°»µ² ¤hÀˤU¤È°OªÌ·|»¡©ú udn.com/news/story/6656/2218848 ¯E¹©®×¦^ÅU ÀˤèÃhºÃ¯Î±Ò´f¦¬¨ü±i©À·O¤£¥¿§Q¯q udn.com/news/story/6656/2218869 |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/9 ¤U¤È 02:14:48²Ä 4213 ½g¦^À³
|
¡i¦uÅ@¯E¹©¡j °OªÌ·|ª½¼½ youtu.be/Tpk8UKvFa6c |
|
|
·|û¡Gksj10141827 µoªí®É¶¡:2017/1/9 ¤U¤È 01:57:26²Ä 4212 ½g¦^À³
|
¯E¹©®× ¤U¤È3ÂI»¡©ú times.hinet.net/mobile/breakingNews/2099 |
|
|
·|û¡G¶Wô10139528 µoªí®É¶¡:2016/11/23 ¤W¤È 06:35:42²Ä 4211 ½g¦^À³
|
S¤p©j¦n¹³¦³·s¶i®i¡A¦ý¬O¼v¤ùÅ¥ø»¡¤°»ò¡A¦³^¤å¼F®`ªº¤H¥i¥HÀ°¦£¸ÑÄÀ¤@¤U¶Ü¡HÁÂÁ |
|
|
·|û¡GD10142776 µoªí®É¶¡:2016/11/21 ¤U¤È 10:03:53²Ä 4210 ½g¦^À³
|
S ¤p©j¥hÀˬd¨Åé¤F... ´Á«Ý¦n®ø®§ |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2016/11/20 ¤W¤È 08:19:37²Ä 4209 ½g¦^À³
|
³\¤j¤j ±z»¡±o¤Ó¦n¤F ¨ü¯q¨}¦h |
|
|
·|û¡G³\¤j10137169 µoªí®É¶¡:2016/11/19 ¤U¤È 11:37:11²Ä 4208 ½g¦^À³
|
¦hÁ³\¤jªºÃö¤ß»P¤p¬G¨Æ¤À¨É¡A¥»¤H¤w¦³¿Ë¦Û¥h¹qµ¹«¼C¤jPºp¨Ã»¡©ú¡A §Ú·Q¦¹¦¸¨Æ¥ó¦b¹Lµ{¤¤¥»ºô½T¦³²¨©¿¥BÃøÃã¨ä©S¡A°£¤FPºp¤]µL¸Ü¥i»¡¡A ½Ð¦U¦ìÅý«¼C¤j¦Û¦æ¨M©w¥h¯d¡A¤Åµ¹¤©¹L¦hªºÀ£¤O¡A´L«¥L¥»¤Hªº·N«ä¡AÁÂÁ¤F~BYª©¥D TO:ª©¥D¤j º¥ý¥ý·PÁ±zªº¥Î¤ßºûÅ@,¤@¸ô¨«¨Ó,ÁÂÁ±zªº¥I¥X,¤p§Ì¯à»¡ªº°£¤F·PÁÂÁÙ¬O·PÁÂ. ¦AªÌ§Ú·Q»¡ªº¬O Ãö©ó«¼C¤jªº»¡µü»P§åµû À³¸Ó¬OÄÝ©ó«D±`ÄY¼F¥BÄY««ü±± («Ý¹Lª÷¿Ä·~©Î°µ¹Lª÷¿Ä¥æ©öªº¤H³£ª¾¹D¸Û«H¬O°ß¤@¤]¬O³Ì«nªº²Ä¤@¹D¨¾½u) ¦Óª©¥D»P¥²´Iºô¦pªGıªº¬O¤lµê¯Q¦³ ¥²µMÀ³¸Ó·|¦³ÄY¼Fªº¤ÏÀ»¥H¥¿µøÅ¥ ¨ì¥Ø«e¬°¤î¦ü¥G¨S¬Ý¨ìª©¥D©Î¥²´Iºô¦³¥ô¦ó»¡©ú¸ÑÄÀ ¥u·PÁ«¼C¤j¹L¥h´X¦~ªº«ü±Ð»P°^Äm ¹ê¦bÅý¤H¯Ç´e¤£¤w! ¤p§Ì¤H·L¨¥»´ ³o¼ËÁ¿¤£ª¾¨ì¬O§_±o©y ¦ýÁÙ¬O·QÁ¿¤@¤U´£¨Ñª©¥D°Ñ¦Ò ¥²´IºôÁöµM«Dª÷¿Ä¾÷ºc ¦ý½T¹ê¦³´£¨Ñ¥¼¤W¥«ªÑ²¼ªº¶R½æ¥æ©ö §Ú·Q«¼C¤j»¡ªºÀ³¸Ó´N¬O«ü¥¼¤W¥«ªÑ²¼ÁÞ°òªº±¾³æ»P¶R½æ(¤p§Ì¤æÁx²q´ú) (§Ú·Q§Ṳ́@¯ë»P½L°Ó¥æ©ö,¤]¬O¹q¸Ü¥æ©ö,¸Û«H¬°¥»¤£¬O¶Ü?) ¦pªG«¼C¤j»¡ªº¬O¨Æ¹ê ¨ºª©¥D¬O§_À³¸Ó¥X±»¡©ú¤@¤U Åýª©¤Í²M·¡©ú¥Õ¨Æ±¡ªº«e«áì©e. ¦ý¦pªG³o¬O¥²´Iºôªº³W«h©Î¬OÂi±¤Uªº¼ç³W«h ©Î¬O¤@¨Ç§ÚÌ©Ò¤£ª¾ªº·~¤º¦æ³W ¨º¬O§_ª©¥D¤]À³¸Ó¥X¨ÓÁ¿²M·¡ Åý¤j®a³£¯àª`·N¨ÃÁקK»~½ò¬õ½u §K±o©Ò¦³ª©¤Í³£¥i¯à¦¨¬°¤U¤@Ó¨ü®`ªÌ ¦]¬°§Ú̳£¥i¯à¬Ý¹L«¼C¤j©Î¨ä¥L¤j¤jªº±ÀÂË ¦b¥²´Iºô±¾³æ¶R½æ¦Ó¨ü®` (¦]¬°¤§«e¨S¬Ý¹L¦³¤H½èºÃ©Î©ê«è±¾³æ³Q¿y§ï,©Ò¥H§Ú§ó¬OºÃ´b¤£¤w) ©Ò¥H¤p§Ì¤æÁx¬O§_¥i¥H½Ðª©¥Dµy¥[»¡©ú¨Æ±¡¸g¹L ¦pªG¦³¿ù·íµMÀ³¸Ó»{¿ù§ï¶i ¥B¦b¤½¶}ª©±¸ò·í¨Æ¤H¹Dºp¨Ãµ¹¤©§ó¦hªº¼¢¯d ¤~¬O¥²´Iºô¥¼¨Óªø»·¤§ºÖ. TO:«¼C¤j(§Æ±æ±zÁÙ·|¤Wª©±¨Ó¬Ý¬Ý) è¬Ý¨ì±zªº¯d¨¥¥H¬°§Ú²´ªá¬Ý¿ù¤F ÅåÀ~¤§¾l ¤S¬Ý¨ìªm¶ý¤]nÃöª©Â÷¶} ²ö«D§ĄâÓ¬O¦P¤@¤H ©ÎªÌ¬O¦nªB¤ÍÁ¿¦nªº¤@°_Â÷¶} ¼K¼K¡K¤@ÂI³£¤£¦n¯º~ ¤p§Ì¥u¯à¤j³Û¤£nÂ÷¶}§Ú̧a!!! «¼C¤j«¼C¤j«¼C¤j(³sÄò«s¨D³Û¤TÁn)~½Ð§A¯d¤U¨Ó!!! ¤p§ÌÁÙ¬O·Q½Ð«¼C¥ý®§«ã¦A¨M©w ¦pªGª©¥D©Î¥²´Iºô¨S¦³¦nªº¦^ÂлP»¡©ú§ï¶i ·íµM¤p§Ì¤]¨S¸ê®æ¦h»¡¤°»òn§A§ïÅܨM©w¯d¤U¨Ó ¦ý¦pªG¥²´Iºô¦³´£¥X¤@¨Ç»¡ªk»P§ï¶i¤§¹D ¬O§_«¼C¤j¥iµy·L®§«ã¦A°µ¨M©w? ¤p§Ìª¾¨ì«Ü¦hª©¤Í³£»Ýn¦U¦ì¤j¤jªº±M·~¤À¨É»P«Øij ¤µ¤Ñ·Q¤j®a¤£¬O¤£·Q¥X¨Ó»¡¨Ç¤°»ò©Î°µ¤°»ò ¦Ó¬O¤£ª¾¹Dì©e ¤]©È±²¤J¤£¥²nªº·¼É¤¤ ¥[¤W²{¦b¥Í§ÞªÑºG¶^ ®M¨cºG½ßªº¤H¤£¤Ö ½Ö¤S¦³¤ß±¡¦h»¡©Î¦h·Q¤°»ò ¥i¬Oª©¤Í½T¹ê«Ü»Ýn¦U¦ì¯«¤H¤j¤jªø´Áªº«ü¾É»P¤ÀªR ¬O§_¥iÅý¤p§Ì¦b¦¹¬°»a¥Í½Ð©R ½Ð±z¥ý¼È®É®§«ã¤£nÂ÷¶} ¦n¶Ü??? ³Ì«á¤p§Ì¥Î¤@Óºô¸ô¤p¬G¨Æ¤À¨Éµ¹ª©¤Í»Pª©¥D Ä@¤j®a³£¯à¦³©Ò¦¬Ã¬ ¦b¬YÓ¹qµø³X½Í¸`¥Ø¤¤¡A¹Å»«¬O¤@¦ì·í¤µ»á¨ãª¾¦Wªº«C¦~¥ø·~®a¡C¸`¥Øº¥ªñ§ÀÁn®É¡A«öºD¨Ò¡A¥D«ù¤H´£¥X¤F³Ì«á¤@Ó°ÝÃD¡C ½Ð°Ý¡G§A»{¬°¨Æ·~¦¨¥\ªº³ÌÃöÁä«~½è¬O¤°»ò¡H ¨I«ä¤ù¨è¤§«á¡A¥L¨Ã¨S¦³ª½±µ¦^µª¡A¦Ó¬O¥ÀR¦a±Ôz¤F³o¼Ë¤@¬q¬G¨Æ¡G ¤Q¤G¦~«e¡A¦³¤@Ó¤p¥ë¤l貦·~´N¥h¤Fªk°ê¡A¶}©l¤F¥b¤u¥bŪªº¯d¾Ç¥Í¬¡¡Cº¥º¥¦a¡A¥Lµo²{·í¦aªºªº¤½¦@¥æ³q¨t²Îªº°â²¼³B¬O¦Û§Uªº¡A¤]´N¬O§A·Q¨ìþÓ¦a¤è¡A ®Ú¾Ú¥Øªº¦a¦Û¦æ¶R²¼¡A¨®¯¸´X¥G³£¬O¶}©ñ¦¡ªº¡A¤£³]À˲¼¤f¡A¤]¨S¦³À˲¼û ¡C¬Æ¦Ü³sÀH¾÷©Êªº©â¬d³£«D±`¤Ö¡C¥Lµo²{¤F³oÓºÞ²z¤Wªºº|¬}¡A©ÎªÌ»¡¥H¥Lªº«äºû¤è¦¡¬Ý¨Ó¬Oº|¬}¡C ¾ÌµÛ¦Û¤vªºÁo©ú«l¡A¥Lºë½T¦a¦ôºâ¤F³o¼Ë¤@Ó·§²v¡G°k²¼¦Ó³Q¬d¨ìªº¤ñ¨Ò¤j¬ù¶È¬°¸U¤À¤§¤T¡C¥L¬°¦Û¤vªº³oÓµo²{¦Óªgªg¦Û³ß¡A±q¦¹¤§«á¡A¥L«K¸g±`°k²¼¤W¨®¡C ¥LÁÙ§ä¨ì¤F¤@Ó¼e¼¢¦Û¤vªº²z¥Ñ¡G¦Û¤vÁÙ¬O½a¾Ç¥Í¹À¡A¯à¬Ù¤@ÂI¬O¤@ÂI¡C ¥|¦~¹L¥h¤F¡A¦WµP¤j¾Çªºª÷¦r©ÛµP©MÀu¨qªº¾Ç·~¦¨ÁZÅý¥L¥Rº¡¦Û«H¡A¥L¶}©lÀWÀW¦a¶i¤J¤Ú¾¤¤@¨Ç¸ó°ê¤½¥qªº¤jªù¡AÅCÃܺ¡§Ó¦a±À¾P¦Û¤v¡A¦]¬°¥Lª¾¹D³o¨Ç¤½¥q³£¦b¿n·¥¦a¶}µo¨È¤Ó¥«³õ¡C¦ý³o¨Ç¤½¥q³£¬O¥ý¼ö±¡¦³¥[¡AµM¦Ó¼Æ¤é¤§«á¡A«o¤S³£¬O°û¨¥¬Û©Ú¡C ¤@¦¸¦¸ªº¥¢±Ñ¡A¨Ï¥L¼««ã¡C¥L»{¬°¤@©w¬O³o¨Ç¤½¥q¦³ºØ±Úª[µøªº¶É¦V¡A±Æ¥¸¤¤°ê¤H¡C ³Ì«á¤@¦¸¡A¥L½Ä¶i¤F¬Y¤½¥q¤H¤O¸ê·½³¡¸g²zªº¿ì¤½«Ç¡An¨D¸g²z¹ï©ó¤£¤©¿ý¥Î¥Lµ¹¥X¤@Ó¦X²zªº²z¥Ñ¡C µM¦Ó¡Aµ²§½«o¬O¥L©l®Æ¤£¤Îªº¡C ¤U±ªº¤@¬q¹ï¸Ü«Ü¥O¤Hª±¨ý¡C ¥ý¥Í¡A§Ų́䣬Oª[µø§A¡A¬Û¤Ï¡A§ÚÌ«Ü«µø§A¡C¦]¬°§Ṳ́½¥q¤@ª½¦b¶}µo¤¤°ê¥«³õ¡A§ÚÌ»Ýn¤@¨ÇÀu¨qªº¥»¤g¤H¤~¨Ó¨ó§U§Ú̧¹¦¨³oÓ¤u§@¡A©Ò¥H§A¤@¨Ó¨D¾ªº®ÉÔ¡A§Ú̹ï§Aªº±Ð¨|I´º©M¾Ç³N¤ô¥«Ü·P¿³½ì¡A¦Ñ¹ê»¡¡A±q¤u§@¯à¤O¤W¡A§A´N¬O§ÚÌ©Òn§äªº¤H¡C ¨º¬°¤°»ò¤£¦¬¤Ñ¤U^¤~¬°¶Q¤½¥q©Ò¥Î¡H ¦]¬°§Ú̬d¤F§Aªº«H¥Î°O¿ý¡Aµo²{§A¦³¤T¦¸¼¤½¨®°k²¼³Q³B»@ªº°O¿ý¡C §Ú¤£§_»{³oÓ¡C¦ý¬°¤F³oÂI¤p¨Æ¡A§AÌ´N©ñ±ó¤F¤@Ó¦h¦¸¦b¾Ç³ø¤Wµoªí¹L½×¤åªº¤H¤~¡H ¤p¨Æ¡H§Ų́䣻{¬°³o¬O¤p¨Æ¡C §Ú̪`·N¨ì¡A²Ä¤@¦¸°k²¼¬O¦b§A¨Ó§ÚÌ°ê®a«áªº²Ä¤@Ó¬P´Á¡AÀˬd¤Hû¬Û«H¤F§Aªº¸ÑÄÀ¡A¦]¬°§A»¡¦Û¤vÁÙ¤£¼ô±x¦Û§U°â²¼¨t²Î¡A¥u¬Oµ¹§A¸É¤F²¼¡C ¦ý¦b³o¤§«á¡A§A¤S¨â¦¸°k²¼¡C ¨º®Éè¦n |
|
|
·|û¡G12310132455 µoªí®É¶¡:2016/11/17 ¤W¤È 11:19:26²Ä 4207 ½g¦^À³
|
«ç·|µo¥Í³o¨Æ±¡¡H¡H¡H |
|
|
·|û¡G«¼CµL¾W10030199 µoªí®É¶¡:2016/11/17 ¤W¤È 10:10:36²Ä 4206 ½g¦^À³
|
§Ún¥Ã»·Â÷¶}¤¦~¨Óªº¥²´Iºô¤F¡C¦]¬°¥²´Iºô ³sÄò ¾Õ¦Û¿y§ï§Úªº©e°U°O¿ý ¦h¦¸¡C³o¬O«D±`¤£¥iì½Ìªº¡C¥B¤£¤¹¦³¥ô¦óÄy¤f¡Cª÷¿Ä(¬ÛÃö)¾÷ºc¡A³Ì«nªº´N¬O ¸Û¹ê/¸Û«H¡A¹H¤Ï¦¹¤@¤Ñ±ø¡A¦Û¦æ·²·~ºâ¤F¡C ³o¦p¦PÀç·~û¡B²z±M¾Õ¦Û§ó§ï!°°³y¥æ©ö¤@¯ë¡A§¹¥þ¤£¥iì½Ì¡C §Ú¤wcall¥²´Iºôµh½|¤@¹y¤F¡C³sÄò!¥B¦h¦¸! ¤Äµ²¯S©w½L°Ó! ³è±ó¥²´Iºô¦p¦¹ ¤£¸Û¹êªºª÷¿Ä§@¬° !! ¥²´IºôÀ³¸Ó¦³¤@ÂI¤Ï¬Ù¤O¡A ¤£n§R¦¹¤å !! ¬Q¤Ñ¤w»P±z¬¢½Í¹L¤F¡Aª¾¹D±z«Ü¤£´r§Ö»P½Ì¸Ñ¡A ·Q¨Ó±z¤j·§®ðÀY¤W¤]Å¥¤£¶i¥ô¦ó¸ÑÄÀ¡A ¦ý¥»ºô¤]¤w°w¹ï¦¹¨Æ»P¤º³¡°Q½×©¹«á¦æ¨Æ¤è°w¡A «Ü¿ò¾Ñ±zªº¨M©w¡A¤]ÁÂÁ±z¤@¸ô¨«¨Óªº°^Äm»P«ü±Ð¤F¡CBYª©¥D
|
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/11/6 ¤U¤È 11:08:44²Ä 4205 ½g¦^À³
|
D¤j «GÂIÂæbASCO,ESMO,·ç¤h«H¶Uªk»¡§ë¼v¤ù»P ¡A¤G¤ëªk»¡»P¤»¤ëªÑªF·|¦^µª»P¥¼µoªíªº½×¤å¤¤¡A¦¹®É¦¹¨è¡A¦h»¡µL¯q¡AÅý®É¶¡¨ÓÃÒ©ú¤@¤Á¡C |
|
|
·|û¡GD10142776 µoªí®É¶¡:2016/11/6 ¤U¤È 10:30:36²Ä 4204 ½g¦^À³
|
¥xÁÞ¤j §O³Qª©¤Wªº§åµûµ¹À»±Ñ¤F ¦bÁ}Ãøªº®É¨è §Æ±æ«GÂI¥i¥HÅܦ¨Ä£²´ªº¥ú¨~ |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/10/8 ¤U¤È 09:15:29²Ä 4203 ½g¦^À³
|
¤j¹ÙÌ¡A±ß¦w 822 §Y±N®i¶}·sªº¸ÕÅç¡AÂX®iªvÀø»â°ì¡X¡X¡XªÍ¡B¤j¸zª½¸z¡BG¡B¨xµ¥Àù¯g ³o¥NªíµÛ¤°»ò·N²[¡H §Ú·Q¡A¤j®a¤ß¸Ì³£¦³¦Û¤vªºµª®× §Ú·Q¡A³o¨Ç·sªº¾AÀ³¯g±N·|±Ä¨ú©MMBCÁ{§É¤T´Áªº¦P¼Ë¿z¿ï³W«h¡A×¥¿¹L¥hMBC¤G´Áªº¤£·í¡A·íµMMBC¤´«Ý´¦¾åOS §Ú·Q¡A³o¬O§_¤]¥NªíµÛ¤½¥qªº¥ø¹Ï¤ß©M«H¤ß¡H¡I §Ú§Æ±æ¡A¸g¹L×¥¿³W«h«áªº·s¾AÀ³¯gÁ{§É¡A¦b¤G´Á´N¯à®i²{ÅQ®ðªºÀø®Ä §Ú°J¤ßªº´Á±æ¡A822¯à¾¨§Ö¤W¥«¡A±Ïªv¨¯Wªº±wªÌ ¯E¹©¥[ªo¡ATFDA¥[ªo¡AFDA¤]½Ð¥[ªo ¶È¨Ñ°Ñ¦Ò ÁÂÁ¤j®a¡I |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/10/1 ¤U¤È 10:59:25²Ä 4202 ½g¦^À³
|
833¦b¥xÆWªºt³dÂå®v ¥x¤jÂå°| ªL®a»ôÂå®v http://www.ntuh.gov.tw/onc/%E6%9C%AC%E9%83%A8%E7%B0%A1%E4%BB%8B/DocLib/%E6%9E%97%E5%AE%B6%E9%BD%8A%E9%86%AB%E5%B8%AB.aspx ¥x¥_Âå¤jªþ³]Âå°| ®L©M¶¯Âå®v http://tmuh.tmu.edu.tw/team/team/AF/AF/020067 ½Ð»{ÃѪº¤j¤j¦h¦h´£¨Ñ¸ê°T ÁÂÁ¤j®a¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/29 ¤W¤È 09:38:11²Ä 4201 ½g¦^À³
|
¤¤¬ã°|9¤ë21¤é ·s»D½Z¤¤«ÂI 1Àù¯gµn¤ëpµe¥Ø¼Ð¬O±N¹wp10¦~¤~¯à§¹¦¨ªºÀù¯g¬ÛÃö¹w¨¾¡B¶EÂ_¡BªvÀø©MÅ@²zµ¥¤u§@´Áµ{ÁYµu¤@¥b¡C (5¦~¤º§¹¦¨) 2¥xÆW¾Ö¦³¥@¬É»â¥ýªº°ò¦]³J¥ÕÅé§Þ³N¡A¬°¥»¦¸¥[¤J¬ü°ê»â¾ÉªºÀù¯gµn¤ëpµe°ê»Ú¦X§@ªº«nÀu¶Õ¤§¤@ 3¤¤¬ã°|©ó2015¦~»P¬ü°êÀù¯g¬ã¨s©Òñ¸p¡qÀù¯g³J¥Õ½èÅé¾Ç¦X§@³Æ§Ñ¿ý¡r 4¦]À³Àù¯gµn¤ëpµeªº¥¿¦¡¶}®i¡AÂù¤è©ó¤µ¦~ñq×¥¿ª©¦X¬ù¡AÂX¤j¦X§@½d³ò¡A»OÆW¦¨¬°¬ü°êÀù¯gµn¤ëpµe¤§¦X§@¦¨û¡AÄâ¤â¦X§@ªüªiùpµe 5»OÆW¤HÅé¥Íª«¸ê®Æ®w°õ¦æªø¨H§Ó¶§ªí¥Ü ¤¤¬ã°|±µ¨ü¬F©²©e°U«Ø¸mªº¡y»OÆW¤HÅé¥Íª«¸ê®Æ®w¡z(Taiwan Biobank)¡A¨ãªø´Á°lÂÜ¡B¸ê®Æ¥þ±µ¥Àu¶Õ¡A»PÀù¯gµn¤ëpµe¤è¦V¤£¿Ñ¦Ó¦X¡A¥[¤W»OÆWªº°·«O¨î«×»P°ª«~½èªºÂåÀø»P¤½¦@½Ã¥Í¤ô·Ç¡A³£¬O»OÆW°õ¦æ¦¹pµeªº«nÀu¶Õ¡C www.sinica.edu.tw/manage/gatenews/showsingle.php?_op=?rid:8467 |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/22 ¤U¤È 12:30:18²Ä 4200 ½g¦^À³
|
µL¤j¤j ÁÂÁ¤À¨É ÁÂÁ±z! |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/22 ¤U¤È 12:29:51²Ä 4199 ½g¦^À³
|
µL¤j¤j ÁÂÁ¤À¨É ÁÂÁ±z! |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/22 ¤U¤È 12:23:24²Ä 4198 ½g¦^À³
|
¥xÁÞ¤j¤j chen6053¤j¤j ÁÂÁ¨â¦ì |
|
|
·|û¡GµL¤j10141864 µoªí®É¶¡:2016/9/22 ¤U¤È 12:22:04²Ä 4197 ½g¦^À³
|
¥xÁÞ¤jªº«Øij¬O«D±`¦nªº.. Ó¤H´N¬O±`±`¨«¸ô,°²¤é´N¥hª¦¤s,³o¬O°ÊºA¤W.. ÀRºA¤W,¥±`¨C¤Ñ³£nÀR§¤,¦Ü¤Ö1~2¤p®É,±Mª`©ó©I§l(¦w¨º¯ë©À),Åý¤ß¯à±Mª`©ó¤î.. ¤d¸U§O²Ö¤F¨Åé,²Ö¤F¤ß... |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/22 ¤U¤È 12:13:54²Ä 4196 ½g¦^À³
|
²q·Q¤j ¤£n¬°¤p¨Æ§ì¨g ¨C¤Ñ´²¨B¨«¸ô40¤ÀÄÁ¦Ü60¤ÀÄÁ §ä¤H²á²á¤Ñ §ïÅÜ·Qªk·|§ïÅܤ߱¡ ¥´§¤ »ó§l®ð ¤fºCºC©I¥X «ö«ö¸}©³ «ö«ö¸}¥À«ü¤¤¶¡ÂI «üÀ£ ¤T³±¥æ ¤Ó½Ä ¯«ªù ¬d¸ß :¬ì¾Ç®aµo²{¹ª«¦p¦ó¼vÅT¤j¸£ www.epochtimes.com/b5/8/7/25/n2204202.htm ¥H¤W¬O»²§U ½Õ©M±¡ºü °Ñ¦Ò´N¦n |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/9/22 ¤W¤È 11:49:50²Ä 4195 ½g¦^À³
|
²q·Q¤j¤j§A¦n, ¹ï§A¬O ·P¿E ·PÁ |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/22 ¤W¤È 11:44:35²Ä 4194 ½g¦^À³
|
¥xÁÞ¤j¤j ±z¨¯W¤F ¨Ì¤p§Ìªº¸gÅç POWER¹LÃö ¨ä¥L¤T¶µ«ü¼Ð À³³£·|¹F¼Ð °£¤F¹ï·Ó²Õªº¨Æ¥ó³£µo¥Í¦b«á´Á¥~ ¤p§Ì³Ìªñ¦]ÃĪ«ªºÃö«Y ¦n¹³±o¤FļÆ{¯g «Ü¶Ë¸£µ¬ §Æ±æ¤j®aì½Ì¤p§Ì³ÌªñªºµL²z¦æ¬°¡@ ¹ï¤£°_¤F! ¤j®a ÁÂÁ¤j®aªº½Ì¸Ñ! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/22 ¤W¤È 11:15:10²Ä 4193 ½g¦^À³
|
²q·Q¤j«e½ú ¨¯W¤F ÁÙ¬O°ò¥»±¥i·R ¨Ì¾Ú«e½úªºpowerpºâ¼ÒÀÀ ¤À¨É §Ú¦³§ä¨ì¶W¹L80% ªº²Õ¦X power 82---65---81.7% 83---66---83.2 % 84---67---84.3% 85---68---86.1% 86---69---87.5% 87---70---88.8% 88---70---87.1 % 89---70---85.3% 95 ¡V 72 - 80.2 % |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/19 ¤U¤È 11:37:47²Ä 4192 ½g¦^À³
|
ÁÞ¤k±¡Âk¦ó³B Where Does Adagloxad Simolenin Fit in? 1 p13 ¹êÅç²Õ224¤H: ¦³²£¥Í§K¬Ì¬Ì¤ÏÀ³»P¨¬°÷§ÜÅé®Ä»ù 112¤H + ¨S¦³²£¥Í§K¬Ì¬Ì¤ÏÀ³»P¨¬°÷§ÜÅé®Ä»ù 112 ¤H ¹ï·Ó²Õ124¤H , °²³]P13 X^2 ( >3.84 p<0.05 ) HR 95%«H¿à°Ï¶¡ power ³£¯à¹F¼Ð´N¯àÃÒ©úÁÞ¤À¤l·sÃĪºÀø®Ä ( ¦w¥þ©Ê+Á`¦s¬¡´ÁªºÀø®Ä ) ¤]´N¯à¨Ì¾Úªk³W¥Ó½ÐÃÄÃÒ,ÁÞ¤k¬O§_¯à¨«¥X¶Â´ËªL¬Ý¨£¬üÄR±mi,¤j®a«Ì®§¥H«Ý 2 Á`¦s¬¡´Á¬OÆ[¹î¤¦~ ¦ý¬O¥unÁ`¦s¬¡´Á²Ä2¦¸´Á¤¤¤ÀªRªº·ÀI¤ñ¤Îp ȹF¨ì¹w©wªºÀø®Ä¤¤¤î¬É½u ¥i¥H´£«eµ²§ôÆ[¹î¤ÀªR,¥H¥[³tÃÄÃÒ¨ú±o®É¶¡ ( ¯E¹©À³¦³»Pªk³W³æ¦ìq©wOS ¹F¨ì¹w©wªºÀø®Ä¤¤¤î¬É½u ) 3¤£n³Q¸ê°T»~¾É¥H¬°¦¸nÀø®Ä«ü¼Ð Á`¦s¬¡´ÁOS ÁÙnµ¥«Ü¦h¦~ 4 ¯E¹©¤G¤ëªk»¡·|²Ä¤@Ó´£°Ýªº¦^µª¤w¸g§i¶D¤j®a ÁöµMPFS ¨S¹F¼Ð ¦ý¥unOBI822 ¦³°ª¦w¥þ©Ê»P¥Í¬¡«~½è¨Ã¯àÃÒ©ú¦³Àø®Ä¬O¥i¥H¦Vªk³W³æ¦ì¥Ó½ÐÃÄÃÒ ( ¼fÃĪk³W¦³½Ö¤ñ¯E¹©²M·¡ ) 5 ¹Ãĸpªí¥Ü:¤£·|¹w³]¥ß³õ¡A¤]¤£·|¥HPÈ¥¼¹F²Îp¤WÅãµÛ®t²§¡A§_©wÁ{§É¸ÕÅç·N¸q¡A¤´·|°Ñ¦Ò«áÄò¬ã¨s¼Æ¾Ú¸ÑŪ»P¦¸nÀø®Ä«ü¼Ð»ùÈ¡C udn.com/news/story/9494/1516580 6 104¦~«×ªÑªF·|¦~³ø ¦³´£¨ì·|¦VTFDA ¥Ó½Ð¦³±ø¥ó¤W¥«³\¥i conditional approval , Ó¤H»{¬°ÁöµM²{¦b§ï¥HOS¥Ó½Ð¥xÆWÃÄÃÒ ¦ý¥Í§Þ²£·~µ¦²¤¿Ô¸ß·|ij«á¬ÛÃöªk³W¤jÃP¸j,¼fÃijt«×»P°·«O®Ö»ù³t«×¹w´Á·|¥[§Ö,Ó¤H±À´ú¯E¹©¨ÅÀùÃÄOBI822¨ÌµM·|¦p´Á¦b2017¦~¤W¥«,¦³À禬¤J±b,¤W¥«±Ï¤H,¥xÆWÃĪº¨ú±o¤]¶H¼xªF¨ó°ê®aÃÄÃÒªº¨ú±o,¥«³õ¬O¥xÆW+ªF¨ó°ê®a ( ÃÄÃÒ®Öã®É¶¡¬ù¬O¥Ó½Ð¤é´Á+ x Ó¤ë ¨Ò¦p 10¤ë´£¥X¥Ó½Ð,°²³]³oÁû°ê®a³Ð·sÃĪ«Àò±o§Ö³t¼f¬d©ú¦~5-6¤ë ¦³¾÷·|Àò±o¥þ²y²Ä¤@±iÁÞ¤À¤l·sÃÄÃÄÃÒ 7 n°µ¥þ²y¤T´Áªº¾÷²v¬ù¤@¥b ( BTD ,AA ¤H¼Æ¤j´T´î¤Öªº¤p¤T´Á ³£¦³¥i¯à)³Ì²z·Qªº±¡ªp¬O¥ýµ¹¤©OBI822 conditional approval,¥ý¤W¥«±Ï¤H(50% ªº¾÷²v)( ¬ù15¸U¦W¥½´Á¨ÅÀùµL¦nÃÄ¥iÂ媺¬ü°ê¤k©Ê ¨C¦~¦º¤`40500¤H ) ¥þ²y¤T´Á¦A¥H¤G´Á/¤T´Á¨ÅÀù¬°¹ï¶H¥l¶Ò¨ü¸Õ ¦A¦V«e±À¶i ÂX®i¥«³õ ( ²q´ú11¤ë«eFDA À³ªíºA¤F) 8 ¦X§@±ÂÅv·|¦bESMO «á§ó¦h¼Æ¾Ú¥X¨Ó¦A°t¦X FDA TFDA ªíºAµ¹¤©OBI822 ¥¼¨Ó¤è¦V½T»{«áµo¥Íªº¾÷·|¸û¤j ¥H¤W¶È¨Ñ¤À¨É°Ñ¦Ò, ¦³¨Ç¬OÓ¤H±À´ú ,¦³¨Ç¬OªÑªF·|»Pªk»¡·|¸ê°T , ½Ð°ö¾i¿W¥ß¤ÀªR»P¬ã§P ,¦³¿ù½Ð§ó¥¿ ¤£½×ªÑ»ù250 ©Î755 §Ú¹ï³oÁû¥xÆW¬ãµoªº·sÃĪº½×z ©l²×¦p¤@ °ß¦³«H»{¤~¯à°í«ù |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/19 ¤U¤È 12:58:19²Ä 4191 ½g¦^À³
|
¦æ¬F°|¥Í§Þ²£·~µ¦²¤¿Ôij©eû·|ij«á,12¤é¥l¶}¦æ¬F¥ßªk¬Fµ¦¨ó½Õ·|³ø¡A·|¤¤¹F¦¨32ÓÀu¥ýªk®×¦@ÃÑ »P·sÃĦ³Ãöªº±Æ¦b 5 9 11 5. ¥Í§Þ·sÃIJ£·~µo®i±ø¨Ò²Ä3±ø×¥¿¯ó®× 9. °ê®aÃĪ«¼f¬d¤¤¤ß³]¸m±ø¨Ò¯ó®× 11.¬ì¾Ç§Þ³N°ò¥»ªk×¥¿¯ó®× |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/19 ¤W¤È 10:14:09²Ä 4190 ½g¦^À³
|
²³¤j¤j 1ÁÞ¤k¦b2016¦~6¤ë¬ü°êªÛ¥[ôASCO¨«§¹³B¤k¨q,±µµÛ±N¦b10¤ë10¤é©ó¤¦³Áô¥»«¢®Ú¨©©Ô¤¤¤ß¶®¨å§°óÁ|¿ìOBI-822¥D°Ê§K¬ÌÀøªk±Ð¨|¬ã°Q·|,³o¬OÁÞ¤k²Ä¤G³õ¤j«¬°ê»Ú¨q ( ESMO ) ±Ð¨|¬ã°Q·|°}®e¬Û·í°í±j 2 ¯E¹©¬°¦ónªá¿ú¿ì³o³õ±Ð¨|¬ã°Q·|? ÁÞ¤À¤l·sÃĬO¥þ·sªº·sÃÄ ±Ð¨|¬ã°Q·|¬OnÅý¦U°ê¸~½F¬ìÂå®v,°ê»Ú¤jÃļtÁA¸ÑÁÞ¤À¤l·sÃĪºÁ{§É¼Æ¾Ú,§ÜÀù¾÷¨î »P¥¼¨Óµo®i¤è¦V¡A³z¹LAdagloxad Simolenin¡]OBI-822¡^ªº§@¥Î¡A¼fµø·s«¬Àù¯g¥D°Ê¦¡§K¬ÌÀøªkªº¥¼¨Ó¡F ¤]¥i¥HÁA¸Ñ¥@¬É¦U°ê±M®a¹ïÀù¯g¥D°Ê§K¬ÌÀøªkªº¬Ýªk»P«Øij,¥t¥~¼Ú¬wÄÝ©ó¦X§@±ÂÅv°Ï,³oºØ90¤ÀÄÁªº¦h¥DÃDªº ¬ã°Q·|¤ñASCO 12¤ÀÄÁn¨q22±i§ë¼v¤ùÃþ(¦³®É¶¡À£¤O ¥§¡32¬í¨q¤@±i)·|§ó²Å¦X¸~½F¬ìÂå®v, °ê»Ú ¤jÃļtªº»Ýn, ¥t¥~¨Ï¥Î§°ó °Ñ»P¤H¼Æ¹w¦ô¤]¬O¤d¤H°_¸õ 3 ºô¸ô¬d¸ß¨ìªº ¤¦³Áô¥»«¢®Ú¨©©Ô¤¤¤ß¤¶²Ð ? ¨©©Ô¤¤¤ßÂ÷ô¥»«¢®Ú¥«¤¤¤ß10¤ÀÄÁ¡A¶ZÂ÷°ê»Ú¾÷³õ¶È6¤½¨½¡C¦û¦a11.1¸U¥¤è¦Ì¡A¬O´µ³ô¦a¯Çºû¨È¦a°Ï³Ì¤jªº°ê»Ú·|ij¤¤¤ß¡A°£¤F¨C¦~¬ù25¡ã30³õ°Ó«~®i¾P·|©M®iÄý·|·N¥~¡AÁÙÁ|¿ì1300³õ¥H¤Wªº¦UºØ®i¾P·|¡B®iÄý·|¡B°ê»Ú·|ij¡B¬ã°Q·|µ¥¡C·|ij«Ç³£³]¸m¤FµL½uºôµ¸¡AÁÙ¥i¥H¼e±a¤Wºô¡A°t³Æ¤FµÀWµøÀWµ¥³Ì·sªº¹q¤l»ö¾¹¡C®iÄýÀ]±`¦~³]¦³¸Ë¹¢³Ã¨ã¼ËªO¶¡¡A¨Ñ°ÑÆ[³]p¨Ï¥Î¡C taiwan-motherofmine.blogspot.com/2016/06/bella-center.html 4 ¬ã°Q·|±N¥Ñ¬Ó®a°¨´µµnNHS«H°U°òª÷·|©MÛ´°Àù¯g¬ã¨s©Òªº¨ÅÀùÂå¾Ç¡B¸~½F¤º¬ì±Ð±Â´µ¸¦ªâ•¬ù¿«´µ¹y³Õ¤h¥D«ù Stephen Johnston :Âಾ©Ê¨ÅÀùªvÀø±M®a´¿µoªí¤F¶W¹L250½g¨ÅÀù¬ÛÃö½×¤å©ó¦P¦æµû¼fªº´Á¥Z¡A¨Ã¦b°ê®a©M°ê»Ú·|ij¸g±`¨üÁܽЪºÁ¿®v¡C¥L¬O¦hÓ¬ì¾Ç©eû·|©MÅU°Ý©eû¡A´¿¥ô¬ü°êÁ{§É¸~½F¾Ç·|¡A¸t¦wªF¥§¶ø¨Å¸¢Àù¬ã°Q·|ºKn¼f¬d©eû, ²{¥ô¨Å¸¢Àù¬ÛÃö°ê»Ú´Á¥Z°Æ¥D½s 5 ¥D«ù¤HÁÙ¥]¬A: ¡´Scripp¬ã¨s©Ò¤Æ¾Ç±Ð±Â¡B¤¤¥¡¬ã¨s°|«e°|ªø¯Î±Ò´f ( °ê»ÚÁ޾Ǯõ¤æ) 2012¦~¡A¬ü°ê¤Æ¾Ç·|¨È·æ¬ì³Õ¼ú. 2014¦~¡A¦]¬°¹ï½ÆÂøªº¦hÁÞÅé©MÁÞ³J¥Õªºµ{¦¡¤ÆÀ³¥Î¦X¦¨ªº³Ð·s¤èªkµo®i¡A°µ¥X«Ü¦hì³Ð©Êªº°^Äm¡AºaÀò¨Uº¸¤Ò¤Æ¾Ç¼ú¡C 2015¦~¡A¦]¬°µo®i¤Æ¾Ç»P»Ã¯À¦X¦¨¤èªkªº°^Äm¡A¤×¨ä¥Î©óÁA¸ÑÁÞ¤À¤l¦b¥Íª«Å餤§êºtªº¨¤¦â¡A¨Ã¶}³ÐÃĪ«¬ãµoªº·s«´¾÷ºaÀò^°ê¬Ó®a¤Æ¾Ç·|¾|»«»¹¼ú ¡´¬ü°ê¥v¶©-³Í¼»µYÀù¯g¤¤¤ß¸~Âå¾Ç±M®a§Æ·æ.³Á§Jªü·æÂå¾Ç³Õ¤h ¸~½F¬ìÂå¥Í,P¤O©ó¨ÅÀù¯f¤H·ÓÅ@,¦o±Mª`©ó¨ÅÀù²©R©Ê¶EÂ_»PªvÀøªº¬ã¨s, ¯S§O¹ï³Ð·sªº§K¬ÌÀøªkµ¦²¤¤è± ¡´¥x¤jÂå¾Ç°|¥~¬ì±Ð±Â¡B¥x¤jÂå°|¨Å©ÐÂå¾Ç¤¤¤ß¥D¥ô¶À«T¤É ¥xÆW¤G/¤TÁ{§É¸ÕÅçp¹º¥D«ù¤H °ê¥ß»OÆW¤j¾ÇÂå¾Ç°|Âå¾Ç¨t²¦·~ ¬ü°ê«¢¦ò¤j¾Ç¤½½ÃºÓ¤h °ê¥ß»OÆW¤j¾ÇÂå¾Ç°|Á{§É¬ã¨s©ÒÂå¾Ç³Õ¤h ¬ü°ê¥[¦{¤j¾Ç¸t¦a¤úô¤À®ÕÀù¯g¬ã¨sû 6 ÁÞ¤k¬ü¼Ú¨«¨q«á, ®ð¶Õ§Î¦¨,º¥¤J¨Î¹Ò ¤é¥»¤d¦~¥j³£·¬¬õ«á, ¯E¹©±N§_·¥®õ¨Ó ¥H¬OÓ¤H¤ß±o¤À¨É ¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/15 ¤U¤È 10:12:16²Ä 4189 ½g¦^À³
|
·PÁ²q·Q¤j«e½úªº¼ÒÀÀ±À¦ô¡A«e½ú¤ß«ä²Ó±K¡A«ä¦Ò¼h¦¸¦h¤¸¡A¥O¤H´Ü¨Ø¡A³oºØ¦h¤¸ªº«ä¦Ò¤ÀªR¤]¥i¦b¤p©_¤j«e½ú¨¤W¬Ý¨ì¡A·PÁ¨â¦ì¤j¤jµL¨pªº¤À¨É¡C |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/15 ¤U¤È 07:12:49²Ä 4188 ½g¦^À³
|
¥xÁÞ¤j¤j ©êºp¤F¡A¤p§Ì§â¥¦²V²c¤F ©Ò¿×17¨ì21Ó¤ë¡A¬O«ü¤p©_¤jªº¤Àªk¨S¿ù¡A¤]´N¬O¨Ì¤½¥qµ¹ªº¦s¬¡¹Ïªº¶q«× ¦ý¬O¡AÀHµÛ®É¶¡±À²¾¡Aµ¥¨ì¨Æ¥óµo¥Í¡A¥i¯à´N¤£¬O17¨ì21¡A¦Ó¬O§ó«á±ªº¤ë¼Æ ¦Ü©ó«e¤¤«á¬q¡AÀ³¬O«ü¾ãÓ¦s¬¡¦±½u¬ù¤T¤Àªkªº¦ì¸m ÁöµM¸Õºâªí©Òpºâªº¼ÆÈ¡A¬O¥¿½Tªº ¦ý¤]¥u¬O¬Y¤@¯S©w¨Æ¥ó±Æ¦Cªº¼ÆÈ¡]¨Æ¹ê¤W¡A¡]81¡A61¡^¦³«Ü¦h±Æ¦C¤è¦¡¡A¤p§Ì¼ÒÀÀªº¡A¥u¬O¨ä¤¤¤@ºØ¡^ ©Î»P¯u¥¿¸Ñª¼ªº±Æ¦C¬Ûªñ¡A©Î¬Û¥h¬Æ»·¡A²{¦bµLªk½T»{ ¥u¯à»¡³o²Õ¨Æ¥ó¼Æ¦³¾÷·|¹F¼Ð¡A¯u¥¿¯à§_³q¹L¡A¤´n¬Ý¯u¥¿ªº±Æ¦C ¶È¨Ñ°Ñ¦Ò ÁÂÁ¤j®a¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/15 ¤U¤È 05:20:19²Ä 4187 ½g¦^À³
|
²q·Q¤j 17-21Ó¤ë¬O¤°»ò·N«ä? «e¬q ¤¤¬q «á¬q ¬O«ü¤p©_¤j¤Àªk ¥Ø«ep13 ¬O¤ÀªR¨ì32Ó¤ë(50,35) 1-16Ó¤ë«e¬q 16-32Ӥ뤤¬q 32-48Ó¤ë «á¬q ¥H¤W½Ð±Ð¡AÁÂÁ²q·Q¤j«e½ú |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/15 ¤U¤È 05:00:08²Ä 4186 ½g¦^À³
|
¥xÁÞ¤j¤j ( 81 , 61 ) ¼ÒÀÀ¼Æ¾Ú¦p¤U ½Ð°Ñ¦Ò X^2 = 4.206 > 3.841 HR = 0.708 HR 95% «H¿à°Ï¶¡ = 0.492 ~ 0.983 »¡©ú: 1.¨Æ¥ó¼Æ¬Ò¸m©ó17Ó¤ë ~ 21Ӥ붡 2.°²¦p¹ï·Ó²Õªº¨Æ¥ó¸m©ó«á¬q, ³o¼Ë·|³y¦¨¤¤¬qÄ~ÄòªÈÄñ,Áö«á¬q©Ô¶},¤´ÂµLªk¹F¼Ð 3.¨â²Õ«á±«p§À¥¥xªºÁ`¦s¬¡¾÷²v,¤À§O¬° 0.55 , 0.37 ¶È¨Ñ°Ñ¦Ò ÁÂÁ¤j®a! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/15 ¤U¤È 04:07:11²Ä 4185 ½g¦^À³
|
²q·Q¤j ©êºp¡A¼ÒÀÀ¨Æ¥ó¼Æ§ó¥¿¬° ¹êÅç²Õ81 ¹ï·Ó²Õ61 ¥HASCO p13 ¶i¦æ¼ÒÀÀ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/15 ¤U¤È 03:35:35²Ä 4184 ½g¦^À³
|
ÁÂÁ²q·Q¤j ¤p©_¤jªº¤À¨É¡A¯¬ºÖ²³¤j¤j¤¤¬î¸`§Ö¼Ö! «Ü·Q¼ÒÀÀ¬Ý¬Ý´£¨Ñºô¯¸¡A¦]¥Xªù¦b¥~¡A¤â¾÷«ÜÃø³sµ²¡A ½Ð±Ð²q·Q¤j«e½ú °²³] ¹êÅç²Õ95Өƥó ¹ï·Ó²ÕÓ72¨Æ¥ó HR ,P value¬ù²¤±¡ªp?(²Å¦X95%«H¿à°Ï¶¡) ·|¤p©ó0.05 ¶Ü ? HR ·|¨ì0.66¶Ü? |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/15 ¤U¤È 01:29:37²Ä 4183 ½g¦^À³
|
¤j¹ÙÌ,¤¤¬î¸`§Ö¼Ö! ų©ó«ù¤[ªº¯E«È¤jªº°Q½×¤j¤å,¤p§Ì¬OÃú¯í¯í¤@¤ù ¬°¤F¤F¸Ñ,©ó¬O§ä¨ì¤F HR ¤Î HR 95% «H¿à°Ï¶¡ ªººâªk ¦b¦¹´£¨Ñ¦³¿³½ìªº¤j¤j¦b°²´Á¤¤¾\Ū¤Î¤ÀªR(¥u¦³¨â¶) https://books.google.com.tw/books?id=HmnIBAAAQBAJ&pg=PT129&lpg=PT129&dq=HR%3D(O1/E1)/(O2/E2)&source=bl&ots=_2y_TneZ4E&sig=ccKOdk2NVzNFaCS_FZOIr_o6Cdk&hl=zh-TW&sa=X&ved=0ahUKEwjkv4KBrpDPAhWKmZQKHT1tBMkQ6AEIHTAA#v=onepage&q=HR%3D(O1%2FE1)%2F(O2%2FE2)&f=false ʼ˵e¸¬Äª,´N¥iºâ±o»P¤½¥q¤½§Gªº¬Û¥é¼ÆÈ ³o¼Ë¼ÒÀÀ°_¨Ó,( P È) ( HR È ) ÁÙ¦³ (HR ªº 95% «H¿à°Ï¶¡ ) ,¤TÓ¼ÆȬҥi±o¨ì «¢!¥i¥H¬Û¤¬¤ñ¸û,´N¼W²K¼ÒÀÀªº°Ê¤O Y¦³¼ÒÀÀ¥Xȱo°Ñ¦Òªº¼Æ¾Ú ¦A¶K¥X¨Ó©M¤j®a°Q½× ¶È¨Ñ°Ñ¦Ò ÁÂÁ¤j®a! |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/13 ¤U¤È 07:45:31²Ä 4182 ½g¦^À³
|
¤p©_¤j¤j ÁÂÁ±zªºµý¹ê ¨Æ¹ê¤W,¤p§ÌÁÙ¤@ª½¦b¼ÒÀÀPÈ §Æ±æ¯à°÷¥Î¦P¼Ë¨Æ¥ó²v¤ñ ( §Y (50/224)/(35/124)=(136/224)/(95/124) ) ¥H¨Æ¥ó¼Æ( 136,95 ) ¬Ý¬O§_¯à¼ÒÀÀ¥X P < 0.05 ªº±Æ¦C ¥H«e¨S¦³§â´¤n»â,¸g¬Q¤é±zªº´£ÂI,¤µ¤é²×©ó¼ÒÀÀ¥X¸Ó±¡ªp ¤]´N¬O«e¬q¤wµ±³Âªá,¤¤¬q¤£¦AªÈÄñ,«á¬qµo´§«pªø§À®ÄÀ³(«pªø§À«Ü«n),©Î¥i¹F¦¨, «¢! µÛ¹êÅý¤p§Ì¼e¤ß¤£¤Ö §Æ±æ822¯à¤@¦p¹w´Áµo´§«pªø§À®ÄÀ³,§Y¨Ï¥H²{¦bªº¨Æ¥ó²v¤ñ,¨ÌµM¦³¹F°}ªº¥i¯à Y¸ÕÅç²Õªº(¨Æ¥ó²v¤ñ)¤ñ²{¦bªí²{±o§ó¦n,´N§ó¤£¦b¸Ü¤U¤F ¶È¨Ñ°Ñ¦Ò,½Ð¤Å§@¬°±z§ë¸ê¨Ì¾Ú ÁÂÁ¤j®a! |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2016/9/13 ¤U¤È 04:05:36²Ä 4181 ½g¦^À³
|
²q·Q¤j¡A ¤p§Ì¯uªº¨ØªA±z¡I ±z¤S§âHRªººâªkµ¹§ä¨ì¤F¡I ¤½¦¡¨S¿ù, ´N¬O (O1/E1)/(O2/E2) ?, O ¥Nªí²ÖpÆ[¹îÈ , E ¥Nªí²Öp´Á±æÈ E=²Öp´Á±æÈ¡A¥¿¬OºâPÈ»PHRªºÃöÁä ¦ý¬O¥Î·§¦ôªk¨ÓºâE1¡BE2¡A¥i¯à·|»P¹ê»ÚªºE1¡BE2¦³¤£¤Öªº®t¶Z KM¦s¬¡¦±½uªº¥Í¦º¦s¤`ªºÅܤƳ£¦bO²ÖpÆ[¹îÈ»PE²Öp´Á±æȪº®t²§ùØ ¤Ó·PÁ±z¤F¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/13 ¤W¤È 10:37:01²Ä 4180 ½g¦^À³
|
¸É¥R 1 §ó¥¿ 2016 ASCO p13 ¦b¥h¦~10¤ë©³(¤w¸g¹L32Ó¤ë 8ӰϬq) ¨ì¤µ¦~6¤ë©³(¤w¸g¹L40Ó¤ë 10ӰϬq) ¨ì¤µ¦~10¤ë©³(¤w¸g¹L44Ó¤ë 11ӰϬq) ¨ì¤µ¦~12¤ë©³(¤w¸g¹L48Ó¤ë 12ӰϬq ) |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/13 ¤W¤È 10:28:53²Ä 4179 ½g¦^À³
|
¤p©_¤j: ÁÂÁ¤p©_¤jªá«Ü¦h®É¶¡¼ÒÀÀ¥X¨Óªº½×z: ¹êÅç²ÕY»P¹ï·Ó²Õ¦³¤F©Ô¶}ªº»â¥ýÁͶաAºâ¥d¤èÈ®ÉÁö¥u¯àºâ´Á¤¤¤ÀªR·í®É¦³µo¥Íªº¨Æ¥ó²Ö¿n¹w´ÁÈ¡A«á±ªº¤@¤j°ï³]¸ê®Æ¨ä¹ê¤]¬O¹êÅç²ÕÀu©ó¹ï·Ó²Õ(¦s¬¡¾÷²v¹êÅç²Õ¤@ª½»â¥ý)¡A¥u¬O¦b·í¤U¤£¯àpºâ¡Aµ¥µo¥Í¨Æ¥ó¤~¯à¤@¤@ºâ¶i²Ö¿n¹w´ÁÈ¡A¥d¤èȤ]´NÀHµÛ¹ê¥óªºµo¥Í³vº¥Åܤj¤F¡A©Ò¥H³Ì«nªº¬O¡A¹êÅç²Õ¤@©wn¦³©Ô¶}ªº»â¥ýÁͶաAÀHµÛ¨Æ¥ó³vº¥µo¥Í¡Apºâªº¥d¤èȦ۵M·|Åܤj¡C ¸É¥R: 1 ±q¥h¦~10¤ë(¤w¸g¹L32Ó¤ë 8ӰϬq) ¨ì¤µ¦~6¤ë (¤w¸g¹L40Ó¤ë 10ӰϬq) ¨ì¤µ¦~10¤ë(¤w¸g¹L42Ó¤ë 10.5ӰϬq) ¨ì¤µ¦~12¤ë(¤w¸g¹L44Ó¤ë 11ӰϬq ) Ó¤H±À¦ô¹ï·Ó²Õ¦b6¤ë«e«á¼Æ¾Ú¤w¦¨¼ô,¥un¦³¤@±ø½u¼Æ¾Ú¦¨¼ô(¦p¹ï·Ó²Õ),¨Ãµ¥¨ì¤F»Pªk³W³æ¦ì¹w¥ý³]©wªº ´£¦°±¤îÁ{§É¸ÕÅçÆ[¹îªºÃä¬ÉÂI (¦pp value HR µ¥) «K¥i¤½§iMOSµ²ªG, ¯E¹©¥Ø«e¦bµ¥°±¤îÁ{§É¸ÕÅçÆ[¹î Ãä¬ÉÂIªº¨ÓÁ{ ( Ãä¬ÉÂIªº¦pªG¨ÓÁ{ ¹êÅç²ÕÁÙ¨S¤U°¦Ü50% ®É ¥i¥H¥H«á¦A¸É¤½§i 2 ˦Y¥Ì½© WºÉ¥Ì¨Ó ¬°®É¤£»· 3 P13 ªº¹F¼Ð ( p <0.05 ) »P ¥xÆWÃÄÃÒ ¬ü°êÃÄÃÒ ®§®§¬ÛÃö ¥H¤W¸ê°T¤À¨É»P´£¨Ñ°Ñ¦Ò ½Ð¦h°ö¾i¿W¥ß«ä¦Ò»P¬ã§P |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/12 ¤U¤È 08:35:38²Ä 4178 ½g¦^À³
|
¤p©_¤j¤j ¯u·PÁ±z¤£¹½¨ä·Ð¦aÁ|¨Ò»¡©ú»P«ü¥¿ ©çÁÂ,¤p§Ì¾Ç±o¦³¨Ç³¢¤½®L¤,½Ð¨£½Ì »¡¯uªº,¤p§Ì¥Î¸Õºâªí¼ÒÀÀ¤£¤U¦Ê¦¸ ¥uª¾¹D,³]¸ê®Æ»P¨Æ¥óªº±Æ¦C¤è¦¡ ,¼vÅTµÛ¥d¤èÈ ©Î¤]Âk¯Ç¤@Óµ²½×, ¨âÓ¦s¬¡¦±½u©Ô±o¶},¥d¤èȤ~·|Åܤj ¶V¨ìÆ[¹î±ß´Á,©¹©¹®t¤@¨âӨƥó¼Æ,¥d¤èÈ´N¤j¦³®t§O ³o´N¦p±z©Ò¨¥ "«ÂI¬O¡A¹êÅç²Õn»P¹ï·Ó²Õ²£¥Í©Ô¶}ªº»â¥ýÀu¶Õ¡C" ¤~¬OÆ[¹î«ÂI¤¤ªº«ÂI ¦Ü©óHRªººâªk ¤p§Ì§ë°¤F ¨º½g¤å³¹ ¤p§Ì¤£ª¾¥á¨ìþ¨à¤F ¥uª¾¤½¦¡¨S¿ù(?), ´N¬O (O1/E1)/(O2/E2) ?, O ¥Nªí²ÖpÆ[¹îÈ , E ¥Nªí²Öp´Á±æÈ À³¸Ó¦³«e´£±ø¥ó,¦ý¬O¤p§Ì§Ñ¤F,©Î¦]¦¹±i«a§õÀ¹¤F ¹ï¤£°_,¨S¯à¸Ñµª ¤U¦¸±z§Ë²M·¡¤F,¦A¨Ó±Ð¤p§Ì ¦b¦¹,¦A¤@¦¸ÁÂÁ±zªº«ü¾É Åý¤p§Ì²×©ó¤F¸ÑÃöÁä,§_«h¼ÒÀÀÓ¤d¦¸,¤´¥u·|¬O¤@ÀYÃú¤ô¥[¦½¤ô ÁÂÁ±z! ¤]ÁÂÁ¤j®a! |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2016/9/12 ¤U¤È 04:32:14²Ä 4177 ½g¦^À³
|
²q·Q¤j¡A ±zª¾¹D±Æª©¹ï»ôªº°ÝÃD ¨Ò¤l¤¤ªº¤T±Æ¼Æ¦r³QÀ½¦b¤@°_ ´N¤@±Æ¤@±Æ¹ï»ôÅo ¥t¥~²Ä¤@¨Òªº®É¶¡14~®É¶¡17ªº¥|Өƥó¬O¹ï»ô¹êÅç²Õªº ÁÂÁ¡I |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2016/9/12 ¤U¤È 04:17:47²Ä 4176 ½g¦^À³
|
²q·Q¤j¡A ÁÂÁ±zªº»¡©ú¡I ¡u§Ú̬O¥ÎÆ[¹îÈ¥h±À±o¨â²Õªº¹w´ÁÈ ¾ãÓ¸ÕÅ窺Á`¨Æ¥ó²v¬° (65+54)/348=¡@0.342 ¦]¦¹¹êÅç²Õªº¨Æ¥ó¹w´Á¼Æ¬° 0.342*224= 76.6 ; ¹ï·Ó²Õ«h¬° 0.342*124=42.4 ±a¤J¤½¦¡ X^2=(65-76.6)^2/76.6+(54-42.4)^2/42.4=4.931¡v ¥Î³oºØ¤èªk¨Ó±ÀºâpȦb¤£¦PªºÆ[¹î´Á¶¡·|²£¥ÍpÈ·¥¤jªº®t²§ §ÚÁ|Ó¨Ò¤l°µ»¡©ú °²³]348¤Hªº¹êÅç¨S¦³drou out¡AÆ[¹î®É¶¡©Ôªø¨ì¹ï·Ó²Õ124¤H¥þ³¡¨Æ¥óµo¥Í¡A¦¹®É¹êÅç²Õ224¤H¤¤¤´¦³20%ªº¤HÁÙ¥¼µo¥Í¨Æ¥ó¡A¤]´N¬O45¤H¤´¦s¬¡¡A179¤Hµo¥Í¨Æ¥ó ¾ãÓ¸ÕÅ窺Á`¨Æ¥ó²v¬° (179+112)/348=¡@0.836 ¹êÅç²Õªº¨Æ¥ó¹w´Á¼Æ¬° 0.836*224= 187.3 ; ¹ï·Ó²Õ«h¬° 0.836*124=103.72 ±a¤J¤½¦¡ X^2=(179-187.3)^2/187.3+(112-103.72)^2/103.72=1.032 Æ[¹î¨ì¹ï·Ó²Õ©Ò¦³¤H³£µo¥Í¨Æ¥ó¡A¹êÅç²Õ¤´¦³20%ªº¤H¦s¬¡¡A ³oÀ³¸Ó¬O¦³Àø®ÄªºÃħa¡AKM¹Ï¨â±ø¦±½u¤]À³¸Ó¬OºCºCªº¤À¶}§a ¥i¬OÆ[¹î¤F«Ü¤[ªº®É¶¡¡Aºâ¥X¨Óªº¥d¤èȳºµM=1.032¡APȤp©ó0.05 ¥O¤HÃø¥H²z¸Ñªº¼Æ¦r ©Ò¥H¤p§Ìı±o¥Î·§²¤ªº¤½¦¡±ÀºâKM¦s¬¡¦±½uªºPÈ«Ü¥i¯à·|¥Ç¤F«Ü¤jªº¿ù»~ nÁ¿³]¸ê®Æ»PPȩΪ̻¡¥d¤èȪº¼vÅT¡A¯uªº«Ü½ÆÂø ¤p§Ì¬Ý¹L±z¥H«eªº¼ÒÀÀ¸Õºâ¡Aºâ¦¡»P¤p§Ìªººâªk§¹¥þ¤@¼Ë ¥H¤U¤p§Ì¥Î¨âÓ¨Ò¤l¨Ó¸ÑÄÀ³]¸ê®Æ¹ï¥d¤èȪº¼vÅT ²Ä¤@Ó¨Ò¤l ®É¶¡ ¹ï·Ó²Õ ¹êÅç²Õ 1. 1 1 2. 1 1 3. 1 1 4. 1 0 5. 1 0 6. 1 0 7. 1 0 8. 1 0 9. 0 1 10. 1 0 11. 0 1 12. 1 0 13. 0 1 14. 1 15. 1 16. 1 17. 1 ¥H¤Wªº1.¡A2.¡A3.¡A¤À§O¬O®É¶¡1¡A®É¶¡2¡A®É¶¡3¡A ¨ä©Ò¹ïÀ³ªº¹ï·Ó²Õ»P¹êÅç²Õ¼Æ¦r¤À§O¬O¸Ó²Õµo¥Íªº¨Æ¥ó¼Æ¡A ¹ï·Ó²Õ»P¹êÅç²Õ¦U¦³10¤H ®É¶¡1~®É¶¡3¡A¨â²Õ¥¤À¬î¦â¡A¨S¦³¿éĹ ®É¶¡4~®É¶¡7¡A¹êÅç²ÕµL¤Hµo¥Í¨Æ¥ó¡A©Ô¶}¤F®t¶Z ®É¶¡8~®É¶¡13¡A¹ï·Ó²Õ¥ýµo¥Í¤@Өƥó¡A¤§«á¤U¤@´Á¹êÅç²Õ¤]µo¥Í¤@Өƥó ³o¬q¨ä¶¡¹ï·Ó²Õ¸¨«á¨S¦³©Ô¤j¡A¸òµÛ¹êÅç²Õ¥ç¨B¥çÁÍ«rµÛ ®É¶¡14~®É¶¡17¡A¥u³Ñ¤U¹êÅç²Õ¤´¦³4¤H¦s¬¡¡A¤À¦¨4´Áµo¥Í¨Æ¥ó °²³]Æ[¹î®É¶¡ªø¹F17´Á¡A¨â²Õ¨Æ¥ó¥þ³¡µo¥Í ¹ï·Ó²Õªº²Ö¿n¹w´ÁÈ=5.825¡A¹êÅç²Õªº²Ö¿n¹w´ÁÈ=10.175 ±a¤J¤½¦¡ X^2=(10-5.825)^2/5.825+(10-14.175)^2/14.175=4.222 ³o¬O³Ì²×¥B³Ì¥¿½Tªº¥d¤èÈ ¦ý¦pªG¦b®É¶¡7¡A¦b¹êÅç²Õ¤w¸g¦³¤F»â¥ýªºÁͶմN´Á¤¤¤ÀªRªº¸Ü¡A §ÚÌ°²³]®É¶¡8~®É¶¡17³£ÁÙ¨SÆ[¹î¨ìµo¥Í¨Æ¥ó¡A¤´³£¬O³]¸ê®Æ(¦AÆ[¹î·|¤@¤@¦¨¬°¨Æ¥ó)¡A ¦¹®É¥d¤èȪºpºâ¥u¯àºâ¨ì®É¶¡7¡A®É¶¡8¥H¤Î¤§«áªº³£¬O³]¸ê®Æ(Á٬ݤ£¨ì¤£¯àpºâ) ®É¶¡1~®É¶¡7¡A¹ï·Ó²Õªº²Ö¿n¹w´ÁÈ=4.743¡A¹êÅç²Õªº²Ö¿n¹w´ÁÈ=5.257 ±a¤J¤½¦¡ X^2=(7-4.743)^2/4.743+(3-5.257)^2/5.257=2.043 ¡÷¥d¤èÈ¥u¦³2.043¡A¦]¬°«á±³£¬O³]¡AÁöµM¹êÅç²Õ¤w¸g¦b®É¶¡4~®É¶¡7²£¥Í¤F»â¥ýÀu¶Õ¡A±µ¤U¨Óªº®É¶¡8~®É¶¡13¹êÅç²Õ¤]¥u¦³¤@¨Ó¤@©¹¡A¨Ã¨S¦³¦A¤j´T»â¥ý¹ï·Ó²Õ¡A¥i¬O¦b®É¶¡4~®É¶¡7©Ò¥´¤Uªº°ò¦¡A¥i¥HÅý¦b®É¶¡8~®É¶¡13¤@¨Ó¤@©¹µo¥Í¨Æ¥ó®É¡A«ùÄò²Ö¿n¹ï¹êÅç²Õ¦³§Qªº¹w´ÁÈ¡A³Ì«áÆ[¹î¨ì®É¶¡17¡A¥d¤èÈ=4.222 ³o´N¬O¤p§Ì»¡ªº¡A¹êÅç²ÕY»P¹ï·Ó²Õ¦³¤F©Ô¶}ªº»â¥ýÁͶաAºâ¥d¤èÈ®ÉÁö¥u¯àºâ´Á¤¤¤ÀªR·í®É¦³µo¥Íªº¨Æ¥ó²Ö¿n¹w´ÁÈ¡A«á±ªº¤@¤j°ï³]¸ê®Æ¨ä¹ê¤]¬O¹êÅç²ÕÀu©ó¹ï·Ó²Õ(¦s¬¡¾÷²v¹êÅç²Õ¤@ª½»â¥ý)¡A¥u¬O¦b·í¤U¤£¯àpºâ¡Aµ¥µo¥Í¨Æ¥ó¤~¯à¤@¤@ºâ¶i²Ö¿n¹w´ÁÈ¡A¥d¤èȤ]´NÀHµÛ¹ê¥óªºµo¥Í³vº¥Åܤj¤F¡A©Ò¥H³Ì«nªº¬O¡A¹êÅç²Õ¤@©wn¦³©Ô¶}ªº»â¥ýÁͶաAÀHµÛ¨Æ¥ó³vº¥µo¥Í¡Apºâªº¥d¤èȦ۵M·|Åܤj¡C ²Ä¤GÓ¨Ò¤l ®É¶¡ ¹ï·Ó²Õ ¹êÅç²Õ 1. 1 1 2. 1 1 3. 1 1 4. 1 0 5. 1 0 6. 1+ 1+ 7. 1 0 +¥Nªí³]¸ê®Æ ¦¹¨Ò¦b®É¶¡6¹ï·Ó²Õ»P¹êÅç²Õ¦U¦³¤@Ó³]¸ê®Æ ¹ï·Ó²Õªº²Ö¿n¹w´ÁÈ=4.362¡A¹êÅç²Õªº²Ö¿n¹w´ÁÈ=4.638 ±a¤J¤½¦¡ X^2=(6-4.362)^2/4.362+(3-4.638)^2/4.638=1.193 »P²Ä¤@Ó¨Ò¤l¬Û¦P¡A¹êÅç²Õ»P¹ï·Ó²Õ¦U10¤H¡A¦ý³o¤@Ó¨Ò¤l§Ú̱N«ÂI©ñ¦b²Ö¿n¹w´ÁÈpºâ¨ì®É¶¡7´N¦n¡A¦¹¨Òªº«ÂI¦b¦]¬°Æ[¹î®É¶¡¤£°÷¤[¡A®É¶¡6¬Ý°_¨Ó¨â²Õ³£¬O³]ªº¸ê®Æ¡AY¦AÆ[¹îµyµyªø¤@ÂIªº®É¶¡(¦h0.5´Á)¡A¹ï·Ó²Õ¦b®É¶¡6ªº³]¸ê®Æ¦b®É¶¡6.5´Á¦¨¬°¨Æ¥ó¡A¹êÅç²Õ¦b®É¶¡6ªº³]¸ê®Æ¦b®É¶¡6.5´Á¤´¬O³]¸ê®Æ¡A¦ý¦¹®É¦]¬°Æ[¹î¨ì¤F¹ï·Ó²Õªº¤@Ó³]¦¨¬°¤F¨Æ¥ó¡A´N¥i¥H¦hºâ¤@Ó²Ö¿n¹w´ÁÈ¡A¥H¤U¨Ó¬Ý³o¼ËªºÅܤƦ³¦h¤j¡C ®É¶¡ ¹ï·Ó²Õ ¹êÅç²Õ 1. 1 1 2. 1 1 3. 1 1 4. 1 0 5. 1 0 6.5 1 1+ 7. 1 0 ¹ï·Ó²Õªº²Ö¿n¹w´ÁÈ=4.779¡A¹êÅç²Õªº²Ö¿n¹w´ÁÈ=5.221 ±a¤J¤½¦¡ X^2=(7-4.779)^2/4.779+(3-5.221)^2/5.221=1.977 ¦AÆ[¹îµy?IMG SRC="/WF_SQL_XSRF.html"> |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/12 ¤W¤È 07:27:39²Ä 4175 ½g¦^À³
|
¤p©_¤j¤j «È®ð¤F,±z¬O¥H¤j¾Ô²¤¥XµoªºÆ[¹îªÌ,¤£¹³¤p§Ì¾Ç¨Ç¾Ô³N¤¤ªºÀJÂΤp§Þ ³o¸ò¤p§Ì·íªì¤£·|ºâHR¤@¼Ë ¡u °²¦p¥Î·§¦ôªk X^2=(65-76.6)^2/76.6+(54-42.4)^2/42.4=4.931¡v ¦¡¤l¤¤ªº76.6¬O«ç»òpºâªº¡H ¥H¤Î ¡u¥Î¤½¥qªº¼Æ¾Ú¡]50¡A35¡^¥uºâ¨Æ¥ó¼Æ¡A¬O1¡P133¡AY¥[p³]¸ê®Æ·|Åܬ°1¡P499 ¤W¥y¤¤ªº1¡P133¤Î1¡P499¬O«ç»ò¨Óªº¡H ¡v 76.6 ©M 42.4 ¤À§O¬°¹êÅç²Õ©M¹ï·Ó²Õªº¨Æ¥ó¹w´ÁÈ ²{¦b¥Îªº¨Æ¥ó¼Æ¬°( 65 , 54 ) §Ú̬O¥ÎÆ[¹îÈ¥h±À±o¨â²Õªº¹w´ÁÈ ¾ãÓ¸ÕÅ窺Á`¨Æ¥ó²v¬° (65+54)/348=¡@0.342 ¦]¦¹¹êÅç²Õªº¨Æ¥ó¹w´Á¼Æ¬° 0.342*224= 76.6 ; ¹ï·Ó²Õ«h¬° 0.342*124=42.4 ±a¤J¤½¦¡ X^2=(65-76.6)^2/76.6+(54-42.4)^2/42.4=4.931 HR=(65/76.6)/(54/42.4)=0.666 ¦P¼Ëµ{§Ç ¤½¥q¤½§Gªº¨Æ¥ó¼Æ( 50, 35); ³]¼Æ ( 174 , 89 ) ¥up¨Æ¥ó¼Æ X^2=(50-54.7)^2/54.7+(35-30.3)^2/30.3=1.133 HR=(50/54.7)/(35/30.3)=0.791 ¨Æ¹ê¤W³oÓÈ·|µ¥©ó¨â²Õ¨Æ¥ó²vªº¤ñÈ=(50/224)/(35/124)=0.791 ¥[¤J³]¼Æ·|Åܬ°1.499(ºâ¥d¤èÈ®É,À³¥up¨Æ¥óµo¥Í¼Æ) ¤p§Ì¸ÑÄÀ±o¤£¦n ½Ðì½Ì ÁÂÁ±z! ¤]ÁÂÁ¤j®a! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/12 ¤W¤È 12:01:21²Ä 4174 ½g¦^À³
|
²³¤j¤j ±q¯E¹©2016 9¤ë 8¤é ·ç¤h«H¶UÁ|¿ì¤§ªk»¡·|²³ø OBI Oncology Pipeline Ó¤H»{¬°¨ä¯S¦â¦p¤U 1 Adagloxad Simolenin (OBI822) OBI833 OBI888 ¤T¤j²£«~¨t¦C¤õ¤O¥þ¶} 2¥H¤¤jÃÄÀu¥ý¶}µo(¨ÅÀù167.6¸U¤H,¤j¸zª½¸zÀù136¸U¤H, ªÍÀù182.4¸U¤H, ¨xÀù78.2¸U¤H ,GÀù95.1¸U¤H) µo¥Í¼Æ/year 3 ¦P®É±a¦³ Globo H, SSEA3, SSEA4 ¤TÓ§Ü쪺Àu¥ý¶}µo (°£¤FColorectal Cancer* Globo H, SSEA4 ) 4 822 833 (¨ÅÀù ¤j¸zª½¸zÀù ªÍÀù GÀù)«Å|¶}µo , «O¦³³Ì¨Î¾÷°Ê©Ê 5 ¼W¥[¬ãµo°ªP¦º·ÀIÀù¯g ( ªÍÀù87% GÀù 76% ¨xÀù95% ) º¡¨¬¥¼³Qº¡¨¬ªºÂåÀø»Ý¨D OBI Oncology Pipeline Stages of Development / Tumor-Associated Carbohydrate Antigens observed in tissue and cell line studies Adagloxad Simolenin (OBI-822) Breast cancer §¹¦¨¥xÆW¤T´Á Globo H, SSEA3, SSEA4 Ovarian cancer ¤G´Á Globo H, SSEA3, SSEA4 Planned studies (ª½±µ¶i¤J¤G´Á ) Lung Cancer* Globo H, SSEA3, SSEA4 Gastric Cancer* Globo H, SSEA3, SSEA4 Colorectal Cancer* Globo H, SSEA4 Liver Cancer* SSEA3, Globo H, SSEA4 OBI-833 ( ¹w¦ô¦~©³§¹¦¨¦¬®×) Gastric cancer ¤@´Á Globo H, SSEA3, SSEA4 Colorectal cancer ¤@´Á Globo H,SSEA4 Lung cancer ¤@´Á Globo H, SSEA3, SSEA4 Breast cancer ¤@´Á Globo H, SSEA3, SSEA4 OBI-888 ¥þ¤O½Ä¨ë ©ú¦~¶i¤JIND Epithelial cancers ¸ê°T¨Ó·½: 6¤ë27¤é ªÑªF·| , 2016 9¤ë 8¤é ·ç¤h«H¶UÁ|¿ì¤§ªk»¡·|²³ø P 10 16 39 42 44 |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2016/9/11 ¤U¤È 10:07:10²Ä 4173 ½g¦^À³
|
²q·Q¤j¡A¥xÁÞ¤j ®¤¤p§Ì¾q¶w ¡u°²¦p¥Î·§¦ôªk X^2=(65-76.6)^2/76.6+(54-42.4)^2/42.4=4.931¡v ¦¡¤l¤¤ªº76.6¬O«ç»òpºâªº¡H ¥H¤Î ¡u¥Î¤½¥qªº¼Æ¾Ú¡]50¡A35¡^¥uºâ¨Æ¥ó¼Æ¡A¬O1¡P133¡AY¥[p³]¸ê®Æ·|Åܬ°1¡P499¡v ¤W¥y¤¤ªº1¡P133¤Î1¡P499¬O«ç»ò¨Óªº¡H ½Ð«ü¾É¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/11 ¤U¤È 12:52:29²Ä 4172 ½g¦^À³
|
«eªÌ¶K¤åÀ³¸Ó¬O»¡NED¤H¼Æ¶V¦h¡AMOS·|¶V¦n¡A 1¥´§¹¤E°w¤S¯à²£¥Í§K¬Ì¤ÏÀ³»P²£¥Í§ÜÅé®Ä»ù>1:160³o¤@²ÕªºMOS¥i¯à¬O³Ì°ª¡ANED¦b³o²Õ²q´ú·|¦û¤j¦h¼Æ¡C 2¥´§¹¤E°wªº²Õ§OMOS¦¸¤§ 3²£¥Í§K¬Ì¤ÏÀ³§ÜÅé®Ä»ù>1:160 MOS¦A¦¸¤§ ¥H¤W¤T²ÕªºMOS ±À´ú·|«Ü´Î¡C 4¹êÅç²Õ224¤H»P±±¨î²Õ124¤H³o²ÕªºMOS¦pP value ¯à <0.05 ¤w¸g«Ü¤£®e©ö¤F¡C ¥H¤W¦sÄݲq´ú¡A¥H¤½¥q¤½§i¬°·Ç¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/11 ¤W¤È 11:10:19²Ä 4171 ½g¦^À³
|
ÁÂÁ²q·Q¤j´£¨Ñªº¸ê°T¡A²q·Q¤j·Q¬Ýªº³o¨â±i¹Ï·|¤£·|¬O¥ÑNEDªº¨ü¸Õ¤@°_µe¥X¨Óªº¡A³o¨â±i¹Ï§Æ±æ¦³¤@±i¯à°÷¥X²{¦b·s^®æÄõÂå¾Ç´Á¥Z¡AÅý¥þ²y¨ÅÀù±M®aÆg¹Ä¥xÆWÁÞ¤À¤l·sÃĦbÀù¯g§K¬ÌÀøªkªº»â¥ý¯à¤O! |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/11 ¤W¤È 10:31:39²Ä 4170 ½g¦^À³
|
¥xÁÞ¤j¤j §¹¾ãªº½d¨Ò,½Ð°Ñ¦Ò https://stat.ethz.ch/education/semesters/ss2011/seminar/contents/presentation_2.pdf ±z·Q¬Ýªº "¥´§¹¤E°w¤S¯à²£¥Í§K¬Ì¤ÏÀ³»P§ÜÅé®Ä»ù>1:160ªºMOS¦s¬¡¦±½u¹Ï", À³¸Ó¬OÀø®Ä³Ì¦nªº ¤p§Ì¤]·Q¬Ý ¥´§¹¤E°wªÌ¨â²Õ OS ªº PK ,ÁÙ¦³³o¨Ç±wªÌªºI´º¸ê®Æ ¥H¤Î¦³§K¬Ì¤ÏÀ³»PµL§K¬Ì¤ÏÀ³¨â²Õ±wªÌªºI´º¸ê®Æ Åý§Ú̬ݬݸӵ¥¤À²Õ¬O§_¦³ÅãµÛ¤£¦P ¤£ª¾¤½¥q·|¤£·|¤½§Gµ¹¤j®a°Ñ¦Ò? ¶È¨Ñ°Ñ¦Ò ÁÂÁ¤j®a |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/10 ¤U¤È 11:50:09²Ä 4169 ½g¦^À³
|
²q·Q¤j §Ú̲{¦b°Q½×ªº³o¤@±ip13 ¹Ïªí¬O¦³²£¥Í§K¬Ì¤ÏÀ³¨Ã²£¥Í§ÜÅé®Ä»ù>1:160»P¨S¦³²£¥Í§K¬Ì¤ÏÀ³»P¨¬°÷§ÜÅ骺¤@°_¥hpºâ¥X¨ÓªºMOS P17¨º¤@±i¹Ï¬O¦³²£¥Í§K¬Ì¤ÏÀ³»P§ÜÅé®Ä»ù>1:160 ªºMOS¡A¬Ý°_¨Ó«D±`¥O¤Hexciting. §Ú¤]«Ü·Q¬Ý¨ì¤@±i¹Ï¤£ª¾¹D·|¤£·|¥X²{: ¥´§¹¤E°w¤S¯à²£¥Í§K¬Ì¤ÏÀ³»P§ÜÅé®Ä»ù>1:160ªºMOS¦s¬¡¦±½u¹Ï¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/10 ¤U¤È 10:46:49²Ä 4168 ½g¦^À³
|
²q·Q¤j ÁÂÁ«ü¥X¿ù»~ªº·Qªk¡Aì¨Ó¬O¤£¯à§â³]¸ê®Æºâ¶i¥h¡AÁÂÁ«ü¥¿¡C |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/10 ¤U¤È 10:31:46²Ä 4167 ½g¦^À³
|
¥xÁÞ¤j¤j ±z§â³]¸ê®Æ¼Æ¤]p¤J ¦b¤p§ÌªºÆ[©ÀùØ¡A¤]¬O¤p©_¤j¤j±Ðªº¡A¸ÓÈ©Î¥u»P¨Æ¥ó¼Æ¦³Ãö¡A¤£ª¾¦³µL¿ù»~¡H ¥Î¤½¥qªº¼Æ¾Ú¡]50¡A35¡^¥uºâ¨Æ¥ó¼Æ¡A¬O1¡P133¡AY¥[p³]¸ê®Æ·|Åܬ°1¡P499 °²¦p¬O³o¼Ë¡A°Z¤£¤Ó«Ó¤F¡H¡I ¬O§_¥i½Ð¤p©_¤j¤jÀ°§Ú̸Ѵb©O¡H «¢¡I¤ÓÄYµÂ¤F¡AÂà¶KÓ¯º¸Ü ¡u¦³¥»®Ñ¡A¦W¥s ¡mHow to change your wife in 30 days¡n¡A¤@Ó¬P´Á¤§¤º°â¥X100¸U¥»¡C ª½¨ì§@ªÌµo²{¡A®Ñ¦W«÷¿ù£¸Ó¦r¥À¡A ¥¿½TªºÀ³¸Ó¬O¡G ¡mHow to change your life in 30 days¡n¡C §ï¥¿«á¾ã¾ã¤@¬P´Á¡A¥u½æ¤F5¥»¡C §@ªÌ«Ü¯Ç´e¡AÃø¹D¨k¤H³£³o»ò¦Û¨p¶Ü¡H¥u·Q§ïÅܦѱC¡A¦Ó¤£·Q§ïÅܦۤv¡H¡v ÁÂÁ±z ÁÂÁ¤p©_¤j¤j ¤]ÁÂÁ¤j®a¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/10 ¤U¤È 09:41:31²Ä 4166 ½g¦^À³
|
²q·Q¤j §Úªººâªk¬O°Ñ¦Ò¥ò´º¤jªººâªk¡A¤]¬O¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/10 ¤U¤È 09:26:52²Ä 4165 ½g¦^À³
|
²q·Q¤j §Úªººâªk¬O 65-76.6=11.6 11.6x11.6=134.56 ¤À§O°£¥H´Á±æÈ 134.56/76.5=1.76 134.56/147.4=0.91 134.56/42.4=3.17 134.56/81.6=1.64 1.76+0.91+3.17+1.64=7.48 ¬dªíPÈ<0.01 |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/10 ¤U¤È 09:08:25²Ä 4164 ½g¦^À³
|
¥xÁÞ¤j¤j °²¦p¥Î·§¦ôªk X^2=(65-76.6)^2/76.6+(54-42.4)^2/42.4=4.931 ¤p§Ì¥Î¸Õºâªí¼ÒÀÀªº¥d¤èȬù¦b4.1¡]·|¨ü±Æ¦C¦ì¸m¼vÅT¡^ ¤Ï¥¿¬O¬ù²¤È¡A°Ñ¦Ò´N¦n ÁÂÁ±zªº«ü¥¿ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/10 ¤U¤È 08:43:38²Ä 4163 ½g¦^À³
|
²q·Q¤j ½Ð°Ý³Ì«á¤@²Õ (65 54) x2 ¬O¦h¤Ö? §Úºâ¥X¨Ó¬O7.48 ¤£ª¾¬O§_»P²q·Q¤j¤@¼Ë¡A¦pªG¤@¼Ëªí¥Ü§Ú̺âªk¬O¤@Pªº¡A¦pªG®t¶Z«Ü¤j¡A¥i¯à§Úªººâªk¬O¿ùªº¡C |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/9/10 ¤U¤È 07:42:20²Ä 4162 ½g¦^À³
|
´£¨Ñ¤j®a¤@Ó¬ù²¤ªº¼ÆÈ°Ñ¦Ò ½Ð¤j®aª`·N" ¬ù²¤ " ¨â¦r ( ®t¤@Өƥó¼Æ,ÁÙ¦³±Æ¦C¦ì¸m¤£¦P,¤]·|¼vÅT¥d¤èȤ£¤Ö ) ¤½¥q¥Ø«e¤½§Gªº¼Æ¾Ú ( 50 , 35 ) ¤p§Ì¼ÒÀÀªº¼Æ¾Ú ( 50 , 42 ) ( 55 , 45 ) ( 60 , 49 ) ( 65 , 54 ) ¥H¤UÃþ±À ¬O¤j¬ù¥i¹F P < 0.05 ªº¨â²ÕÁ{¬É°t¹ï¨Æ¥ó¼Æ ¶È¨Ñ°Ñ¦Ò ÁÂÁ¤j®a |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/9/10 ¤U¤È 01:08:45²Ä 4161 ½g¦^À³
|
¯E¹©¨ÅÀùÃħڬ۫Hª©¤W°ª¤â¤w¼ÒÀÀ±À¦ô¥X¤K¤ë«eP value´N¤w¸g¤p©ó0.05 (2016ASCO§ë¼v¤ù P13)¡A²{¦b¯E¹©¦bµ¥§óº}«Gªº¼Æ¾Ú¦b¦~©³¥X²{¡Aª©¤W°ª¤â¥u¬O§C½Õ¦A§C½Õ¡A¦p±ø¤j©Ò»¡ªº¤Q¤ëESMO ·|§ó·s¼Æ¾Ú¡AÓ¤H¬ã§P¦X§@±ÂÅv¦b¤C¤ë·íP value ¤p©ó0.05®É´N¤w¿n·¥®i¶}¡A¬Û«H¤½¥qªº§V¤O»P¸Û«H´N¹ï¤F¡A¦nªº¥Í§ÞªÑ¾A¦X©ñªø¡A¤£¥HªÑ»ù°ª§C½×¦¨±Ñ¡C¥H¤W¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡G¥Ó¥|®ü10139653 µoªí®É¶¡:2016/9/9 ¤U¤È 01:30:29²Ä 4160 ½g¦^À³
|
§ð§J¨ÅÀù§Q¾¹¡I¦WÂå¼B¨}´¼¡G·f°t¶WµªiÀˬd+§K¬ÌÀøªk ¼B¨}´¼Âå®vªí¥Ü¡A¥Ø«eÁÙ¦bÁ{§É¸ÕÅ綥¬qªº§K¬ÌÀøªk¡A¥¼¨Ó¥i±æ¦¨¬°¨ÅÀùªvÀøªºÁͶաC ²{¦æ¨ÅÀùªvÀø5¤èªk °Æ§@¥Î±`Åý¤H¨ü¤£¤F ¦Ü©ó¨ÅÀùªºªvÀø¡A²{¦æ¦³5¤j¤è¦¡¡A¥]¬A§½³¡±±¨îªº¶}¤M¤â³N©M©ñ®g½uªvÀø¡A¥H¤Î¥þ¨©Ê±±¨îªº²üº¸»XªvÀø¡B¤Æ¾ÇªvÀø©M¼Ð¹vªvÀø¡CÁ{§É·|¨Ì·ÓNCCN¨ÅÀùªvÀø«ü¤Þì«h¡A®Ú¾Ú¤£¦Pªº¨ÅÀù´Á§O©MÃþ«¬¡AÀÀ©w¤£¦PªºªvÀøµ¦²¤¡C ¤£¹L¡A¥H©¹ªº¨ÅÀùªvÀøÃĪ«¡AµL½×¬O²üº¸»XÃĪ«¡B¤ÆÀøÃĪ«©Î¼Ð¹v¥ÎÃÄ¡A³Q¤HÅé¦Y¤U¨{«á¡A¤£¶È·|±þ¦ºÀù²ÓM¡A¤]·|±þ®`¦nªº²ÓM¡A¦]¦¹Åý±wªÌ³´¤J°Æ§@¥ÎªºµhW¤§¤¤¡C ¨ÅÀùªvÀø¡I§K¬ÌÀøªk10¦~¤º¥i±æ¦³·s¬ð¯} §K¬ÌÀøªk¥i±æ¬ð¯}²{¦æ¨ÅÀùªvÀøªº§x¹Ò¡I¥Ø«e¥¿¿n·¥§ë¤J¨ÅÀù§K¬ÌÀøªk¬ã¨sªº¼B¨}´¼Âå®vªí¥Ü¡A§K¬ÌÀøªkn³z¹L±Ò°Ê±wªÌ¦ÛÅ骺§K¬Ì¾÷Âà¡AÅý¦Û¤vªº§K¬Ì²ÓM¥\¯àÅܱj¡A¥i¥Hª½±µ¿ëÃѸ~½F²ÓM¨Ã±N¨ä±þ¦º¡A²z½×¤W¨Ó»¡¡A§K¬ÌÀøªkªº°Æ§@¥Î©M·ÀI·|¤ñ²{¦æÀøªk°¾§C¡A¸~½F±±¨î²v§ó¦n¡A¦s¬¡²v§ó°ª¡C µM¦Ó¡A§K¬ÌÀøªk¯A¤Îªº½d³ò«Ü¦h¡A¥]¬A¬r±þ©ÊªºT²ÓM¡BPD-1©MPDL-1ªº§ÜÅé§í¨î¡A©Î¬O·|»¤µo³¡¤À¨Åé§K¬Ìªº²ÓM¡AªvÀø½ÆÂø«×«Ü°ª¡A¤£¬O³æ¯ÂªºªvÀø¦Ó¤w¡C¦]¦¹¦b¨ÅÀùªvÀø¤è±¡A¥Ø«eªº§K¬ÌÀøªkÁÙ¥u¦bÁ{§É¸ÕÅ綥¬q¡C§Y¨Ï¦p¦¹¡A¼B¨}´¼Âå®v¤´¼ÖÆ[¦aªí¥Ü¡A§K¬ÌÀøªk¹B¥Î©ó¨ÅÀùªvÀø¡A¦b¥¼¨Ó10¦~À³¸Ó·|¦³«Ü¤jªº¶i®i¡C times.hinet.net/news/19277387 |
|
|
·|û¡G561910141205 µoªí®É¶¡:2016/8/4 ¤W¤È 11:24:32²Ä 4159 ½g¦^À³
|
¯E¹©»·¤j§»°¶ªºÄ@´º¡A¦b¥xÆWªº¤½¥q¸Ì¡A¨u¨£©Î¶È¨£¡C ª©¤W³\¦h¤j¤jªº«H©À©M°õµÛ¡A¦bªÑ¥«¸Ì¤]¨u¨£¡A¥O¤H·P¨Ø¡C ¦³¤@º¦è¬v¶m§ø¦Ñºq¡Aªí¹F¤F«H©À©M°õµÛ¡Aºqµü¥¤Z¦Ó¦³²`·N¡A ¦±½ÕÀu¬ü°Ê¤H¡CÄ@©Mª©¤Í¤À¨É¡C That¡¦s How I Got To Memphis¡A¤p§Ì¬Ý¤F¬ü¼@The Newsroom¤~»{ÃÑ¡C www.youtube.com/watch?v=MALFwMdHq94 ¡]Tom T Hall ì°Û¡^ www.youtube.com/watch?v=kp04NqmwWn4 ¡]The Newsroom »á·P¤Hªº¤ù¬q¡^ |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/8/2 ¤U¤È 06:27:22²Ä 4158 ½g¦^À³
|
½Ð±Ð¤j®a ¥iª¾¤½¥qn¦bESMO°Ñ®i¤°»ò¡H |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/8/2 ¤U¤È 06:12:56²Ä 4157 ½g¦^À³
|
±ø¤j ¯u¬O°T®§ÆF³q Awesome |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/8/2 ¤U¤È 04:00:05²Ä 4156 ½g¦^À³
|
¼ç¤ô³\¤[¡A¤W¨Ó©I§l¤@¤U ¤U¥b¦~¯E¹©ªº²±¨Æ´N¬O¦b10¤ë7~11¤é¤¦³Áô¥»«¢®ÚªºESMO(EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY) ¹w®Æ±N·|§ó·s822¤T´Á¼Æ¾Ú¡A¨S·N¥~ªº¸Ü¹ï·Ó²ÕªºM OSÀ³¸Ó·|¬Ý¨ì¡A¦Ó¹êÅç²ÕªºM OSÁÙ¦b°ª³B ¶V¨ì«á´Á¡A¯E¹©ªº»ùÈ·|¶V°ª¡A³Ìªñ¨«¶Õ¤@ȶ^¤£¤U¥h¡A¥~¸ê¤@ª½¶R¤]¬O¥t¤@Óì¦] ¥x¿n¹q¤À¬õ¡A70%µ¹¥~¸êÁȨ«¤F¡A¯E¤Í¥i±o§â¤â¤WªÑ²¼¬Ýºò¡A¦nÀ¸¦b«áÀY ~~ ESMO 2016, the world¡¦s premier congress in medical oncology will be taking place in Copenhagen from the 7 - 11 October 2016. The congress will attract an international community of experts, across disciplines and all focused on finding the most effective cancer treatment solutions available today. This is the ultimate goal of ESMO 2016 and we count on our Industry Partners active in oncology to help us again further our science and improve the lives of patients through continued education. Who has already signed up? We gratefully acknowledge the valuable contribution of the following organisations in the ESMO 2016 Congress through their presence in the exhibition hall, organisation of sponsored sessions, or via sponsorship activities (as of July 2016): AbbVie Inc. Advanced Accelerator Applications Agena Bioscience GmbH Agendia N.V. Amgen (Europe) GmbH ... Novartis Oncology Novella Clinical, a Quintiles company Nutricia OBI Pharma Inc. --- --- ¨S¿ùOBI Pharma Inc.¤w¸g¦b¨ä¤¤¡A«ø¥Ø¥H«Ý ~~ |
|
|
·|û¡G©Ó¤Ñ10142520 µoªí®É¶¡:2016/7/6 ¤U¤È 11:53:36²Ä 4155 ½g¦^À³
|
¦Ñ´¤j ¯E¹©¦³»¡n¦bÂå¾Ç´Á¥Zµoªí½×¤å¡A§Ú¥uª¾¹D¤U±³o¨âӫܦ³¦W¡A¤£ª¾ÁÙ¦³¨º¨Çª¾¦WªºÂå¾Ç´Á¥Z? The Lancet ¬h¸¤M The New England Journal of Medicine ·s^®æÄõÂå¾Ç´Á¥Z JAMA ³o¤TÓ¬O¤ñ¸û·|©ñÁ{§É¸ÕÅ窺´Á¥Z ¨ä¥Lªº¤ñ¸û¬O¾÷¨îªº±´°Q |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/7/6 ¤U¤È 05:01:57²Ä 4154 ½g¦^À³
|
¤¤j³Ð·s¬ãµop¹º¤§¤T¡G¨È¤Ó¥Í§ÞÂåÃĬãµo²£·~¤¤¤ß ¥xÆW¦³«Ü¦hÅý¤Hź¶Æªº¦a¤è¡A¨ä¤¤¤§¤@¡A´N¬O§Ú̪º¥Í§ÞÂåÃÄ¡C§Ú·QnÅý¥xÆW³oӨ㦳Àu¶Õªº²£·~¯à¥R¥÷µo´§¡A³o¬O§Úªº¤ßÄ@¡C¥xÆWªº¥Í§ÞÂåÃIJ£·~¬Û·íÀu¨q¡A§Ú̯ʥFªº¡A¥u¬O¤@Ó»R¥x¡B¤@Ó¾÷·|¡A©M¤@ÓÄ@·N§ß«ù¥¦¦¨ªø_§§ªº¬F©²¡C ¥xÆWªºÁ{§ÉÂå¾Ç©MµØ¤H¯S¦³¯e¯f¬ã¨s¡A¦b°ê»Ú¦W¦C«eT¡C§ÚÌ¥ÍÂå¬ãµo³]¬Iªº«Ø¸m¡A¦³µÛ¥R¨Kªº¬ãµo¯à¶q¡F¤£¶È¦³Àu½èªºÂåÀøÅé¨t¡B¥R¨¬ªº±M·~ÂåÀø¤Hû¡B§¹µ½ªºÂåÀø³]¬I¡A·sÂåÃÄ«~¬ãµo¦¨¥»¡A¤]¤ñ·s¥[©Y¡B¤é¥»¡B¿D¬w§ó§C¡C ÀHµÛ¤H¤f¦Ñ¤Æ¡BÂåÀø¬ì§Þ¶i¨B¡B·s¿³¶Ç¬V¯f¼h¥X¤£½a¡B¥H¤ÎÓ¤H¤Æºë½TÂåÀøªºµo®i¡A¤Q¦~¤º¡A¥þ²y°·±d¥Í§Þ²£·~ªº²£È¡A±N·|¹F¨ì5¦Ü6¥ü¬ü¤¸ªº³W¼Ò¡C¥¼¨Ó¡A¥Í§ÞÂåÃIJ£·~±N·|¦¨¬°¥þ²y³Ì¼öªùªº²£·~¡A³o´N¬O§ÚÌÀ³¸Ó¥R¤À´x´¤ªº«´¾÷¡I §ÚÌn¥Î¤T¤j¥D¶b¡A¥þ¤O¥´³y¥xÆW¦¨¬°¡u¨È¤Ó¥Í§ÞÂåÃĬãµo²£·~¤¤¤ß¡v¡G ¤@¡B ³sµ²¥¼¨Ó¡G¾ã¦X®Ö¤ß³]¬I»P¸ê·½¤¤¤ß¡B¤ä´©²£·~ªº³Ð·s¬ãµo¡B«Øºc¥xÆW°·±d¥¨¶q¸ê®Æ®w¡A¼W¶iÁ{§É«e¸ÕÅ窺®Ä²v©M®Ä¯à¡C¿n·¥°ö¨|³Ð·s¬ãµo¤H¤~¡B²£·~¸gÀç°ª¶¥»â¾É¤H¤~¡A¹ªÀy¾Ç¬ã¤H¤~°Ñ»P·s³Ð¤½¥q¡C ¤G¡B ³sµ²°ê»Ú¡G±µy¥]¬A¬ü°ê¤T¤j¥Í§ÞÂåÃĬãµo«Âí--ªi¤h¹y¡B¥[¦{ÆW°Ï¡B¸t¦a¤úô¡A¥H¤Î¼Ú¬w·sÃĬãµo°ê®a--·ç¤h¡B¤ñ§Q®É¡B·ç¨å¡B²üÄõµ¥¥ý¶i°ê®a¡C±Ò°Ê¸ó°ê¬ãµo¦X§@¤ÎÁ{§É¸ÕÅçpµe¡B«Ø¥ß¤H¤~¥æ¬y¤Î©µÅó¾÷¨î¡A±À°Ê¥ø·~¬Û¤¬§ë¸ê¡B¥H¤Î³Ð§ë¤Î¨p¶Ò°òª÷¦X§@¡C±À°Ê°ê»Úªk³W¼Ð·Çªº¨ó¦X¡A¸¨¹ê¨â©¤ÂåÃĽåͦX§@¨óij¡C ¤T¡B ³sµ²¦b¦a¡G¥xÆW¦³¥R¤À±ø¥ó¡A¥i¥H°µ¬°¥ý´Á¥«³õ©M¸ÕÅç°ò¦a¡A¥ý¦]À³¦b¦a»Ý¨D¡A¶i¤@¨B±À¼s¨ì°ê»Ú¥«³õ¡C´x´¤¬J¦³ªº²£·~Àu¶Õ¤Î¸ê·½¡A¦êÁp¤À´²ªº»E¸¨¡A¾ã¦X¥Í²£»P»Ý¨D¨âºÝ¡A¦¨¬°§¹¾ã¤£Â_Ã쪺²£·~»E¸¨¡C iing.tw/posts/224 ¨È¤Ó¥Í§ÞÂåÃĬãµo²£·~¤¤¤ß www.youtube.com/watch?v=32h9j9nzr34 |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/6/28 ¤W¤È 11:10:26²Ä 4153 ½g¦^À³
|
¦Ñ´¤j ¯E¹©¦³»¡n¦bÂå¾Ç´Á¥Zµoªí½×¤å¡A§Ú¥uª¾¹D¤U±³o¨âӫܦ³¦W¡A¤£ª¾ÁÙ¦³¨º¨Çª¾¦WªºÂå¾Ç´Á¥Z? The Lancet ¬h¸¤M The New England Journal of Medicine ·s^®æÄõÂå¾Ç´Á¥Z |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2016/6/28 ¤W¤È 10:32:28²Ä 4152 ½g¦^À³
|
SAM1969¤jªº®ø®§«ÜÆF³qò¡A¤½¥qº¥º¥ªº¥u°µ¤£»¡¤F¡A«ç»ò»¡³£¦³¤H»~¸Ñ©Î¨è·N»~¾É¡A¤@¤Á³£¦bÀn¤l·Æ¤ô¤¤¡Aª¾§ÚªÌ¡A¿×§Ú¤ß¼~¡A¤£ª¾§ÚªÌ¡A¿×§Ú¦ó¨D¡C±y±y»a¤Ñ¡A¦¹¦ó¤H«v¡I |
|
|
·|û¡Gyuki10141394 µoªí®É¶¡:2016/6/28 ¤W¤È 10:21:53²Ä 4151 ½g¦^À³
|
·PÁÂ¥xÁÞ¤j±zªº¾ã²z¤ÀªR¡A¤]·PÁ¦U¦ì¤j¤j̪º¸ê°T´£¨Ñ~~º¡º¡·P®¦~~ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/6/28 ¤W¤È 10:20:17²Ä 4150 ½g¦^À³
|
²³¤j¤j Á{§É¸ÕÅ窺¸ê°T·j¶°¬O³v¨Bµo²{ªº¡A¦³¦h¤Ö¼Æ¾Ú»¡¦h¤Ö¸Ü¡A¦³Ãö¤½¥q¦^µª§ÜÅéºû«ù¦h¤[¡A¦] ¬°n°Ñ¥[ESMO¡A¦³¨Ç¨ãÅé¼Æ¾Ú¤£¯à»¡¡A¥u¯àÂI¨ì¬°¤î¡A¤]´N¬O¥´§¹¤E°w¦pªG¤£¦A¥´¤F¡A§ÜÅé·|·L´T¤U·Æ¡A¦b¨â¦~Æ[¹î¤¤µo²{§ÜÅélevel ¤´µMºû«ù¦b¤ñì¨Ó°_ÂIÁÙn°ªªº¦ì¸m(¦pªGÄ~Äò¥´¡A§ÜÅé¤S·|¤W¨Ó)¡A¹ïÂಾ©Ê¨ÅÀù¯f±w¨Ó»¡¡A ¦³³o¼Ëªººû«ù®É¶¡¡A¸Û¹ê¤£©ö¡A¥u¬OnÅé«G¤½¥qn¦b«n°ê»Ú¸~½F·|ijµoªí¡A¤£¯à»¡¥X¨ãÅé¼Æ¦r¡C 5619¤j §ó·s¼Æ¾Ú´N¬O´£¦¤½§G¡A´N¤£¯à¦bESMOµoªí¤F¡C |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/6/28 ¤W¤È 09:57:42²Ä 4149 ½g¦^À³
|
SAM1969¤j¤j Æg ²¦³º ¤@¤Á ²×¨s ÁÙ¬On°Ó·~§Q¯qÅé²{ ´Á«Ý ¶§¥ú¦b·«B²{¨ |
|
|
·|û¡GSAM196910138913 µoªí®É¶¡:2016/6/28 ¤W¤È 09:37:27²Ä 4148 ½g¦^À³
|
¥xÁÞ¤j ÁÂÁ±zªº¸ê°T ·d¤£¦n¤£¥Î¨ì9¤ë³á!! ¦pªG±i±Ð¥D¬ðµM½Ð°²u¬ü(°Å±¼¤]¦P·N¤F) ±zı±o½Ð°²²z¥Ñ¦³¥i¯à¬O¥h«×°²´²¤ß¶Ü??? ¦L¶H¤¤³\°Æ±Ð¥D¤@ª½ÁÙ¦b¬ü°ê~~¯u¬O¨¯W!! ¶§¥úÁ`¦b·«B¹L«á ´Á«Ý¤¤ ~~~~ |
|
|
·|û¡G561910141205 µoªí®É¶¡:2016/6/28 ¤W¤È 09:27:35²Ä 4147 ½g¦^À³
|
¥xÁÞ¤j±z¦n¡A·PÁ±zªº«ÂI·J¾ã¡C¤p§Ì¤ß¸Ì¦³ÓºÃ´b¡A¤£ª¾¯à§_½Ð±z«ü±Ð¡H 2016¦~2¤ë¤½§G¸Ñª¼ªº¼Æ¾Ú¤î©ó2015¦~10¤ë©Ò²Îp¡AASCO¦b¤µ¦~¤»¤ëªì¶}·|®É¡A¤½¥qµoªíªº¸ê®Æ©M¤ÀªR©Ò¥Î¼Æ¾Ú¤]¤î©ó2015¦~10¤ë¡C¤p§ÌºÃ´bªº¬O¬°¦ó¤£¯à±Ä¥Î§ó·sªº²Îp¼Æ¾Ú¡HPFS¤£¥i°l¡A¦ÓOS ©|¦bµo®i¤¤¡Atrending significant ªí¥Ü³Ì·sªº¼Æ¾Ú¥i¯à¥i¥H¬Ý¨ì822§ó¥[ÅãµÛªºÀø®Ä¡A¬Æ¦Ü§C¤ÏÀ³²ÕªºOS¹ê»Ú¤W¤v³Ó¹L¹ï·Ó²Õ¡C¤E¤ë¼Ú¬w³Ì¤jªºÀù¯g·|ij ESMO Á|¦æ®É¡AÃø¹D¤½¥qµoªíªº¤ÀªRµ²ªG¡A¤´µM·|¬O¥H¤î©ó2015¦~10¤ëªº²Îp¼Æ¾Ú¨Ó¤ÀªR¡H©ÎªÌ·|¥H¸ûªñªº¡A¨Ò¦p2016¦~6¤ë¡A¼Æ¾Ú¨Ó¤ÀªR¡HÁÂÁ¡C |
|
|
·|û¡G©Ó¤Ñ10142520 µoªí®É¶¡:2016/6/28 ¤W¤È 09:16:19²Ä 4146 ½g¦^À³
|
¤ô°Õ ÁÂÁÂ¥xÁÞ¤j |
|
|
·|û¡G99910140657 µoªí®É¶¡:2016/6/28 ¤W¤È 09:04:55²Ä 4145 ½g¦^À³
|
¥xÁÞ¤j«e½ú¡G·PÁ±z¾ã²zªº¸ê°T¡C «H¥ô±i¸³¨Æªø¡A«H¥ô¤½¥q©Ò¦³¦P¨Æªº§V¤O...... ´N¬O¤W¤Ñ½ç¤©§Ú̳̤jªºÂ§ª«¡C ·PÁ±z¡C |
|
|
·|û¡G¦³FUªº¤H10136189 µoªí®É¶¡:2016/6/28 ¤W¤È 08:44:50²Ä 4144 ½g¦^À³
|
¥xÁÞ¤j~~~ ·PÁ±zªº¸ê°T |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/6/28 ¤W¤È 07:07:19²Ä 4143 ½g¦^À³
|
§ó¥¿»P¸É¥R 4 ±i¸³¬O¦³¸gÅ窺²îªø 6,7 >>7,8 9 Medica>>Medical European Society For Medical Oncology ¼Ú¬w¸~½FÂå¾Ç·| (9¤ë) AACR:American Association For Cancer Research¬ü°êÀù¯g¬ã¨s¾Ç·| (4¤ë) |
|
|
·|û¡GµL¤j10141864 µoªí®É¶¡:2016/6/28 ¤W¤È 12:43:07²Ä 4142 ½g¦^À³
|
¥xÁÞ¤j¤j.. «D±`·PÁ±zªº¾ã²z»P¬Ýªk.. ¶â..°í©wªº«H¤ß¥Ñ¦¹ÂIÂIºwºw¦Ó²£¥Í.. ·PÁ±z |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/6/28 ¤W¤È 12:13:18²Ä 4141 ½g¦^À³
|
9 ¯E¹©·|°Ñ¥[¤E¤ë¼Ú¬w³Ì¤jªºÀù¯g·|ij ESMO ,European Society For Medica Oconoglogy, ©ú¦~¥|¤ë¡AAACR, American Association For Cancer Research. 10 104¦~«×¦~³øÂ泫ܦh«n¸ê°T |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/6/27 ¤U¤È 11:35:26²Ä 4140 ½g¦^À³
|
6 OBI833¦~©³´N·|¦¬§¹®×¡AOBI888©ú¦~¶i¤JÁ{§É¤@´Á¡A³o¨âÓ¨t¦C¦p¦POBI822¤@¼Ë¤]¬O±j´Î¡A¥t¥~¿n·¥¥l¶Òû¤u¡A·Ç³Æ¤jÅ㨤â¡C 7¨ÅÀùOBI822·Ç³Æ¦V¬ü°êFDA¥Ó½ÐBTD °Ñ¥[¤E¤ë¦b¼Ú¬wÁ|¿ìªºESMO,¤Î§ë½Z«n´Á¥Z ¤Î¨ä¥L«n¸~½F°ê»Ú·|ij¡A¼Æ¾Ú¶V«á±·|¶Vºë±m¡AÁÞ¤k¨«§¹°ê»Ú¨q¬O¥²µMn¨«ªº¸ô¡A²³¤j¤jÀ³¦b@¤ßµ¥«Ý¤¤µ¹¤©ÁÞ¤k§ó¦hªº¯¬ºÖ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/6/27 ¤U¤È 11:11:27²Ä 4139 ½g¦^À³
|
5²`«ä¼ô¼{ªºªÑªFnª¾¹DÁÞ¤kÅS¤T¤Àªºõ²z¡A¤£n«æ¤Áªº·Q¬Ý¨î¯Å¡C¦b¥þ²yÄvª§ªº®É¥N¡A°Ó·~¾÷±K§óÅã«n¡C 6 ¤µ¤Ñ¦³ªÑªF´£°Ý«e»¡¯E¹©¥¼¨Ón·m¹¤»õ¬ü¤¸ªºÂಾ©Ê¨ÅÀù¥«³õ¡AÃø©Ç±i¸³ª½·nÀY (Ó¤H»{¬°¼¥H¤K¨ì¤Q¿®t¤£¦h) |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/6/27 ¤U¤È 10:23:39²Ä 4138 ½g¦^À³
|
1¤µ¤Ñ¤½¥q´£¨Ñªº¾ãÅ黡©ú»P°Ýµª¤w°÷¦h¤F¡AºÝ¬Ý²³¤j¤jªº¤ß¦³ÆFµR¤@ÂI³q¡A¯S§O¬O§Ú³ÌÃö¤ßªº§ÜÅé¨ì©³¥iºû«ù¦h¤[¡A¤½¥qªº¦^µª¥O¤HÆf¥Ø 2 IgG §ÜÅéºû«ù¤G¦~®É¶¡¬O¥i´Á«Ýªº¡A¦³¤F³oÓ´Á«Ý¡A´N¤£¥²¾á¤ßÁ`¦s¬¡´Á»PNED ¡A¦³NED¡A¤T³±©Ê¨ÅÀù¤]¦³NED¡A¤H¼Æ¼È®É«O±K¡C 3¦³¤F³oÓ¥O¤HÅå³ßªºµª®×¡A±ÂÅv¡A¥þ²y¤T´Á¡AÃÄÃÒ´N¤£¥Î¾á¤ß¡C 4±ÂÅvn«½è¡A¦³¨ÇÃļt¥Î°ª»ù±ÂÅvµM«á§â©p©ñ¦b¦B½c§Ná¡AÁ{§É¸ÕÅç¥þ±°±Â\¡AÅý§A°Ê¼u¤£±o¡A±i¸³¬O«Ü¦³¸gÀÙªº²îªø¡C |
|
|
·|û¡Gwalker10141977 µoªí®É¶¡:2016/6/27 ¤U¤È 09:24:21²Ä 4137 ½g¦^À³
|
¤]³\ªÑªF̤]¸Ó´«Ó¤ßºA¤F... ¸Õ·Q, ¥x¿n¹qªºªÑªF·|¸Ì, ±i©¾¿Ñ«ç»ò¥i¯à·|¤½¥¬²{¦b 7 ©`¦Ì»sµ{¨}²v, §ó¤£¥i¯à¤½¥¬¥x¿n¹q»P¤T¬P pk ªºµ²ªG§r! ´NºâÁpµo¬ì¦b ISSCC µoªí«nªº¤åÄm, ¤]¤£¥i¯à¦bªk»¡¥h´£¨º¨ÇijÃD ¤µ¤Ñ¯E¹©ªÑªF·|¦pªG¥u´£¸gÀ祬§½, ¨º´N¹ï¤F, ³o¬O¤ñ¸û¥¿±`ªºªÑªF·|§r |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2016/6/27 ¤U¤È 08:14:22²Ä 4136 ½g¦^À³
|
¦A¸É¥R¤@ÂI¬O¡A¤½¥q´£¨ì¥Ø«e¸êª÷¤´¨¬°÷¡A¦³¯à¤O¥i¦Û¤v°µ¥þ²y¤T´ÁÁ{§É¡A822¥]»q±ÂÅv¨Æ©y·|¼f·Vµû¦ô¡C »¡ªº¥Õ¸Ü¤@ÂI¡A¤½¥q¹ï¦Û¤vªº²£«~¦³«H¤ß¡A·Qn½Í±ÂÅv¡A¤]n¬Ý®³¤°»ò±ø¥ó¨Ó½Í¡A¦Ó«D«æ¦£ªº±ÂÅv¥X¥h¡IY«æ¦£ªº±ÂÅv¥X¥h¡A¥Nªí²£«~¤]¨S¦h¦n¡I¦n³f¤£©È¨S¤Hn¡I¨Ñ°Ñ¡ã ¯E¹©¦¹¦¸ÂÔ·V«O¦uªºªí²{¡A¤£ºÞ¬O¥qªkÀ£¤O¤Uªº¸T¤f¡A¤S©ÎªÌ¬O¼Æ¾Ú©|¥¼¦¨¼ô¡Aµ¥«Ý¦b°ê»Ú«nÂå¾Ç·|ijµoªí¡A¨ä¹ê¬O§k¦Xªø§ëªÌªº¤º¤ß§Æ±æ¡A¥u¦³ÀqÀq°µ¦n¨Æ±¡¡A¤U¦¸ªº«°T´N¬Oª½±µ«Å§G°±µP(½Í§´±ÂÅv)¡A³o°}¤l´N·í¬O¬~º°¤£¦w¨S«H¤ßÄw½Xªº°}µh´Á¡AÀR«Ý§a¡I |
|
|
·|û¡GPT10139061 µoªí®É¶¡:2016/6/27 ¤U¤È 08:10:19²Ä 4135 ½g¦^À³
|
5619¤j §Ú¬Û«HNED¤H¼Æ¬O½Í§Pªº«nÄw½X,¥i¥H±µ¨ü¡u±i¸³ª¾¹D,¦ý±i¸³¤£»¡¡v~~ |
|
|
·|û¡G561910141205 µoªí®É¶¡:2016/6/27 ¤U¤È 07:53:15²Ä 4134 ½g¦^À³
|
¤p§Ì¤]¨Ó»¡»¡¤µ¤é°Ñ¥[ªÑªF·|ªº¤ß±o¡C ¸³¨Æ·|¿ïÁ|¥»¨Óp¹º¿ï¥ô¸³¨Æ¤E¤H¡AÁ{®É¥ÍÅÜ¡A¥Ñ³Ì¤jªÑªF©y®õ§ë¸ê´£¥Xקï¡A¥X®uªÑªF¦P·N¡A§ï©w¬°¤C¤H¡C ¿ïÁ|µ²ªG¥|®u¤@¯ë¸³¨Æ°£¤F±i¸³¡A¥t¤T¦ì³£¬O¼í®õ¶°¹Î¥Nªí¤H¡C ²q·Q¦~³ø©Mij¨Æ¤º®e¦b¨â¤TÓ¤ë«e½sq¡Aªñ´Áµo¥Íªºªi§é¡A¥O·ù¥D¤ß¥Íĵ±§¡A¥²¶·¥[±j¸³¨Æ·|ªº´x±±¡A¨¾¤î¨ä¥L¶Õ¤OÁ»¿Ì¸³¨Æ·|¡C ¥t¡A³ø§i¨Æ¶µ²Ä¤»®×©M²Ä¤C®×¡Aªí²{¥X¤½¥q¹ï©ó¬ì¬ã¤H¤O/¾÷±K¤å¥ó/´¼¼z°]²£ªº«OÅ@·NÃѤw¤j´T«×¥[±j¡C ³ø§i¨Æ¶µ²Ä¤»®×¡A×q¸³¨Æ·|ij¨Æ³W«h-- ¨î¤FÓ§O¸³¨Æ¤¶¤J¤º³¡ºÞ²z¹B§@ªº¥i¯à©Ê¡C ³ø§i¨Æ¶µ²Ä¤C®×¡A×q¸³¨Æ¤Î¸g²z¤H¹D¼w¦æ¬°·Ç«h-- ¨î¤FÓ§O¸³¨Æ¾\Äý¨ú±o¾÷±K¤å¥óªºÅv§Q¡C ¬°¤F«OÅ@¤½¥qªº»ùÈ¡]¥Dn¬O¤H¤~©M´¼°]¡^¡A«O»ÙªÑªFªºÅv¯q¡A³o¨ÇÁ|±¹¬O¥²nªº¡C¬°ªÑªF©Ò¼Ö¨£¡C Q&AªºÆ[¹î¡C 822 ¤G´Á¤ÀªR»P¤T´Á³W¹º¤è±ªº´£°Ý¡A¤½¥q¦³«O±K¤§ÅU¼{¡A¤£Ä@¦h½Í¡C ¥O¤H³Y²§ªº¬O¡A¶ÀÁ`¦b¤@Å|´£°Ý¯È¸Ì¡A¯S§O¬D¥XÃö©ó¯E¹©©MÁÞ°òÄv¦XÃö«Y¡A¥H¤Î¥i¤£¥i¯à¦X¨Öªº´£°Ý¡AÅý±i¸³¦^µª¡C¡H¦³·Q¹³ªÅ¶¡¡H 888«n©Ê¬ð¥X¡A¦³«G¡C ¾ãÅé¦Ó¨¥«GÂI¤£¦h¡A¤]¤£©úÅã¦a«G¡CÂI¨ì¬°¤î¡C¡]>>§QªÅ¥XºÉ¡Aªø©]±NºÉ¡^ ³Ì«á¤@¦ìÁ{®É¤fÀY´£°ÝªºªÑªF¡A°Ý¨ì¹êÅç²Õ¦³µLNED¡C±i¸³»¡¦³¡C¦A°Ý¤T³±©Ê¦³¨S¦³NED¡A±i¸³»¡¦³¡C ¤p§Ì¦³ÂI®ð¾k¡§¯E¹©¦¡¡¨ªº³ø§i¡C¦³NED¡A»¡±o¦nÀ³¸Ó¥i¥H¦¨¬°«Ü«GÂI¡A¡§À½¤ú»I¦¡¡¨³q±`¾A¥Î©óÃa¨Æ°Ú¡C |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2016/6/27 ¤U¤È 07:11:30²Ä 4133 ½g¦^À³
|
¦U¦ì¤j¤j¦w¦n ¤p§ÌˬOÅ¥¨ì£¸Ó«ÂI ½Ð¦U¦ì¤j«ü¥¿ ¯Eô°£¤F822¥~,²{¥¿n¥þ¤Oµo®i888 ¥Hº¡¨¬¥t¤@¥bµLªk²£¥Í§ÜÅé ©Î§ÜÅé®Ä»ù¤£¨¬ªº»Ý¨D ¦¹Ãþ³Q°Ê§K¬Ì³æ®è§ÜÅé ¯Eô·|°µ¡A§O¤H¤]¯à°µ ¥u¬O§O¤H»Ý±q¹«·½¡A¶i¦Ó¤H·½ ¯Eô¤w¦³«Ü¥R¨¬ªº¤H·½¡A³o¬OÀu¶Õ ¤]»Ý¨«¦b¨ä¥LÄvª§ªÌªº«e± |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2016/6/27 ¤U¤È 06:10:37²Ä 4132 ½g¦^À³
|
¤µ¤ÑªºªÑªF·|¡A«Ü¦hªÑªF³£°Ñ»P¤F¡A¤S©ÎªÌ¬Ý¹êªpÂ༽¤ÎÅ¥¿ýµ±a¡A¬Û«H±M·~ªº¯E¤Í³£¯à²z¸Ñ¤j·§¡A§Ú¤]¥u¯à¤À¨É¤ß±o¡A¥H¤U¤À¨É«Ü¦h³£¬O¦Û§ÚªºÁr´ú¡A¨S¦³±o¨ì¤½¥qªº¿Ë¤fÃÒ¹ê¡A©Ò¥H¶È¨Ñ¤j®a°Ñ¦Ò¡A¦Û¦æ§PÂ_Åo¡I º¥ý¬O¡A¤½¥q«ü¥X¡AÁ{§É¥´§¹¤E°w«á¡A§ÜÅé®Ä»ù·L´T¤U·Æ¡A¤TӤ뤺¤]¤£·|¦³¤°»ò°ÝÃD¡A¬Æ¦Ü¬ãµoªø»{¬°ºû«ù2¦~ªº§ÜÅéÀø®Ä¤]¬O¥i¥H´Á«Ý¡C§Úªº²z¸Ñ¬O¡A¥un®Ä»ù¤U·Æ¡A¦pªG¦A¤©¥HÄ~Äò¬I¥´822(Á{§É³W½d¥u¯à¤E°w)¡A¤]³\¯àºû«ù°ª§ÜÅé¿@«×¤£P¤U·Æ¡Aæí¯f±wªºÀø®Ä¡C 822¥b¦~¤º«n¼Æ¾Ú¡A±N³°Äò¦b¦UÓ«nªºÂå¾Ç·|ij¤½§G¡A©ÎªÌµoªí¦b°ê»Ú´Á¥Z¡A·N«ä¬O¦Aµ¥³Ì¦h¥b¦~´Nª¾822¬O¬ü¬OÁà¡A§Ú»{¬°ÁÙ¦³¤@Ó©¶¥~¤§µ¡A´N¬O±ÂÅv¥b¦~¤º¥i±æ½Í§´¡A¬°¦ó¦p¦¹Â_©w©O¡H²{¦b¤£»¡¥XÁô§t¥¼¤½§Gªº¼Æ¾Ú¡A°£¤F³\¦h©|¥¼¤ÀªR¦¨¼ô¥~¡AºÝ¥X¨Óªºµæ¦âY³Q²³¤H¬Ý¥ú¤F¡A¤½¥q¤â¤¤ªºÄw½XÅãµM¦³¡A¥Ø«e¥u¦³Ä@·Nñ©w«O±K·N¦V®Ñªº¸ó°êÃļt¡A¤~¥i¥H¶i¤@¨B¬Ý¼Æ¾Ú¨ó°Ó½Í§P±ÂÅv¡A¦Ó822¦b¥b¦~«á±N³°ÄòÃn¥ú¡A©Ò¥H¦b²³¤H¬Ý¥ú«e¡AÓ¤H»{¬°¦³±æ§â822²Î¥]±ÂÅv¥X¥h¡CADR¤Þ¶iµ¦²¤¹Ù¦ñ¡A´N¬OÁÚ¦V°ê»Ú¤Æ¡A¥[³t±ÂÅv¶i¦æªº¥²n¨}µ¦¡C ±ÂÅv¹ï¶HY©È822»P¤G¥N²£«~833¦³Ävª§¤§¸·¡A¥i¥H©¹¤@Ó¤è¦V«ä¦Ò¡A¨Ò¦p±ÂÅv8ºØÀù¯gµ¹822¡A³Ñ¤U8ºØÀù¯gµ¹833¡A©¼¦¹¤£·|¤¬¬ÛÄvª§§]»k¥«³õ¡C 888¥i±æ±qÁ{§Éªº¯f±w»s³Æ¥X¥þ¤H·½§ÜÅé¡A¬Æ¦ÜÁÞ¤À¤l§¡¬Û¤Æ§ÜÅé³£¥i¯à¦Û¤v¨Ó¡A³»¦h±ÂÅvµ¹¤¤¬ã°|©ÎÁÞ°ò»s³Æ¡Aªí¥Ü·¥¤j¤ÆªºÄw½X³£´¤¦b¤â¤¤¡A§O®aÄvª§ªÌ³»¦h±q¹«·½©Ê§ÜÅé°µ°_¡A¦b¤HÅ餺®e©ö¤Þ°_§Ü¸Ó³æ®è§ÜÅ骺§ÜÅé¢w§Y©Ò¿×HAMA (human antimouse antibody)¡A¥[³t±Æ¥¸¤ÏÀ³¡AÃø¥H¦³®Äºû«ù§ÜÅé§@¥Î¼Ðªº¸~½F²Õ´ªº®É¶¡¡A´Nºâ³Ì²×¯à»s³Æ¥X¥þ¤H·½§ÜÅé¡A±µ¤U¨Óªº§¡¬Û¤Æ§ÜÅé¤S¬O¤@Ó¤jÃøÃD¡A¦]¦¹Â_©w888¥i¥H»¡¥¼¨Ó¨S¦³¤°»òÄvª§ªÌ¡C¬O¤£¬O¤Ñ¤W±¼¤U¨Óµ¹¥xÆWªºÂ§ª«¡A¨º´N«ø¥Ø¥H«ÝÅo¡I |
|
|
·|û¡Gming10140949 µoªí®É¶¡:2016/6/20 ¤W¤È 08:34:45²Ä 4131 ½g¦^À³
|
¥xÁÞ¤j¤j: «¢«¢,¯uªº¬O¤W¯Z¨Sªk¥h,n¤£¯uªº«Ü·Q¿Ë¦Û°Ñ¥[, ¤£¹L¨SÃö«Y,ªB¤Í·|¥h,·|§â°ÝÃD½Ð¥L±a¥h°Ý! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/6/20 ¤W¤È 08:14:52²Ä 4130 ½g¦^À³
|
Ming¤j §A¥i¯à¤]n¤W¯ZµLªk°Ñ¥[ªÑªF¤j·|¡A§Ú¥u¬O©ß Ó¤è¦V¡A§Æ±æ±q¤£¦P¤è¦V¤Á¤Jªº²`«ä¯à°Ý¨ì³ÌÃöÁ䪺°ÝÃD¡A§Æ±æ²³¤j¤j¶°«ä¼s¯q¡A¦³20-30Ó¦n°ÝÃD¥X²{¨Óº¡¨¬¤j®aªººÃ´b¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/6/19 ¤U¤È 11:28:57²Ä 4129 ½g¦^À³
|
Ming¤j ªÑªF·|¥i¥H°Ý¨ì«Ü¦h°ÝÃD¡A§A¦³·Q¨ì¨º¤@ÃD ¬O¹ê²{¹Ú·QªºÃöÁä°ÝÃD? ¼vÅT±ÂÅv¡A¼Ú¬ü¤T´Á¡AÃÄÃҳ̫nªº¤@ÃDÓ¤H»{¬°¬OIgG¨ì©³¥i¥H¼µ¦h¤[¡A¦h¤[«á·|°¤U¨Ó? ³oÓ»PÁ`¦s¬¡´Á¦³Ãö¡A¬Ý¹L§ë¼v¤ù¦³¥Î¤ß«ä¦Òªº¤j¤jÀ³¸Ó¥i¥H±q¹Ïªí²q´ú¥X¨Ó¡A¤£¹L°Ý¤@¤U¤ñ¸û¦w¤ß¡C ³o¤@ÃD´N¥æµ¹§A¤F! |
|
|
·|û¡GµL¹Ð10141268 µoªí®É¶¡:2016/6/19 ¤U¤È 11:03:45²Ä 4128 ½g¦^À³
|
¦pªG¥ÎIgG¥H160¬°¥ÎÃĪùÂe,¦Ó¤£ºÞÀù¯g¨ì©³¬O´X´Á,³o¼Ë¦b¥þ²yªº²£È·|¦³¦h¤j?½Ð¦U¦ì¯E¤Í·Q·Q?ÁÙ¦³½Ö³Ì©È³oºØÃĤW¥«µM«á²{ª÷¤@¤j°ï,¨ÖÁʳ\¦hÃļt¦ÓÀò±o±M§Q. |
|
|
·|û¡Gming10140949 µoªí®É¶¡:2016/6/19 ¤U¤È 10:17:10²Ä 4127 ½g¦^À³
|
¥xÁÞ¤j¤j: §ÚÌ6/27´N¯à¦n¦n°Ý¬Ý¬Ý¶ÀÁ`½Íªº¦p¦ó? §Ṳ́]¯à¦n¦n°Ý¤½¥q«ç»ò³W¹º3´Á? §ó¯à¦n¦n°Ý°ÝADR¸òFDA½Í§Pªº³W¹º ·PıªÑªF·|,¥i¥HÄÀ«Ü¦hºÃ°Ý |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/6/19 ¤U¤È 09:38:10²Ä 4126 ½g¦^À³
|
¥t¥~Ó¤Hı±o¦³Ãö±ÂÅv½Í§P½è¤ñ¸û«n¡AASCO«á¤TӤ뤺¯à½Í¥X²Å¦XªÑªFÅv¯q»P°ê»Ú¦æ±¡»ù½Xªº±ÂÅv®×ºâ¬O«Ü¦¨¥\ªº½Í§P¡C³æÃĩγæ¨t¦C¡A©ÎÂù¨t¦C¡A©Î¤T¨t¦C½Í§P¡A¿ùºî½ÆÂø¡AÀ³µ¹¤½¥q¦h¤@ÂI®É¶¡¦b¨S¦³À£¤O±¡ªp¤U¨Ó½Í¡C ¬Q±ß¹Ú¨£¤ÑªÅ¸¨Ó¤@¦·²»·ç¶³±m¸ü¨«ÁÞ¤k¡A ·|¬O¦n®ø®§¤£»·¤F¶Ü? |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/6/19 ¤U¤È 08:10:40²Ä 4125 ½g¦^À³
|
Åó±ø±ø¤j ÁÂÁ±ø¤j´£¨Ñ¤À¨É¡A¨ØªA§A¨C±i§ë¼v¤ù³£¬Ý«Ü¤[¡A°t¦X«ä¦Ò¤~¯à¬Ý¥XºÝÙ¡C ¥t¥~¥|¦~¤@¦¸Âå¾Ç¤¤¤ßµûŲ§â°ê¤º¦Û¦æ¬ãµo·sÃįǤJµûŲ¡A³o¬O¦³§Q·sÃĬãµo |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/6/19 ¤U¤È 03:58:40²Ä 4124 ½g¦^À³
|
¥xÁÞ¤j¡A ¤£¦n·N«ä³Ìªñ¸û¦£¡A²{¦b¤~·|±zªº¦ÒÃD¡A§Ú¨Ã«D¥ÍÂå²£·~ªº±M®a¡A¶È´N¬Ý¨ìªº¼Æ¦r¨Ó°µ±À¦ô¦Ó¤w 1 ¹êÅç²Õ¶W¹L90¶g¤´¨S¦³´_µoªº25% 52¤H ¬O§_´N¬O §¹¥þ¤ÏÀ³(CR) NED ? --> §Ú»{¬°CR¤ñ¨Ò¤£¤@©w·|¬O25%, ¦ýªÖ©w·|¤ñRoche HER 2 ¶§©Ê Âù¼Ð¹vÃÄ §¹¥þ¤ÏÀ³(CR) 5.5%°ª«Ü¦h ì¦]¬O´N¤@´Á¼Æ¾Ú¨Ó¬Ý¡A¥|¦~¥¼PD¤H¼Æ¤ñ¨Ò¡A¸òOS>9~10¦~ªº¤H¼Æ¤ñ¨Ò¬Ûªñ ¸Õ·Q¦pªG¤w¸g¦b¥|¦~¤ºPDªº¤H¡An¯à¼µ¨ìOS 9~10¦~¬O¦³Ãø«×ªº§a ¦P¼Ë¤G´ÁY¶VºCPD, OS¤]·|¶Vªø¡A¬O§_¬O(CR)NED¡A¬Û«H·|¦³³¡¤À¤H(¦pS¤p©jªºCASE) ¥Ñ©ó»Ýn§ó¶i¤@¨B¸ê®Æ¦õÃÒ¡A©Ò¥H¤ñ²v¦h¤Ö¡A¹ê¦b¤£¯àÀH·N²q´ú 2 ±ø¤j¬ã§P¥»¦¸¥xÆW¤T´Á «ÈÆ[¤ÏÀ³(CR + PR) §¹¥þ¤ÏÀ³(CR) ³¡¤À¤ÏÀ³(PR) ¬ù¦h¤Ö¦Ê¤À¤ñ? --> ¦P¤Wz¡A³o§ÚµLªk¦^µª¡A¦ý¬O´N¸Ñª¼µ²ªG¨Ó¬Ý¡A¤Ö¼Æ(25%)±wªÌ·|"«D±`¦³®Ä" ³o¤]¬O§Ú»{¬°822¯à°÷¦¨¥\ªº³Ì¤jÃÒ¾Ú |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/6/17 ¤W¤È 10:55:08²Ä 4123 ½g¦^À³
|
Åó±ø±ø¤j «ö¹Ï¯ÁÆk ¤ÀªRªº«Ü¦n ½Ð±Ð: 1 ¹êÅç²Õ¶W¹L90¶g¤´¨S¦³´_µoªº25% 52¤H ¬O§_´N¬O §¹¥þ¤ÏÀ³(CR) NED ? Roche HER 2 ¶§©Ê Âù¼Ð¹vÃÄ §¹¥þ¤ÏÀ³(CR) 5.5% 2 ±ø¤j¬ã§P¥»¦¸¥xÆW¤T´Á «ÈÆ[¤ÏÀ³(CR + PR) §¹¥þ¤ÏÀ³(CR) ³¡¤À¤ÏÀ³(PR) ¬ù¦h¤Ö¦Ê¤À¤ñ? ¥H¤U¬O PERJETA® +trastuzumab + docetaxel ( Roche HER 2 ¶§©Ê Âù¼Ð¹vÃÄ ) «ÈÆ[¤ÏÀ³(CR + PR) 80.2 §¹¥þ¤ÏÀ³(CR) 5.5% ³¡¤À¤ÏÀ³(PR) 74.6% |
|
|
·|û¡GµL¤j10141864 µoªí®É¶¡:2016/6/17 ¤W¤È 10:17:51²Ä 4122 ½g¦^À³
|
±ø±ø¤j.. ±z»¡ªº¬O«Ü¦³¹D²z.. §Þ³N¤u¨ã¨¤«×,³o¬O¦±ßªº.. ±q¯Å¼Æ´`Àô¸û¤jªº©P«ü¼Ð(¤¤½u),¤£ºÞ¬O755.718.630µ¥°ª, ³£¥¼¥X²{°ªÀÉIÂ÷, °ò©ó°ò¥»±¬O¦³®Æªº,¬O¦n®Æªº.. ³o³£·|¶V¹L,¥u¬O®É¶¡¦±ß°ÝÃD¦Ó¤w ¤]·|ÃÒ©ú±ø¤j©Ò»¡ªº.. @¤ß..¤~¥i¥H»P¤½¥q¦¨ªø,»P¦Û¤v²ü¥]¦¨ªø,³oºÙ¦Û§Q¤]§Q¤H..¤Ó¦nªº¦N²»¨Æ |
|
|
·|û¡G¤p¹xµ£10141398 µoªí®É¶¡:2016/6/17 ¤W¤È 09:54:20²Ä 4121 ½g¦^À³
|
¿à³Õ¬Q¤Ñ¬O»¡¡AIGM ¥H¥L̹êÅç¬Ý¨Ó¡A¥´§¹²Ä¤@°w«á¤j¬ù´Nª¾¹D¤ÏÀ³ªºª¬ªp ¤]³\¯uªº¬On¬ÝIGG¸òIGMªº¥¿¬ÛÃö©Êµ{«×¦h°ª¡A·|¼vÅT¬O¤£¬O´N´úIGM§ÜÅé¶q´N¦n¦Ó¤£¥Îµ¥¨ìIGGªº§ÜÅé¶q |
|
|
·|û¡G©Ó¤Ñ10142520 µoªí®É¶¡:2016/6/17 ¤W¤È 09:49:01²Ä 4120 ½g¦^À³
|
§Úı±o¥i¥H¥ý´úIgM ¨S¦³IgM§ó¤£¥Î»¡IgG |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/6/17 ¤W¤È 09:31:05²Ä 4119 ½g¦^À³
|
ÁÂÁ¹x¥Û¤jªº§ó¥¿¡A ¤£¦n·N«ä¡Aµ§»~°Õ ¬Ý³ÌªñªººA¶Õ¡A«¦^600À³¸Ó«Ü§Ö¬Ý¨ì¡A²³©Ò´Á¬ßªº755¤ÑªáªO¤]À³¸Ó·|§ð¯} ´Á«Ý¦b8¤ë22¤é¬Ý¨ì822¤¸ ~~ ¨rÆN¨éªÅªº¤H¯uªºn·Ç³Æ¦R¦å·wˤF |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/6/16 ¤U¤È 11:20:13²Ä 4118 ½g¦^À³
|
±ø¤j¡A 822ªºÂ²³ø¤¤¡A©Ò¦³ªº OS ²Îp³£¬O¥H ¤ë pºâ¡A¦Ó PFS ³£¬O¥H ¶g pºâ¡C |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/6/16 ¤U¤È 03:03:30²Ä 4117 ½g¦^À³
|
«U¸Ü»¡"Å]°Âæb²Ó¸`¸Ì" ¤½¥q»¡¦³§ÜÅé´N¦³Àø®Ä¡A¨S¿ù¡A¦ý¦p¦ó¦b¨S¥´822¤§«e´Nª¾¹D§ÜÅé°ª§C? ¤w¤Î«áÄòÀø®Ä? n¦p¦ó¿z¿ï¤T´Á±wªÌ? ²³©Ò©Pª¾¡A§K¬ÌÀøªkn¦³®Ä¡A±wªÌªº§K¬Ì¨t²Î¦nÃa§ñÃöÀø®Ä°ª§C 1.¨ºnÃÒ©úÃīܦ³®Ä¡A·íµM´Nn±N§K¬Ì¤ÏÀ³®tªº±wªÌ±Æ°£ 2.¥t¥~¤G´Á¸ÕÅç®ÉY±wªÌPD´N°±ÃÄ¡A¤]·|³y¦¨Àø®Ä¦]¬°¨S¦³¥´º¡9°w"¨S¦³¨º»ò¦n" ½Ð¬ÝASCO PPT,P14,¥´9°wM PFS=90Ó¤ë¡AP16´Nºâ°ª§ÜÅé²ÕM PFS¤]¥u¦³48Ó¤ë ²{¦bn¨Ó½ÍÅ]°¤F¡AP14¹êÅç²Õ¥´9°w¦³104(46.2%),M PFS=90,ªí¥Ü¦³52¤H23.1%ªº¤H¶W¹L90Ó¤ë¤~´_µo ¦A¨Ó¬ÝP12, ¹êÅç²Õ»P90Ó¤ë¥æ¤eÂI¤j·§¦b25%¤H¼Æ¥ª¥k --> ·N«ä´N¬O»¡¹êÅç²Õ¶W¹L90Ӥ뤴¨S¦³´_µoªº25%¤H¼Æ¡A´X¥G¥þ³£¬O¥´º¡9°w23.1%ªº¤H µ²½×´N¬O¤T´Á¦¬±wªÌ®Éª`·Nn"¥´¦n¥´º¡"¡A¦]¬°§ÜÅ馳©µ¿ð©Ê¤Ï¬M 1.¤Ó§ÖPD´N¨S±oªvÀø¤F (¤£n§ä¤ÓÄY«ªº±wªÌ¡A®¦·OÀøªkOK,¦ýnÁ{§É¸ÕÅç´N·|¨S¦³ÅãµÛ®ÄªG) 2.P15¤w¸g§i¶D¤j®a»Ýnµ¥IgM, IgG¤W¨Ó¤~¦³Àø®Ä (¬O§_PD«áÁÙÄ~Äòµ¹ÃÄ¡Aµ¹±M®a¬ã¨s¤F) Y¹êÅç²ÕM PFS=90, ¹ï·Ó²ÕM PFS=72 ¤]¨SÃö«Y¡A¦pP14, PȤw¸g0.0566 ¦AÆ[¹î´X©P°¨¤W´N<0.05 Ynµ¥P13 M OS¥X²{¡A¥i¯àÁÙn2¦~«á¡Aˤ£¦p´N²{¦³¸ê®Æ³]p¦n¤T´ÁÁ{§É ¦P®É¥Ó½Ð¬ü°êFDA¬ð¯}Àøªk¡A±N¤ô¨ì´ë¦¨ ¦P¼Ë¥Î¦b´c©Ê§ó«¤jªº¯ØŦÀù¡AÁöµMGHªí²{²v100%, Y¦¬Àù¯g±wªÌ¤@´Á¤G´Á¨Ó°µ¡A¬Û«H¤ñ¤T´Á·|§ó¦n ¦]¬°¤T´Á¥i¯à³£¦s¬¡¤£¨ì1¦~¡Aµ¥¤£¤Î²£¥ÍIgG, IgM.... º~¬°¬ì¬O§_¬°¥xÆW¤§¥ú? ¨S½æ«e³£¦³¾÷·|¡A½æ±¼«á¥Ã»·¨S¾÷·| ¦P¼ËY¥~¸ê¥Î1000»õ¨Ó¶R¯E¹©¡A¥i¤d¸U¤]¤£¯à½æ¡A822/833¤W¥««á¡A¤@¦~¤½¥q¥iÁȤ£¥u³o¨Ç§a |
|
|
·|û¡G12310132455 µoªí®É¶¡:2016/6/10 ¤U¤È 07:13:42²Ä 4116 ½g¦^À³
|
º¦¤Ó§Ö¡A¤S¶^ªº§Ö¡A¤W¨R¤U¬~¤£¦n¨ü¡AÁÙ¬O§Æ±æºCºCº¦¤W¥h¡A²{¦b¥u¯à§Æ±æ§ÖÂI±ÂÅv¥X¥h¡A©Î¬OFDA§ÖÂI¦³®ø®§¶i«×¡A¤~¯àÅý§ë¸ê¤H¤F¸Ñ¡A¤]Åý·Q·d°ªº¤Hª¾¹D822ªº¦n |
|
|
·|û¡G§d½n¶¯10142119 µoªí®É¶¡:2016/6/10 ¤U¤È 04:51:46²Ä 4115 ½g¦^À³
|
Ŧb×¥¿¡A¤£¦b¹w´ú...¤§«e¤½¥q¡A¥i¯à«æ±ýÃÒ©ú¤°»ò§a¡H§Æ±æ¤é«á¡A¯à¦h°µ¤Ö»¡... |
|
|
·|û¡GµL¹Ð10141268 µoªí®É¶¡:2016/6/10 ¤U¤È 04:06:55²Ä 4114 ½g¦^À³
|
¥»¦¸¤T´ÁÁ{§É¦¬ªº¯f±w¬O¸ûÄY«ªº·í¤¤¦³³\¦h¥H¨Ó¤é¤£¦h,§ÜÅé¶q¸û¤£§Qµo´§®ÄªG,¦pªG¤T´Á©Î®Ö¥i¥ÎÃÄ«á¥Îªº¬O§ÜÅé¶q¨¬°÷ªº¯f±w±N¦³·N·Q¤£¨ìªºµ´¹ïÀu¶Õ,¨Ã¥BÅý¨ä¥LÀù¯g¤]¥[³t¶i¦æ,¦P¾÷Âà¨ä¥LÀù¯g¥iª½±µ¶i¤J¤T´Á¶Ü?³o¬O«Ü¦h¤H·Qª¾¹Dªº,ªÑªF·|·í¤Ñ¥i¯à·|°Ý³o°ÝÃD |
|
|
·|û¡G¥¤ß¦Ó½×10139639 µoªí®É¶¡:2016/6/10 ¤U¤È 03:50:54²Ä 4113 ½g¦^À³
|
¥¤ß¦Ó½×¡A822·|¬O¥xÆW¤§¥ú¡A ¥i±¤³Q¾`Åé¾ß±¼§Q©e·d¯ä¤F¡A ÃÒ©ú¤½¥q²M¥Õ¨S¦³§¾¥Î¡A ¥u¦³¥~¸ê¤~ª¾¹D³{§C¶i³õ¡A ¤j¦h¼Æ´²¤á¦´N³Qª±¦º¤F¡A ¤×¨ä³sÄò¶^°±¨â¤Ñ¡A «e¤Ñ¬O³Ì«á²M²z¾Ô³õ¡A ¤U©P¶}©l±Nª½±µ§ð755, ¦]¬°°ê»Ú±ÂÅv¦³¥i¯à¤ë©³ªÑªF·|´N·|«Å§G «e¨â¤Ñ¥¿¦n¨ÓÓ¤j´«¤â 822¥un¯à¦³50wªº¤H¥Î¡A´N¤£±o¤F ¦óªp¹ï10´XºØÀù¯g¤]¦³®Ä ¾÷Âà½T»{¡A´N¬O¬°¤F¤T´Á¶¶§Q¶i®i ¤T´Á·|«Ü²³æ¡A¦]¬°´ú§ÜÅé´N¦æ ¤½¥q¥un¨q§ÜÅé¶q»PÀø®Äªº¦±½u ¦ÛµM´N·|©ñ§¬¶¨ì¤d¨½¸ô¤F |
|
|
·|û¡GPT10139061 µoªí®É¶¡:2016/6/9 ¤U¤È 04:08:07²Ä 4112 ½g¦^À³
|
¨â¦ì¤£¥h¦E²î¦b³oª¦ª©ªº¤j¤j,¥i¬O³o½g? ²Ä¤Q¤HÆ[ÂI www.berich.com.tw/dp/TalkTalk/Talk_Detail.asp?ii=155282&CNpg=1 ·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/6/5 ¤U¤È 09:31:06²Ä 1073 ½g¦^À³ 2. ²Ä¤G«GÂI: IgG¥H160¬°¬É ¦³§K¬Ì¤ÏÀ³²Õ(50%)¹ïµL§K¬Ì¤ÏÀ³²Õ»P¹ï·Ó²Õ ¦bpfs ¬Ò¦³ÅãµÛ®t²§,os¥¼¦¨¼ô ¦¹½×ÂI¤ä«ùADCC§K¬Ì¾÷¨î ¡C¤§«e¶È¨£¦Ñ¹«¹êÅç »P¤@´Á¹êÅç ¦³¦¹³¡¤À²{¶H ¬ù11%¤ñ²v ¥B¦³§K¬Ì²Õ4¦~¦s¬¡²v78% »P¤@´Á¥|¦~¦s¬¡µ²ªG¬Û¦P ®Ú¾Ú¤@´Áµ²ªG ¥i¹w¦ôMos 9.13¦~ 7.¯}¸Ñª¼ÂI2 µL§K¬Ì¤ÏÀ³¡AIgG<160²Õ¤ñ¹ï·Ó²Õ¦bPFS®t ¹FÅãµÛ¡A¦bOS¥Ø«e¤]¤ñ¸û®t¡A³Q°ê®õ¼g¦¨822¹ï§C(µL)§K¬Ì²Õ¨ü¸ÕªÌ¦³®`¡A©úÅã»~¾É¡Cº¥ý¤£¯à±Æ°£®û¼í¤ÏÀ³¹ï§C(µL)§K¬Ì²Õ°§CPFSªº¼vÅT¡A®û¼í¤ÏÀ³·|¾ÉP°²©ÊPD¡A´£¦PFS¡A¹ê»Ú¤W³o¬O¦nÂà¤ÏÀ³¡C²Ä¤G¡AOS¥¼¹F¦¨¼ô¡A¥»§K¬ÌÀøªk¬O¬Ý«¤¦~«á¯u¥¿ªºOS¡A¥Ø«e¤£¯à¤UOS¤£¨Îµ²½× ²Ä¤T¡A¹êÅç²Õ¤º°ª§C§K¬Ì¤ÏÀ³²Õªº¶Pº¸»XªvÀø¤ñ¨Ò¡A¥¼¯à½Tª¾¡A¤]¥¼¯à½T»{¬O§_²Îp¤W±Æ°£¦¹¼vÅT(µø¬°¦@Åܼƨӱư£)¡A§C§K¬Ì¤ÏÀ³²Õ¥i¯à¨ü¦¹¼vÅT ²Ä¥| Cycloposphamide ¥i¯à³y¦¨§C§K¬Ì¤ÏÀ³²Õ¦³¤zÂZ°Æ§@¥Î ¹ï°ª§K¬Ì²Õ¤£·| |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/6/9 ¤U¤È 03:54:27²Ä 4111 ½g¦^À³
|
¥xÁÞ¤j ©Î³\¬O§Ú°O¿ùPO¤å¤é´Á ¨º¤£«n §Ú·í®Éªº°²³] ¬O¥H±z¤§«ePO¥X¤@´ÁªºOS¬ã¨sµ²ªG ¨Ó°²³]¤G´Á¤]¬O¦p¦¹½u©Ê¹w´ú ¬O¤ñ60¤ëªø ¶È¨Ñ°Ñ¦Ò |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/6/9 ¤U¤È 03:14:59²Ä 4110 ½g¦^À³
|
¯E§J¤j 6/5·í¤Ñ ¥ß§YPO¤å¦³MOSªº¹w´ú ¤S¬O¤£¦P©ó³oӼƦr ¨º¬O°ò©ó¤£¦Pªº°²³] ½Ð°Ñ¦Ò ½Ð°Ý¦b¨º¤@ª©? §Ú·Q¾\Ū |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/6/9 ¤U¤È 02:28:00²Ä 4109 ½g¦^À³
|
±ø¤j ¤Ñ©R¤j ³£¬O¹w´ú°ª¤â ³£¬O§ì¨ìP17 °ª§K¬Ì²ÕMOS ±µªñªº¼Æ¦r §Ú¤]¹w´ú¨ì¦¹¼Æ¦r ¦ý¬O ½Ð·Q·Q ±z¨â¦ì³o¼Ë¹w´úªº°²³]¬O»ò? ¦¹°²³]¬O§_¥i¯à¸ò¹ê»Ú¥´822ªºÀø®Äª¬ªp¦³½Ä¬ð?Y¬O MOS¬O³Q§C¦ô©Î°ª¦ô¶Ü? ¤p§Ì¦b6/5·í¤Ñ ¥ß§YPO¤å¦³MOSªº¹w´ú ¤S¬O¤£¦P©ó³oӼƦr ¨º¬O°ò©ó¤£¦Pªº°²³] ½Ð°Ñ¦Ò ¥t¥~¼B¤ÀªR®vªº¤å ¥i¥H½Ð¤½¥q¥h´£§i¤F |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/6/9 ¤U¤È 01:52:33²Ä 4108 ½g¦^À³
|
¶°¨¹¬ì§Þ¥Í§Þ²£·~¤ÀªR®v¼B¾A¹ç«ü¥X¡G ¡y¥»¦¸¸ÕÅ窺´Á¤¤°h¥X²v¡]drop-out rate¡^°ª¹F 52%¡A´«¨¥¤§¡A¦³ 180 ¦W¨ü´úªÌ¨Ã¥¼§¹¦¨¥»¦¸¸ÕÅ窺Àøµ{¡C¦¹¥~¡A³o¨Ç°h¥Xªº¨ü´úªÌ¼Æ¾Ú¤´µM¯Ç¶i¥»¦¸Á{§É¸ÕÅ禨ªG¤ÀªR¤§¤¤¡A§Y«K¬O¿í·Ó·N¦V¤ÀªRì«h¦Ó¯Ç¤J¡A¤´¤£§K¦³©ÒºÃ¼{¡C¡z ¥¼§¹¦¨Àøµ{´Nºâdrop-out¡Hµ´¤j¦h¼Æ¨S¦³¥´§¹¤E°wªº¨ü¸ÕªÌ (µL½×¬O¹êÅç²Õ©Î¬O¹ï·Ó²Õ) À³¸Ó³£¬O PD ¤F§a¡A«ç»ò¯àºâ¬O°h¥X¹êÅç©O¡H ¬JµM¦ÛºÙ¬O¥Í§Þ²£·~¤ÀªR®v¡A¨º»ò¹ï¹êÅç³]pªº°ò¦¸ê®ÆÀ³¸Ó¥ýªáÂI®É¶¡¬Ý¤@¤U¡C´N³o»ò§ì¨ì¼Æ¦r´N¼g¤å³¹¡AÁÙ¦n¹³§ì¨ì¤F¦h¤jªº¤pÄ|¤l¡Cü¡I ¯E¹©ªº¼Æ¾Ú»P§e²{¤è¦¡¤£¬O¨S¦³¥i¥H¬D窺¦a¤è¡A¦ý¬O³o¼Ëªº¤å³¹¦n¹³¨S¦³¦^À³ªº¥²n¡C |
|
|
·|û¡G«êô10142131 µoªí®É¶¡:2016/6/7 ¤U¤È 04:42:59²Ä 4107 ½g¦^À³
|
ª¼¦£¯í¡A¯E¹© OBI-822 Àù¯g¬Ì]©|¦sºÃ¼{«Ý¸Ñ technews.tw/2016/06/07/obipharma-obi-822-doubt/ ½Ð±Ð¦U¦ì¥ý¶i¤j¤j̪º¬Ýªk¡H |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/6/7 ¤U¤È 04:37:49²Ä 4106 ½g¦^À³
|
©ú¥Õ¤F¡AÁÂÁÂÅó¤j¡I |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/6/7 ¤U¤È 04:18:17²Ä 4105 ½g¦^À³
|
Lu¤j¡A À³¸Ó¤£¬O¬Ý¦º¤`²v ¬O¬Ý¦º¤`ªÌ¦b²Ä´XÓ¤ë¥÷µo¥Í ¦pªG³£¶°¤¤¦b¤ñ¸û¦ªº¤ë¥÷¡A¸ò±ßªº¤ë¥÷¡A¹ïPÈ´N¦³®t |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/6/7 ¤U¤È 04:01:11²Ä 4104 ½g¦^À³
|
Åó¤j¡G §Ú¤£©ú¥Õªº¬O¡A³o¤T²Õ¤¤¡G ¡u°ª§ÜÅé¡vªº¦º¤`²v³Ì§C¡A¡u¹ï·Ó²Õ¡vªº¦º¤`²v³Ì°ª¡A¨âªÌ®t²§³Ì¤j¡A©Ò¥H¡A¨âªÌ¬Û¤ñ¡APÈÀ³¸Ó³Ì§C¤~¹ï¡H¡I ¦ý¥L̪º¼Æ¾Ú¡A¤£¬O³o¼Ë¡I |
|
|
·|û¡G¹Ç§AÅó±ø±ø10135894 µoªí®É¶¡:2016/6/7 ¤U¤È 03:43:30²Ä 4103 ½g¦^À³
|
Lu¤j¡A P17 PÈÀ³¸Ó¨S¦³¿ù¡A±z¬ÝP16 PȤ]¬O²Ä¤@¶µ°ª©ó²Ä¤T¶µ¡A P17 °ª§ÜÅé¸ò¹ï·Ó²Õ½uÂ÷¤ñ¸ûªñ¡A°ª§ÜÅé¸ò§C§ÜÅé½uÂ÷¤ñ¸û»· |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/6/7 ¤U¤È 03:32:30²Ä 4102 ½g¦^À³
|
ASCO¼Æ¾Ú¡A²Ä17¶¡A´Á¤¤OS¡APȬO§_¼g¿ù¤F¡I¡H °ª§ÜÅé¤ÏÀ³ªÌ(IgG>1¡G160) ¦¹²Õ¦³112¤H¡A¦º¤`21¤H §C§ÜÅé¤ÏÀ³ªÌ(IgG<1¡G160) ¦¹²Õ¦³112¤H¡A¦º¤`29¤H ¹ï·Ó²Õ ¦¹²Õ¦³124¤H¡A¦º¤`35¤H 1¡B°ª§ÜÅé¤ÏÀ³ªÌ(IgG>1¡G160) ©M ¹ï·Ó²Õ ¤ñ¡AP¡×0.0399 2¡B§C§ÜÅé¤ÏÀ³ªÌ(IgG<1¡G160) ©M ¹ï·Ó²Õ ¤ñ¡AP¡×0.6837 3¡B°ª§ÜÅé¤ÏÀ³ªÌ(IgG>1¡G160) ©M §C§ÜÅé¤ÏÀ³ªÌ(IgG<1¡G160) ¤ñ¡AP¡×0.0207 ¡u²Ä1¶µ¡v©M¡u²Ä3¶µ¡vªºPÈ¡A¬O§_¼g¤Ï¤F¡C §Y¡G¡u°ª§ÜÅé¤ÏÀ³ªÌ(IgG>1¡G160) ©M ¹ï·Ó²Õ ¤ñªºPÈ¡v¡AÀ³¸Ó¤ñ¡u°ª§ÜÅé¤ÏÀ³ªÌ(IgG>1¡G160) ©M §C§ÜÅé¤ÏÀ³ªÌ(IgG<1¡G160) ¤ñªºPÈ¡v n§C¤~¹ï¡A©Ò¥H¡GP¡×0.0399©MP¡×0.0207¬O§_¼g¤Ï¤F¡An¹ï½Õ¤~¹ï¡I¡H §Y¡A¤U±³o¼Ë¤~¹ï¡G 1¡B°ª§ÜÅé¤ÏÀ³ªÌ(IgG>1¡G160) ©M ¹ï·Ó²Õ ¤ñ¡AP¡×0.0207 2¡B§C§ÜÅé¤ÏÀ³ªÌ(IgG<1¡G160) ©M ¹ï·Ó²Õ ¤ñ¡AP¡×0.6837 3¡B°ª§ÜÅé¤ÏÀ³ªÌ(IgG>1¡G160) ©M §C§ÜÅé¤ÏÀ³ªÌ(IgG<1¡G160) ¤ñ¡AP¡×0.0399 ¤£ª¾¹D¦U¦ì¤j¤jªº¬Ýªk¦p¦ó¡H |
|
|
·|û¡G¤p·s10141589 µoªí®É¶¡:2016/6/7 ¤U¤È 03:31:37²Ä 4101 ½g¦^À³
|
slide ²Ä17¶OS¤ÀªR,§C§ÜÅé¹êÅç²Õ¦b²Ä25Ó¤ëOS¤w¶}©lĹ¹L¹ï·Ó²Õ,¥Nªí¦p¥xÁÞ¤j©Ò¨¥¥un¦Aµ¥¤@¬q®É¶¡(¤]³\¦~©³)¾ãÅ骺OS ²Ä13¶¦³¥i¯àÅܦ¨P¤p©ó0.05 ,°¨¤W¥i¥Ó½ÐFDAÃÄÃÒ,¨º®É´N¨S¦³¥ý¥´´X°w¶q§ÜÅé¤j©ó160 µ¥ª§Ä³¤F,¾A¥Î¹ï¶H±N¤j´TÂX¤j,¥un¥´°w´N¬O¤F,¦]¦³OS «OÃÒ ¦³»~½Ð«ü¥¿ ÁÂÁ |
|
|
|